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1 
CHAPTER 1 
NEW INLET AND VACUUM IONIZATION METHODS                                                
FOR MASS SPECTROMETRY 
 
1.1 Introduction 
Mass spectrometry (MS) is an important analytical tool because of its wide 
applicability, dynamic range, sensitivity, specificity, speed of analysis, and the ability to 
simultaneously observe many constituents in a mixture. Its advancement in analyzing 
nonvolatile and large biological molecules has made a huge impact in the area of 
biological research. Key to this advancement is the development of two commonly used 
ionization methods in MS: electrospray ionization (ESI) [1] and matrix-assisted 
laser/desorption ionization (MALDI) [2,3] to ionize nonvolatile and high-mass 
compounds such as peptides and proteins.  ESI, with the production of multiply charged 
ions from solution at atmospheric pressure (AP), has gained much attention because of 
the simplicity to interfaced with chromatographic and electrophoretic liquid-phase 
separation techniques.[4]  In addition, the formation of higher charge states can extend 
the mass range of high resolution mass range limited mass spectrometers and provide the 
advantage of better fragmentation for structural characterization and identification. On 
the other hand, MALDI with time-of-flight (TOF) mass analyzers [3,5] rapidly gained its 
popularity for analyzing large biomolecules. The production of predominantly singly 
charged ions makes data interpretation simpler.  MALDI-TOF-MS, due to its high 
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sensitivity and analysis directly from the surface, is the chosen analytical tool for 
molecular tissue imaging [6,7], important for biomedical applications [8]. 
A long term interest of our research group is the analysis of solubility restricted 
materials, especially directly from surfaces.  ESI is limited to samples that can be 
solubilized. It is in this area where ESI-MS has challenges when dealing with poorly 
soluble and insoluble compounds such as membrane proteins. Although MALDI can 
analyze directly from the surface, structural characterization is challenging because of 
poor fragmentation using singly charged ions. The limitation of ESI to analyze directly 
from the surface and the difficulty of MALDI to provide better fragmentation are reasons 
to develop ionization techniques that have the benefits of ESI and MALDI. Ionization 
developments described in this dissertation demonstrate the ability to detect and 
characterize compounds directly from a surface such as tissue, and use gas phase ion 
mobility separation to reduce complexity and improve the dynamic range of the 
experiment. 
1.2 Motivation 
Cellular membranes are important in the area of biological research to understand 
diseases associated with it. The available analytical tools have limitations in analyzing 
these compounds because of their complexity and limited solubility. Membrane proteins 
are an example of solubility restricted compounds in the cellular membrane for which the 
current understanding in relation to disease is limited because of the inability of current 
analytical technologies to unravel the chemical make-up of this complex system.[9,10]  
Approximately 70% of drugs are said to target membrane proteins and 20 to 30% of the 
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human genome encodes membrane proteins but less than 1% of the proteins of known 
structure are membrane proteins.[9,11,12]  Diseases related to the membrane architecture 
are Alzheimer’s disease (AD), Huntington’s diseases, Parkinson’s disease, and 
misfolding/aggregation (e.g. prion disease).[13-18] 
Advances needed to better analyze membrane proteins include improved sample 
preparation to solubilize intact proteins, instrumentation to allow characterization and 
identification especially of protein isoforms, and better liquid chromatographic (LC) 
performance involving bottom up and top-down proteomics.[9,19] MS has been a 
powerful analytical approach in developing comprehensive analysis of membrane 
proteins.  ESI and MALDI are the most used MS techniques in determining the molecular 
weights of intact proteins followed by enzyme digestion, separation, and tandem MS/MS 
for characterizing and identifying the proteins.[20] However, the approach of bottom up 
or shotgun proteomics which involves the use of high performance LC combined with 
MS requires solubilization of these compounds. In addition, analyzing membrane 
proteins directly from their native environment requires new analytical technologies 
especially when dealing with complex systems such as tissue which is important for 
pharmacology and disease treatments.  Efficient ionization of these compounds still 
remains an issue due to their limited solubility. 
AP-MALDI has been demonstrated [21] and offers advantages over vacuum 
MALDI, including speed of analysis and compatibility with instruments built for 
atmospheric pressure ionization (API) [22]; however, vacuum MALDI offers better 
sensitivity and the analysis of large biomolecules [23] than AP-MALDI.  AP-MALDI is 
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limited in mass range because of the mass-to-charge (m/z) limitations of API instruments 
and the production of predominately singly charged ions. Thus, methods that have 
attributes of AP-MALDI, but provide improved sensitivity and/or multiply charged ions 
are needed.  Sheehan and Willoughby modeled AP ionization and reported that if a high 
electric field is present in the AP region, >90% of the ions are lost to the walls (rim 
losses) entering the AP to vacuum orifice.[24]  Willis and Grosu demonstrated a laser 
ablation experiment using the backside approach where the laser beam passes through the 
glass sample holder causing an explosive expansion of the material irradiated.[25] The 
feasibility of a backside (transmission geometry, TG) approach in AP-MALDI for laser 
ablation using a glass plate as a sample holder positioned close (1-3 mm) to the mass 
spectrometer ion entrance was also previously demonstrated.[26] Combining these 
configuration with field-free (FF) conditions was anticipated to ensure high transmission 
of ions into the mass analyzer. An ionization source was configured for AP-FF-TG 
MALDI.[27,28] The sample holder was a glass plate and the laser illuminates from the 
backside so the sample holder can be placed close (1-3 mm) in front of the MS orifice. 
This back-side laser ablation approach desorbs/ionizes similar to the front side (reflectron 
geometry, RG) approach. The laser ablates the matrix/analyte crystals from the surface 
and the expanding matrix plume brings them sufficiently close to the MS ion entrance 
inlet so that they become flow entrapped in the air entering the inlet to the vacuum of the 
mass spectrometer. With this transmission geometry (TG) approach, the spatial 
resolution is improved because shorter laser focal lengths can be used to provide a 
smaller laser spot at the point of ablation.  Imaging can be achieved by moving the 
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sample through the laser beam focused on the sample and aligned with the MS inlet. 
Most important, however, was the discovery that multiply charged ions, similar to what is 
observed with ESI, were produced using laser ablation of a MALDI matrix.  Initially, the 
methods was deemed to be a MALDI method,[27,28] but later was termed laser spray 
ionization (LSI) [29].  This initial discovery is the starting point of the research presented 
here in which a number of ionization methods were uncovered.  For some, ionization 
occurs in a heated inlet and for others in vacuum.   
1.3 LSI Inlet and Vacuum Ionizations  
The newly discovered ionization methods are summarized in Scheme 1.1. LSII, 
the first inlet ionization method produces multiply charged ions similar to ESI at AP 
(Scheme 1.1.IA) but directly from the solid state similar to MALDI.[30] Ionization 
occurs in a heated inlet tube between AP and vacuum. Since LSII has similar attributes to 
MALDI, which uses a matrix to produce ions, initial understanding on the ion formation 
for LSII is that the laser results in a free jet expansion of the matrix producing highly 
charged matrix/analyte clusters that become desolvated in the heated inlet capillary of a 
mass spectrometer (Scheme 1.1.IA).  
To understand the fundamental aspects of LSII, the ablated material was collected 
on a glass plate before it enters the ion entrance of the mass spectrometer and analyzed 
using microscopy. Microscope image of this ablated material shows particles and 
formation of liquid droplets [31] similar to what has been experimentally observed in 
vacuum MALDI [32-34] and theoretically shown through dynamic molecular modeling 
studies [35-38]. In addition, a temperature study on the heated inlet transfer capillary 
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shows that ion abundance of the multiply charged ions increased significantly as the 
transfer capillary is heated from 100 to ~350 C.[29] Contrary to MALDI, a laser is not 
required as identical mass spectra were obtained by physical means (e.g. tapping) of 
transferring the matrix/analyte crystals into the heated transfer capillary of the mass 
spectrometer. This approach is called matrix assisted ionization inlet (MAII) (Scheme 
1.1.IB).[39]  
 
Scheme 1.1. (I) Inlet ionizations: (A) LSII and (B) MAII, and (II) Vacuum ionizations: 
(A) LSIV and (B) MAIV. 
 
In addition, a study of over 200 small molecule matrices showed that aromaticity and 
functionality similar to that of common UV-MALDI matrices (e.g., 2,5-
dihydroxyacetophenone, 2,5-DHAP and 2,5-dihydroxybenzoic acid, 2,5-DHB) (Scheme 
1.2) is not a requirement to produce multiply charged ions since matrixes that are linear, 
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or aromatic compounds with no other functionality, produces multiply charged ions so as 
long as it is heated at ~450 C.[40] A number of these matrixes worked at temperatures 
as low as 50 C. Because LSII and MAII produce ions within a heated tube linking AP to 
the first vacuum region of the mass spectrometer and the ionization occurs within the 
heated inlet tube, these methods have been termed ‘inlet ionizations’.  
 
Scheme 1.2. Structures of LSII (A,B,C), LSIV (B,C) and MAIV (D) matrixes. 
A number of these matrixes that have lower thermal requirement were tested on a 
SYNAPT G2 vacuum MALDI source that operates at intermediate pressure (IP) and the 
source uses RG laser alignment. The TG approach in LSII is not a limitation in the 
production of multiply charged ions because RG had previously been demonstrated using 
an AP-MALDI source for LSII.[41] With the vacuum MALDI source, the only source of 
thermal energy is the laser ablation event.  The pressure drop for LSII still applies to this 
setup because the source operates from IP to vacuum. Two matrixes, 2,5-DHAP and 2-
nitrophloroglucinol (2-NPG) (Scheme 1.2) were shown to produce multiply charged ions 
NO2
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in the IP-MALDI vacuum source with the use of a laser, similar to what has been 
obtained using LSII.  This approach was thus called laserspray ionization vacuum (LSIV) 
(Scheme 1.1.IIA).[42,43]  2-NPG also produces stable multiply charged ions in high 
vacuum MALDI-TOF instruments.[44,45] Among the few matrixes that produced 
multiply charged ions at 50 C, 3-nitrobenzonitrile (3-NBN) (Scheme 1.2) astonishingly 
produces multiply charged ions just by exposing the matrix/analyte crystals to the 
vacuum of the IP-MALDI source of the mass spectrometer without initiating the laser. 
This method is called matrix assisted ionization vacuum (MAIV) (Scheme 1.1.IIB) 
[46,47] in analogy to MAII.  The classification defines the main driving force for the 
formation of the analyte ions by using a heated inlet (Scheme 1.1.I) or by the vacuum 
(Scheme 1.1.II) of the mass spectrometer. 
This dissertation presents the results, application, and insights to the fundamental 
aspects of the three new ionization methods developed during the course of the work 
described here: LSII, LSIV, and MAIV in ten published papers.  Chapter 2 describes 
general experimental procedures including the materials, sample preparation, set-up, 
acquisition conditions, and instrumentation involved.  Experimental methods relevant to 
each chapter are included in the chapter.  Chapters 3-7 shows the results obtained for 
LSII on three different mass spectrometers: Thermo Scientific Orbitrap Exactive 
[28,29,48] and LTQ Velos [48], and Waters SYNAPT G2 [49,50] documented in five 
published papers. Chapter 3 reports the first FF-TG-AP-MALDI experiments using a 
2,5-DHB, a matrix common to MALDI, to produce multiply charged ions. Singly or 
multiply charged ions can be selectively produced by changing the matrix or sample 
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preparation conditions for 2,5-DHB. Using 2,5-DHB matrix, multiply charged ions are 
produced from angiotensin I using solvent-based sample preparation while singly charged 
ions are formed using solvent-free sample preparation. ESI-like mass spectra are 
observed by applying as low as attomole amounts of the analyte with the matrix on the 
target plate. The production of multiply charged ions similar to ESI extends the mass 
range of high resolution mass spectrometers that have limited mass-to-charge (m/z) ratio 
(4000).  
Chapter 4 discusses briefly the fundamental aspects and the conditions for LSII 
in producing ESI-like ions in MALDI-like sample preparation. ESI produces multiply 
charged ions by a mechanism involving highly charged solvent/analyte droplets.[1,51-53] 
In MALDI, the dominant production of singly charged ions was postulated to occur from 
multiply charged matrix:analyte clusters by the “lucky survivor” model [54] and latter 
modified to formation of singly charged ions from clusters [55]. Multiply charged cluster 
formation has been proposed in MALDI by a mechanism similar to ESI.[54,56,57] For 
LSII, the formation of liquid droplets and clusters of the laser ablated material was shown 
from the microscopy studies [31] at AP. These observations are similar to the droplets or 
cluster formation by MALDI and has been experimentally observed [32-34] and 
theoretically demonstrated thru molecular modeling studies [35-37]. For LSII, these 
liquid droplets and clusters are believed to be highly charged and with appropriate 
desolvation condition as shown from the temperature study of the heated transfer 
capillary produces abundant multiply charged ions. In vacuum MALDI, it is proposed 
that charged droplets/clusters are produced by laser ablation, but for LSII after the 
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discovery of MAII, it is shown that removing charged droplets/particle/ions with high 
voltage before they enter the inlet does not significantly alter the ion abundance in LSII.  
The tapping method to demonstrate MAII clearly shows that the charges are produced in 
the inlet for LSII. With the production of ESI-like mass spectra by LSII, the first protein 
fragmentation is reported from a MALDI-like sample preparation using electron transfer 
dissociation (ETD) [58]. Fundamental aspects in producing multiply charged ions by 
LSII includes the field-free and proper desolvation conditions using a heated transfer 
capillary in the presence of a pressure drop region from AP to vacuum. 
MS methods are limited to the separation of ions measured and displayed by m/z 
ratios and ion intensities thus it becomes a challenge to analyze complex systems such as 
tissue by MS due to its complexity including solubility, volatility, hydrophobicity, 
isobaric, and isomeric compositions. Current technologies employ liquid based separation 
approaches coupled to MS, but perform poorly with solubility restricted materials 
[10,30]. Ion mobility spectrometry (IMS) MS has been noted for the ability to separate 
ions in the gas-phase according to the number of charges and cross-section defined by 
size and shape.[59-67] IMS-MS has many advantages compared with even high-
resolution mass spectrometers because of its ability to extend the dynamic range and 
separate isomeric composition.[64-67]  
With the ability of LSII to produce multiply charged ions, Chapter 5 presents the 
results of LSII coupled to a Waters SYNAPT G2 mass spectrometer with IMS-MS 
capability. The Waters SYNAPT G2 has a source that can only be heated up to 150 C. 
Fabrication of a desolvation device mounted on the z-spray ESI skimmer cone of the 
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SYNAPT G2 mass spectrometer provides the external heat needed to desolvate 
efficiently the 2,5-DHB matrix from the highly charged matrix/analyte clusters to 
produce the multiply charged molecular ions.[29]  The total ion current displays almost 
no ion abundance when the external heat supply is off. With the IMS dimension, one can 
readily observed the separation of the components in the mixture from the pictorial 
snapshot [66] as displayed from the 2-dimensional plot of drift time vs. m/z. The 2-D plot 
display allows the extraction of drift time and/or m/z which is very useful for the 
separation of components in a complex mixture. In the absence of a heated inlet, another 
approach to efficiently desolvate the highly charged matrix/analyte clusters is to lower 
the thermal requirement of the matrix for the desolvation process.  
Chapter 6 reports the use of 2,5-DHAP matrix that allows the operation of 
Waters SYNAPT G2 mass spectrometer at 150 °C without applying external heat to the 
fabricated desolvation device. The multiply charged ions produced from an isomeric 
mixture are well separated in the drift time dimension. Distinguishig isomers by MS 
alone is currently not possible. The extracted drift time information using LSII shows 
baseline separation of the isomeric mixture. The LSII drift times obtained from a surface 
are identical to the extracted drift times using solution ESI suggesting similar softness. 
Conditions that lower the thermal requirement in the formation of multiply charged ions 
by LSII are very important in retaining the structure of proteins during ionization and 
when coupled with IMS, provide the benefits of efficient separation and characterization 
of protein mixture including isomers as well as cross section analysis from surfaces 
which is important for biomedical application involving tissue samples.  
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Chapter 7 reports for the first time the detection of intact peptides and proteins of 
up to ~20 kDa by LSII directly from mouse brain tissue mounted on a microscopy glass 
plate and spotted with 2,5-DHAP matrix. The multiple charging of LSII allows the 
analysis of proteins from the mouse brain tissue on a high performance mass 
spectrometer that has limited m/z. The use of a high resolution mass spectrometer 
provides the mass accuracy which is useful in identifying the protein from the measured 
molecular weight. With sufficient ion abundance of the multiply charged ions from the 
tissue, ETD fragmentation is demonstrated for the first time directly from the tissue 
providing sequence coverage and identification of an endogenous peptide when 
combined with the high mass resolution and mass accuracy data obtained from the same 
tissue samples. With the TG approach for LSII, improved spatial resolution for tissue 
imaging can be attained.  As shown in this study , ~15 µm diameter laser ablated areas on 
the tissue are seen thru microscopy images. In addition, the AP condition allows the 
analysis of tissue at ambient conditions and speed of analysis beneficial for tissue 
imaging.   
Chapter 8 reports the first example of the production of highly charged ions in 
vacuum similar to LSII, thus termed LSIV using the commercial IP-MALDI vacuum 
source of the SYNAPT G2.  In the absence of a heated inlet, important factors 
influencing the production of multiply charged peptide/proteins ions in a vacuum 
MALDI source at IP are the use of a suitable matrix and the appropriate settings and 
acquisition conditions (e.g. laser power, voltages) for ion acceleration and transmission. 
With IMS dimension, singly charged lipid ions are well separated from multiply charged 
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peptide/protein ions detected from mouse brain tissue.  The extracted drift times of the 
identified endogenous peptide directly from the mouse brain tissue are identical to the 
synthesized standard using LSII and ESI confirming the presence of the endogenous 
peptide in the tissue.  
In a search for more matrixes that have low thermal requirements for desolvation 
in the absence of a heated inlet, Chapter 9 introduces another matrix, 2-NPG, that 
produces higher charge states than 2,5-DHAP in vacuum. Spotting 2-NPG on a delipified 
mouse brain tissue allows the detection of higher mass compound in the tissue than 2,5-
DHAP using LSIV. The use of 2-NPG for tissue imaging by LSIV, which was not 
possible for 2,5-DHAP, shows the first example of images of multiply charged ions from 
delipified mouse brain tissue. 
Another matrix, 3-NBN, produces multiply charged ions with high ion abundance 
even at very low temperature using MAII. Chapters 10-12 reports for the first time the 
production of ions in vacuum without the use of a laser by using 3-NBN as the matrix on 
the IP-MALDI vacuum source of a SYNAPT G2 mass spectrometer.  Chapter 10 
introduces this new ionization as MAIV and shows the ability to ionize a variety of 
samples from small molecule, lipids, peptides, to proteins up to ~66 kDa by simply 
exposing the matrix/analyte crystals to the vacuum of the mass spectrometer without the 
use of the laser. MAIV ionizes both in positive and negative mode measurements. Low 
femtomole concentration can be analyzed without optimization for small proteins. This 
new ionization in vacuum without the use of a laser is softer than MALDI for the analysis 
of fragile molecules, post translational modification, and molecular complexes. The 
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sublimation process makes it possible for MAIV to improve the spatial resolution in 
analyzing tissue samples since matrix deposition on the tissue can be miniaturized.  
Chapter 11 presents a brief mechanistic aspect on the ion formation by MAIV. 
The conversion of the matrix/analyte crystals into gas-phase ions without the use of laser 
suggests that the ion formation is via a sublimation process in which 3-NBN has the 
property to sublime.[68]  In addition, 3-NBN is a triboluminescence compound [69,70] 
that produces a strong dinitrogen discharge emission as a result of the high electric field 
created during crystal fracturing leaving the opposing surfaces having opposite charges. 
This phenomenon also explains the ability of 3-NBN to ionize molecules both in positive 
and negative ion mode detection. Thus, the formation of ions by MAIV in vacuum using 
3-NBN is hypothesized to be a sublimation driven triboluminescence process. Different 
surfaces can be used for MAIV including filter paper, foil, thin layer chromatography 
plates, and paper currency. Basic small molecules are ionized with less or no chemical 
background which is an advantage in comparison to MALDI for small molecule analysis. 
Sensitivity of basic small molecule is achieved at very low femtomol and with MS/MS 
high attomole concentrations in the positive ion mode. Analysis of mixture of lipid, 
peptides, and proteins by MAIV ionizes efficiently all the components in the mixture and 
with the IMS dimension are well separated and the charge state distribution are readily 
observed from the pictorial snapshot. Because ions are formed by using a suitable matrix, 
e.g. 3-NBN, and by exposing the matrix/analyte crystals to the vacuum of the mass 
spectrometer, MAIV extends its utility using a custom modified ESI source.[46,47,71]  
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Chapter 12 reports the utility of MAIV for real time applications in combination 
with IMS for ionization, separation, and characterization of small molecule such as drugs 
to lipids, peptides, and proteins. Mixtures of small molecules are ionized instantaneously 
by MAIV and separated by IMS. Characterization by MS/MS without precursor ion 
selection makes the method rapid for clinical applications. MAIV is very specific in 
ionizing small molecules such as drugs as shown from the results obtained from drug 
treated mouse brain tissue, and drugs with their metabolites from biological fluids such as 
urine. MAIV ionizes efficiently both in positive and negative mode measurements, and 
with IMS dimension, comparison of extracted drift times can be compared between 
positive and negative mode, and with ESI. Identical drift times are observed between 
MAIV from the surface and ESI from solution. The production of higher charge states is 
advantageous to improve fragmentation by CID. With IMS dimension, multiply charged 
ions formed from isomeric mixture are baseline separated and with IMS, characterized by 
MS/MS in the transfer region. The sublimation process in the ionization allows 
miniaturization of matrix deposition on the tissue and detection of the higher mass 
compounds from mouse brain tissue in vacuum compared to LSIV. MAIV stands out 
among the three ionization methods, but currently has its limitation for tissue imaging.  
Both LSII and LSIV have the potential for tissue imaging and with LSII improving the 
spatial resolution. The quest in searching for an ionization method to efficiently ionized 
solubility restricted materials directly from the surface leads to a discovery that 
encompasses both the benefits and advantages of the traditional ionization methods in 
mass spectrometry. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
2.1 Materials and Sample Preparation 
Salts, sugars, lipids, peptides, and proteins were purchased from Sigma Aldrich 
(St. Louis, MO) unless otherwise noted. Amyloid peptides were purchased from 
American Peptide Co. (Sunnyvale, CA), other lipids from Cayman Chemicals (Ann 
Arbor, MI), synthesized N-acetylated myelin basic protein fragment (MBP) from 
Anaspec (Fremont, CA), modified peptides from Protea Biosciences (Morgantown, WV),  
clozapine from Santa Cruz Biotechnology (Santa Cruz, CA), and commonly used illicit 
drugs from Cerilliant (Round Rock, TX). Waters Co. (Milford, MA) provided leucine 
encephalin, [Glu1]-fibrinopeptide (GFP), and myoglobin. The matrixes were purchased 
from Sigma Adrich except for 2,5-DHAP which was obtained from Fisher Scientific Inc. 
(Pittsburg, PA). Solvents used were purchased from Fisher Scientific Inc. (HPLC grade 
water, acetonitrile (ACN), methanol (MeOH), ethanol, acetic acid, and trifluoroacetic 
acid (TFA)). Purified water was purchased from Millipore (Billerica, MA) acetic acid 
and ammonium hydroxide from Mallinckdrodt Chemicals (Phillipsburg, NJ), and HPLC 
grade water and methanol from EMD Chemicals (Gibbstown, NJ). Microscopy glass 
slides used was from Gold Seal (about 80% transmission) Products (Portsmouth, NH).  
Stock solutions of peptides and proteins were prepared as 1 mg mL
-1
 in water 
except for bovine insulin in 1:1 by volume methanol/water with 1% acetic acid. Lipids 
and drugs were prepared in either 100% ACN, methanol, or ethanol. Salts were dissolved 
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in water to make 1 M concentration. Peptides and proteins were diluted in 100% water or 
1:1 ACN/water with or without 0.1% acid. Lipids and drugs were diluted in 100% water 
or 1:1 methanol/water or ACN/water. Most of the matrixes were dissolved in 1:1 
ACN/water. For solvent-based matrix/analyte preparation, the dried droplet method [3] 
was used. Both the matrix and analyte were dissolved separately in a common solvent, 
mixed by vortexing, placed 1 μL of the matrix/analyte mixture on the microscope glass 
slide or target plate, and air dried or using a heat gun (low heat).  A layer method was 
also used by placing 1 μL of the analyte on the glass slide, added 2 μL of the matrix 
solution and mixing before allowing to air dry or blow dry using a heat gun. The method 
for solvent-free sample preparation is described elsewhere.[72,73] 
Mouse Brain Tissue - The mouse brain tissue sections were provided by Dr. Ken Mackie 
from Indiana University (Bloomington, IN). Twenty week old C57 Bl/6 mice were 
euthanized with CO2 gas and perfused transcardially with ice-cold 1X phosphate-buffered 
saline (150 mM NaCl, 100 mM NaH2PO4, pH 7.4) for 5 min to remove red blood cells. 
The brains were frozen at -22 °C and sliced into 10 µm sections in sequence using a 
Leica CM1850 cryostat (Leica Microsystems Inc., Bannockburn, IL). The tissue sections 
were placed onto a pre-chilled plain or matrix pre-coated microscopy glass slides that 
were briefly warmed with the finger from behind to allow sections to relax and attach. 
Care was taken to avoid water condensation by storing at -20 °C. The tissue-mounted 
glass slides were placed in an airtight box containing desiccant and transported under dry 
ice.  
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For drug treated mouse brain, the mouse received 50 mg kg
-1
 of clozapine by 
intraperitoneal introduction for 90 min before it was sacrificed.  For peptides and protein 
analysis, the mouse brain tissue sections mounted on the glass plate were washed to 
remove the lipids according to a published procedure.[74]  Before washing the tissue 
twice with ethanol, the glass slide with the mounted mouse brain tissue was dried in the 
desiccator.  In the first wash, the glass slide with the mounted tissue was immersed in a 
glass Petri dish filled with 70% ethanol, swirled for 30 s, and removed carefully. The 
glass slide was then tilted to remove the solvent for about 10 s and immediately washed 
with 95% ethanol in another Petri dish for an additional 30 s. After the second wash, the 
glass slide was allowed to dry in the desiccator for 20 min prior to analysis or stored at    
-20 °C until use or shipment under dry ice.  
2.2 Laserspray Ionization Inlet (LSII) 
Laserspray ionization inlet (LSII) operates at AP in FF-TG. The laser, a Spectra 
Physics, VSL-337ND-S nitrogen laser, is aligned at approximately 180 to the mass 
spectrometer inlet. The beam is focused using a focusing lens on to the matrix/analyte 
spot applied to a glass microscope at about 1-3 mm distance from the ion entrance 
(Scheme 1.1.IA). The laser fluence must be sufficient to ablate the matrix/analyte 
crystals from the surface. The fluence is substantially higher than that used with most 
MALDI experiments (typically on the order of 1-2 J cm
-2
). The higher laser fluence does 
not result in detrimental effects on the observed mass spectra, including resolution. The 
LSII set up was used on an Orbitrap Exactive and LTQ Velos from Thermo Scientific 
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(Scheme 2.1)  (Bremen, Germany) and SYNAPT G2 (Scheme 2.2) from Waters Co. 
(Manchester, UK). 
Orbitrap Exactive - The Ion Max source was removed to have open access of the inlet of 
the mass spectrometer by overriding the interlocks. External voltages were set to zero and 
there were no external gas flow. ESI tuning condition was used for capillary voltage 
(typically 20-140 V) and the tube lens voltage (typically 80-150 V). Necessary precaution 
was exercised so that no potential hazardous exposure to the laser beam or hot surfaces 
near the ion entrance orifice. The ion transfer capillary was heated up to ~400C. 
Resolution was set at 100,000 (m/z 200, full width at half height definition) and the 
maximum ion inject time was set at 500 ms.  Positive ion mass spectra were obtained for 
1 s giving 100,000 mass resolution.  
 
Scheme 2.1 Representation of FF-TG AP-MALDI (now called LSII) Source Design.[28] 
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LTQ Velos – Similar to the Orbitrap Exactive, the Ion Max source was removed and the 
interlocks were overridden to perform LSII, or with the Ion Max source with the removal 
of the front window for the laser beam to pass thru and aligned 180 C to the mass 
spectrometer ion entrance. Also, the side window was removed so that the glass plate can 
be placed in front of the ion entrance. The temperature at the heated inlet ranged from 
150-350 C. Xcalibur 2.1.0 was used for data analysis.  
LTQ Velos ETD - Fluoranthene was used as the electron transfer reagent and a mixture 
of ultrapure helium and nitrogen (25% helium and 75% nitrogen; purity, ~99.995%) was 
used as the reaction gas to perform the ETD experiments.  
SYNAPT G2 – The Nanolockspray ion source of Waters SYNAP G2 was used to set up 
LSII.[49] This was achieved by removing the lockspray motor. In addition, the ion 
entrance orifice of the skimmer of the SYNAPT G2 mass spectrometer was modified 
since the source temperature can be heated only up to 150 C. To have a source 
temperature above 150 C, external heat was supplied to a fabricated external tube 
attached to the skimmer cone. A 1/8 in. outer diameter x 1/16 in. inner diameter x 1 in. 
length copper tubing was sanded on one end to fit through the cone gas nozzle (outer 
cone) and fitted on the ion entrance of the sample cone (inner cone) of the skimmer 
(Scheme 2.2). The copper tubing coated with Sauereisen cement (Insolute Adhesive 
Cement Powder no. P1), dried and 24 gauge nichrome wire (Science Kit and Boreal 
Laboratories, Division of Science Kit, Inc., Tonawanda, NY, USA) was coiled around the 
coated tube and again coated with a layer of Sauereisen cement and allowed to dry. The 
coated copper tubing was then attached to the skimmer and held to the cone gas nozzle 
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with a layer of Sauereisen cement. Both ends of the coiled nichrome wire were connected 
with alligator clips to the insulated copper wire from a variac (Powerstat Variable 
Transformer type 116). The copper desolvation device was heated by application of up to 
12 V from the variac. The temperature measured on the outside of the device was > 200 
°C. The nitrogen laser was placed 180 C to the outer end of the attached copper tubing 
so that the laser beam fires at TG and focused on the sample. The x,y,z-stage of the 
Nanolockspray ion source was used to move the glass microscope slide with the 
matrix/analyte spot relative to the outer end of the copper tube and the laser beam.  
 
 
 
Scheme 2.2 Schematic representation of laserspray ionization inlet (LSII) with the 
fabricated desolvation device used on Waters SYNAPT G2 mass spectrometer.[49]  
 
The SYNAPT G2 instrument was operated in positive and resolution modes. The 
sample cone was set at 40 V and the extraction cone at 4 V. The source temperature was 
set at 150 °C. The scan time was set for 1 s. All acquisitions were obtained up to 2 min at 
a scan time of 1 sec although sampling of the spot was frequently completed in a shorter 
time period. The gas used for the drift time (td) separation was nitrogen with a flow set at 
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22 mL min
-1
. The IMS wave velocity was set at 650 m s
-1
 with a wave height of 40 V. 
The pressure in the drift cell of ~3.2 mbar was recorded. Acquisition was set in mobility-
TOF mode on the SYNAPT G2 mass spectrometer to obtain both the m/z ratio and drift 
times. After acquisition, the mass spectrum was extracted using MassLynx 4.1 (Waters 
Corp., Manchester, UK) and 2-D plots of td vs. m/z ratio using DriftScope ver. 2.1 
(Waters Corp., Manchester, UK).  
2.3 Laserspray Ionization Vacuum (LSIV) 
A commercial intermediate pressure MALDI source of SYNAPT G2 mass 
spectrometer from Waters Co. (Manchester, UK) equipped with an IMS and operated 
using a Nd:YAG laser (355 nm) in reﬂection geometry mode (Scheme 1.1.IIA) was used 
in this study. Acquisition mode was set using mobility-TOF and operated in positive ion 
and sensitivity mode (also referred as V mode) with the following settings: 0 V sample 
plate, 10 V “extraction”, 10 V “hexapole bias”, and 5 V “aperture 0”.  LSI (ESI-like, 0 V 
sample plate) and/or MALDI (20 V sample plate) settings were used.[42,45]  The laser 
fluence ranged from “50” to “500” (1.33 – 45.84 J cm-2) [45] at a firing rate set at 200 
Hz.  The laser operates with an average power of 20 mW and a pulse energy of 100 μJ.   
The sample plate once loaded was under vacuum conditions of ~0.2 mbar (ca 0.16 Torr) 
[75]. Scan time was set at 1 sec and acquisitions were summed for 1 to 2 min. Nitrogen 
gas was used for the drift time separation with a flow set at 22 mL min
-1. 
The IMS 
pressure in the drift cell was ~3.2 mbar. The wave velocity used ranges from 550 to 650 
m s
-1
, and the wave height was at 40 V. After acquisition, MassLynx 4.1 and DriftScope 
ver. 2.1 software were used for data processing. 
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2.4 Matrix Assisted Ionization Vacuum (MAIV) 
 MAIV was performed on an IP-MALDI vacuum and custom modified ESI 
sources. By simply mixing the analyte solution with the matrix, 3-NBN, and expose the 
matrix/analyte crystals to the vacuum of the mass spectrometer, molecular ions are 
formed. 
MAIV on a Commercial Vacuum MALDI Source - The commercial IP-MALDI source 
of Waters SYNAPT G2 with IMS capability conventionally operated with an Nd:YAG 
laser (355 nm) was employed with the laser off (Scheme 1.1.IIB). Matrix/analyte sample 
was prepared using 3-NBN as matrix similar to MALDI sample preparation protocols [3] 
and spotted 1 µL on a sample plate. The source pressure when the sample plate was 
loaded was ~0.2 mbar. Ions are observed from the matrix and the analyte once the sample 
plate with the matrix/analyte spot is positioned near the extraction lens, a process that 
takes ca. 2 min (Scheme 2.3). The TOF mass analyzer was operated in positive or 
negative ion V mode (also referred to as sensitivity mode).  “MALDI” or “LSI” settings 
[42,45] were used to perform MAIV-IMS-MS measurements. Acquisition times in MS 
and MS/MS ranged from 30 s to 2 min for standard samples and up to 4 min for the 
mouse brain tissue section sample, but single scan acquisitions were sufficient for most 
analytes. Mobility-TOF measurements were acquired with a drift cell pressure of ~3.2 
mbar, wave velocity at 650 m s
-1
, and wave height at 40 V.The nitrogen gas used for the 
drift time separation was set at 22 mL min
-1
.
 
 MassLynx 4.1 and DriftScope ver. 2.1 
software were used for data processing. 
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Scheme 2.3 (A) Representation on the ion formation of MAIV using an intermediate 
pressure vacuum MALDI source without the laser. (B) Screenshot during MAIV 
acquisition using the intermediate pressure vacuum MALDI source showing formation of 
multiply charged ions without the use of the laser.[47,71] 
 
MAIV on Commercial Atmospheric Pressure ESI Source SYNAPT G2- MAIV on the 
ESI source of the SYNAPT G2 mass spectrometer was performed by modifying the 
skimmer cone of the z-spray. The outer cone aperture of the skimmer was widened to 
about ~4.5 mm to allow a metal ferrule to form a gas-tight seal with the inner skimmer 
cone (Scheme 2.4). Non-standard inner cone with ~3 mm inner diameter inlet aperture 
was used and assembled to the modified outer skimmer cone with the ferrule attached. 
The glass plate with the matrix/analyte spot was placed on the ferrule facing the source 
entrance, and once the vacuum isolation valve was opened, the glass plate was held to the 
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ferrule by the vacuum of the mass spectrometer. Ions were observed until the matrix was 
no longer visible. The ion source temperature for the experiments was set at 50 °C. The 
instrument was operated in mobility-TOF and sensitivity (‘V’) modes acquiring in both 
positive and negative ion detection. ESI default settings were used with 40 V sample 
cone and 4 V extraction cone voltages using mobility-TOF settings as described above. 
MassLynx 4.1 and DriftScope ver. 2.1 software were used for data processing. 
 
Scheme 2.4 MAIV on the ESI source of Waters SYNAPT G2: (A) Representation of the 
simple modification of the skimmer cone simply by inserting a ferrule, (B) picture of 
components of home-built modified skimmer cone (left to right): connecting ferrule, 
outer and inner skimmer cones, and (C) photographs of typical operation: (1) vacuum 
valve closed, (2) glass on, (3) vacuum valve open, (4) matrix/analyte sample enters 
readily mass spectrometer by vacuum forces.[46,47] 
 
MAIV on Commercial Atmospheric Pressure ESI Source LTQ Velos - The Ion Max 
source was removed and the interlocks were overridden to have open access of the mass 
spectrometer inlet. The outer end of the transfer capillary was modified by inserting a 
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ferrule on the outer opening of the inlet tube to hold the glass plate. Nonstandard 750 µm 
inner diameter inlet capillary was used (Scheme 2.5). MAIV-ETD fragmentation for 
peptide sequencing used conditions similar to those described in a previous report [48]. 
Mass spectra were acquired using a maximum injection time of 50 ms and 2 microscans 
with an inlet capillary tube temperature of 150 °C. ETD acquisition was set at 1 m/z 
isolation width and 100 ms activation time. Xcalibur 2.1.0 was used for data analysis. 
 
Scheme 2.5 MAIV on the ESI source of Thermo Scientific LTQ Velos. The outer end of 
the inlet capillary is inserted with the ferrule with wider opening. The sample plate with the 
matrix/analyte spot is held by the vacuum of the mass spectrometer thru the ferrule. 
 
2.5 Microscopy Measurement 
Optical microscopy (Nikon Eclipse LV100) was performed to obtain qualitative 
information on the ablated area of matrix/tissue ablated per laser shot after mass spectral 
analysis of the tissue using LSII. Various magnification conditions were used, ranging 
from 5x to 100x, providing detailed views to ~1 µm resolution. 
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CHAPTER 3 
MATRIX-ASSISTED LASER DESORPTION/IONIZATION MASS 
SPECTROMETRY METHOD FOR SELECTIVELY PRODUCING EITHER 
SINGLY OR MULTIPLY CHARGED MOLECULAR IONS “Reprinted (adapted) 
with permission from (Trimpin, S.; Inutan, E.D.; Herath, T.N.; McEwen, C.N. Anal. 
Chem. 2010, 82, 11-15). Copyright (2010) American Chemical Society.” 
 
Introduction 
Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (MS), 
along with electrospray ionization (ESI), has had an enormous impact on science because 
of the capability to ionize nonvolatile and high-mass compounds such as peptides and 
proteins.[2,3] MALDI is characterized by the production of low-charge state ions with 
singly charged ions being dominant, especially for compounds with molecular weights  
below  10-20 kDa, while ESI [1] is characterized by much higher charge states 
sometimes reaching hundreds of charges per molecule for larger proteins and polymers. 
The observation of mostly singly charged ions in MALDI reduces mass spectral 
complexity, which is especially useful for mixtures such as those found in polymer 
distributions, but they limit structural characterization because of the difficulty of 
producing fragment ions and requires a mass analyzer with a m/z range at least equal to 
the molecular weight of the compounds being analyzed. 
Here, we report the ability to selectively produce either ESI-like multiply charged 
or MALDI-like singly charged ions using a MALDI process at atmospheric pressure 
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(AP). Thus, multiply charged molecular ions dominate the mass spectrum when the 
analyte along with the common MALDI matrix, 2,5-dihydroxybenzoic acid (2,5-DHB), 
is applied to a glass MALDI target plate using the standard dried droplet sample 
preparation method [3] and ablated using a nitrogen laser (337 nm). Under the same 
instrumental conditions, except that the sample preparation is by the solvent-free method 
[72,73] where analyte and matrix are ground together and placed on the MALDI target 
plate without the use of any solvent, MH+ singly charged molecular ions are dominant. 
The ability to produce, at will, multiply charged ions in a MALDI process is potentially 
analytically important as it extends  the  mass  range  of  common  atmospheric  pressure 
ionization  (API)  mass  spectrometers  and  provides  enhanced user initiated 
fragmentation, similar to ESI. 
AP-MALDI offers advantages over vacuum MALDI, including time and 
volatility constraints as well as the ability to analyze materials under more 
physiologically relevant conditions, which is especially important in the developing area 
of compound-specific tissue imaging. Vacuum MALDI which is more sensitive than AP- 
MALDI, and often more sensitive than ESI,[23] imposes analysis limitations with 
materials that are not compatible with vacuum and solvent conditions.[10] Thus, methods 
that offer improved sensitivity for AP-MALDI are needed. Some sensitivity improve- 
ment for AP-MALDI is achieved by the implementation of pulse dynamic focusing 
(PDF),[76] but part of the sensitivity gain is due to sampling a larger area. Thus, PDF 
only provides minimal sensitivity gain for imaging where spatial resolution (small 
sampled area) is important. A new AP-MALDI configuration based on theoretical studies 
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by Sheehan and Willoughby [24] and by laser ablation studies by Willis and Grosu [25] 
is reported here. Sheehan and Willoughby modeled AP ionization and reported that ~90% 
of the ions entering the AP to vacuum orifice are lost to the walls (so-called rim losses) if 
a high electric field is present in the AP region.[24] Forward momentum caused by the 
explosive expansion of materials irradiated in a transmission geometry (TG) laser 
ablation experiment in which the laser beam passes through the holder (glass or quartz) 
before striking the sample was demonstrated by Willis and Grosu.[25] Thus, combining 
these ideas into the configuration shown in Scheme 1.1IA with field-free (FF) conditions 
to minimize rim loses and placement of the sample in close proximity to the ion entrance 
orifice to enhance momentum transfer of material in the expanding gas jet is expected to 
ensure high transmission of ions into the mass analyzer. TG using glass microscope 
slides as the MALDI target plate is also ideal for such a source configuration as well as 
for tissue imaging microscopy.[77]  The initial results from this ion source, with minimal 
optimization, demonstrate the FF-TG AP-MALDI concept by successfully obtaining 
mass spectra of lipids, carbohydrates, peptides, proteins, and polymers. The potential 
analytical utility of this new MALDI approach is discussed and representative examples 
presented. 
Experimental Section 
Materials and sample preparation are included in Chapter 2.1, and the LSI set-up 
using the Orbitrap Exactive mass spectrometer is described in Chapter 2.2. For solvent-
based matrix/analyte preparation, lipids in 70:30 or peptides/proteins in 50:50 ACN/water 
was mixed with 2,5-DHB using dried droplet method.[3] One µL of the matrix/analyet 
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mixture (200/1 or 5000/1) was placed on the microscope slide and dried using a heat gun 
(low heat). Alternatively, the solvent-free sample preparation method was used as 
described elsewhere.[72,73] The ion transfer capillary was heated to 350 C. Resolution 
could be set from 10,000 to 100,000 (m/z 200, full width at half height definition) and the 
maximum ion inject time was set to 50 ms. 
Results and Discussion 
The mass spectra obtained from laser ablation of the solution based matrix/analyte 
preparation dried on a glass microscope slide using FF-TG AP-MALDI are nearly 
identical to ESI mass spectra. Thus, singly charged ions are produced from compounds 
that do not have basic sites for attachment of more than one proton. Therefore, only 
singly charged ions are observed with FF-TG AP-MALDI using solvent-based sample 
preparation with 2,5- DHB, as well as with ESI using 50:50 acetonitrile/water, for lipids 
such as N-arachidonoylethanolamine (molecular weight [MW] 347.3), N-arachidonoyl 
glycine (MW 361.3), phospatidyl glycerol (MW 770.5), sphingomyelin (MW 812.7), and 
phospatidyl inositol (MW 886.6) as well as small peptides such as leucine enkephalin 
(MW 555.3) and -amyloid 33-42 (MW 914.5) (Appendix A Figures S1, S2 , S3). 
However, for bradykinin antagonist (MW 1109.6), angiotensin I (MW 1295.7), 
angiotensin II (MW 1045.5), and adrenocorticotropic hormone (ACTH 18-39 human; 
MW 2464.2) using the same solvent-based sample preparation conditions with AP-
MALDI or ESI, multiply charged ions dominated the mass spectrum while singly 
charged ions were either not observed or in very low abundance. Under these FF-TG AP-
MALDI conditions, higher mass peptides, proteins, and synthetic polymers produce 
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higher charge states: insulin B chain oxidized, (MW 3536.7) < β-amyloid (1-42), (MW 
4511.5) < porcine insulin (pancreas, MW 5772.6) < polyethylene glycol, (PEG) 6590 < 
ubiquitin, (bovine red blood cells, MW 8561) (Figure 3.1A-F).  
 
Figure 3.1. LSII inset mass spectra showing multiply charged molecular ions for (A) 
bovine insulin oxidized B chain (MW 3536.7, +3), (B) amyloid (1-42) (MW 4511.5, +4), 
(C) bovine pancreas insulin (MW 5772.6, +5), (D) PEG 6690 (+6), (E) ubiquitin (MW 
8561, +7), and (F) cytochrome c (MW 12 224, +12). 
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Ubiquitin for example displayed ions from charge state +5 to +13.  The  mass  spectrum  
of  cytochrome  c  (MW 12,224) obtained from a single 1 s acquisition of 4 pmol applied 
to a microscope slide shows multiply charged ions from +8 to +15 in Figure 3.2A.  
 
Figure 3.2. Full-range LSII-MS: (A) 4 pmol of cytochrome c applied to the microscope 
slide with 1- s acquisition at 100,000 resolution (MW 12,224) and (B) PEG 6690 in 2,5-
DHB and NaCl prepared solvent-free and then dissolved in 70:30 ACN/water and 1 μL 
placed on the microscope slide using the dried droplet method. 
 
As with ESI, the higher charge states allow MALDI mass spectra to be obtained for 
compounds beyond the mass limitation (m/z 4000) of the mass spectrometer. Mass 
spectra can be obtained from complex mixtures such a protein digests or polymers. 
Multiply or singly charged mass spectra were obtained from narrow polydisperse PEG 
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samples with MWs below the 4000 m/z limit of the mass spectrometer using 2,5-DHB 
and a trace of NaCl employing solvent-based or solvent-free preparation, respectively. 
However, molecular ions of PEG 6590 were only observed with the solvent-based sample 
preparation as multiply charged ions that fall within the m/z range of the mass 
spectrometer (Figure 3.2B). Ionization with the singly or multiply charged mechanism 
was by Na+ adduction, showing that metal adduction is favored for this polymer when 
sodium salt is present. 
The ability to produce multiply charged ions in a MALDI process has important 
advantages. It potentially enables production of enhanced fragmentation from processes 
such as collision induced dissociation (CID),[78] electron transfer dissociation 
(ETD),[58,79] and electron capture dissociation (ECD).[80,81] It also extends the mass 
range of mass spectrometers with limited m/z range, typically found with AP ionization 
instruments. Additionally, just as with nanospray ESI, the amount of sample necessary 
for an analysis can be reduced by minimizing the amount of matrix/analyte solution 
placed on the glass slide. Sufficient signal was obtained in a single laser shot to produce 
the isotope distribution of the doubly charged ions from 0.1 µL of a 400 amol solution 
(80 amol) of angiotensin II in 2,5-DHB placed on a glass slide (Appendix A Figure S4). 
Singly charged molecular ions can be produced for the compounds discussed 
above that are within the m/z limit of the Orbitrap Exactive simply using the solvent-free 
sample preparation method with 2,5-DHB. The advantage of producing only singly 
charged ions is the simplified mass spectra obtained from complex mixtures such as 
found in plasma or even synthetic polymers (Appendix A Figure S5). The mechanism 
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for producing singly charged ions is distinct from that for producing multiply charged 
ions and is shown to originate in the matrix choice or matrix/analyte preparation method. 
This is shown in Figure 3.3 for angiotensin I prepared using 2,5-DHB employing the 
solvent-based (Figure 3.3A) and solvent-free (Figure 3.3B) methods. The mass spectra 
obtained with the singly charged mechanism often displayed matrix or Na+ adduction, 
especially for peptides (Appendix A Figure S6). These adductions were rarely observed 
and then in low abundance with the multiply charged ionization mechanism. 
 
Figure 3.3. LSII mass spectrum of angiotensin I (MW 1295): (A) solvent-based dried 
droplet sample preparation using 2,5-DHB in 50:50 ACN/water and (B) solvent-free 
sample preparation using 2,5-DHB. 
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It was even possible with 2,5-DHB to produce a mixed mode of ionization with 
observation of singly and multiply charged ions by, for example, adding a drop of solvent 
onto the solvent-free prepared matrix analyte mixture on the glass plate. After solvent 
evaporation, the matrix/analyte mixture is only partially dissolved and the mixed mode 
ionization can be observed. The activation of the singly charged ion mechanism was also 
achieved using a thin layer experiment and increasingly non-incorporating conditions. 
Laser ablation of an aqueous solution of 2,5-DHB placed on angiotensin II which had 
been dried on the glass slide produced, after drying, exclusively doubly charged ions 
whereas an acetone solution of 2,5-DHB placed over the dried peptide produced mixed 
ionization and a dichloromethane 2,5-DHB solution produced only singly charged ions 
(Appendix A Figure S7). 
With α-cyano-4-hydroxycinnamic acid (CHCA), even under solvent-based 
conditions, only singly charged ions are observed for angiotensin II (Appendix A Figure 
S8) and substance P. This  observation  is  in  line  with  previously  described  field-
constrained TG AP-MALDI experiments.[26] Other compounds such as dithranol, ortho-
chlorobenzoic acid, and benzoic acid were examined as matrixes for AP-MALDI. With 
angiotensin II, benzoic acid produced singly and no doubly charged ions while o-
dichlorobenzoic acid produced low abundance doubly charged ions (Appendix A Figure 
S9). Dithranol, besides producing singly charged ions with angiotensin II, also produced 
notable matrix-adducted analyte molecular ions. 
Previous studies have shown a moderate increase in multiple charging in MALDI 
using different sample preparations, high laser fluence, a metal-free sample stage, and 
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atmospheric pressure.[56,57] From the work presented here, it is clear that the MALDI 
process can generate analytically useful ion currents from mechanisms that produce 
multiply charged ions as well as singly charged ions. The ease and speed of the FF-TG 
AP-MALDI method for producing either singly or multiply charged ions from a wide 
variety of compound types with high sensitivity using a focused laser beam demonstrates 
analytical utility.  
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CHAPTER 4 
LASERSPRAY IONIZATION – A NEW AP-MALDI METHOD FOR 
PRODUCING HIGHLY CHARGED GAS-PHASE IONS OF PEPTIDES AND 
PROTEINS DIRECTLY FROM SOLID SOLUTIONS “This research was originally 
published in Molecular and Cellular Proteomics (Trimpin, S.; Inutan, E.D.; Herath, T.N.; 
McEwen, C.N. Mol. Cell. Proteomics 2010; 9:362-367) © the American Society for 
Biochemistry and Molecular Biology.” 
 
Introduction 
Two primary differences between ESI and MALDI methods are the sample 
environment (solution vs. solid) and the observable charge state(s) (multiply vs. singly 
charged). The multiply charged ions observed in ESI mass spectrometry (MS) enhance 
the yields of fragment ions, a key benefit in structure characterization, and allow analysis 
of high molecular weight compounds on mass spectrometers with a limited m/z range. In 
contrast, MALDI-MS is ideal for the analysis of heterogeneous samples because it often 
requires less sample, and spectra of singly charged ions are easier to interpret. We report 
here the astonishing observation of highly charged molecular ions by laser ablation of a 
solid matrix/analyte mixture typically used in MALDI-MS analyses. The distribution and 
abundances of the observed ions are similar to those obtained by ESI. Importantly, the 
MALDI mechanism that produces singly charged ions can be “turned on” at the 
operator’s will by changing only the matrix or matrix preparation conditions; this 
capability is not available with any other ionization method. These findings show for the 
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first time that singly charged ions as well as multiply charged ions are available in 
MALDI. Besides having important mechanistic implications relating to MALDI and ESI, 
our findings have enormous practical analytical utility. 
ESI and MALDI combined with MS revolutionized the study of biological 
materials and earned the Nobel Prize in Chemistry for their ability to ionize proteins for 
analysis using MS. However, after two decades of extensive studies, the mechanism for 
ion formation in MALDI remains controversial [35,54,55,82-87]. At the heart of these 
debates lies the predominance of singly charged ions in MALDI mass spectra; the 
exception being very high mass compounds. A mechanism for the formation of multiply 
charged ions in MALDI has previously been proposed [54] based on molecular modeling 
studies [36,38] and glimpses of multiply charged ions have been observed in lower 
molecular weight compounds [56,57,88,89]. The formation of these multiply charged 
ions has been attributed to sample preparation, high laser fluence, a metal-free sample 
stage, use of an IR laser, and atmospheric pressure (AP) conditions. Multiply charged 
ions were also recently observed by laser ablation of a liquid surface in the presence of a 
high electric field [90]. The inability in that experiment to observe ions from a solid 
MALDI matrix/analyte sample or in the absence of an electric field suggests an 
ionization process involving liquid droplets in a high field similar to ESI [1] or other 
liquid based, field-induced ionization methods [91,92]. 
Here, we show analytically useful ESI-like MALDI mass spectra obtained using 
standard MALDI conditions but using a non-traditional source [27] mounted in place of 
the standard atmospheric pressure ionization source on a mass spectrometer most 
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commonly used with ESI. The utility of this MALDI-MS method for extending the mass 
range of mass spectrometers as well as the capability of peptide/protein sequencing using 
electron transfer dissociation (ETD) [58] is demonstrated. Because highly charged ions 
have not previously been observed with any MALDI ion source configuration, we briefly 
discuss the fundamental concepts that lead to their production. Key aspects of laserspray 
ionization (LSI) are laser ablation using a UV laser aligned in transmission geometry 
(TG) [26], field-free (FF) at AP [21], using a heated AP to vacuum ion transfer capillary. 
In order to emphasize the MALDI sample preparation but distinguish laserspray from 
conventional AP-MALDI, the new ionization method will here- after be referred to as 
FF-TG AP-MALDI. 
Experimental Procedure 
Materials and sample preparation are included in Chapter 2.1. An Orbitrap 
Exactive mass spectrometer was used for LSI experiments (see Chapter 2.2). Peptides 
and proteins were further diluted in 30:70 ACN/water solution and premixed with 2,5-
DHB, prepared as a concentrated solution in a room temperature 50:50 ACN/water 
solution using a standard solvent- based MALDI preparation method [3]. The premixed 
matrix/analyte solution was deposited on a glass microscope slide followed by 
evaporation of the solvent. The temperature of the ion transfer capillary was used to 
control the desolvation conditions for the temperature study with angiotensin I. For ESI, 
1 µL of a 1 pmol µL
-1
 solution of lysozyme was injected into a 50:50 ACN/water solution 
infused at a flow rate of 2 µL min
-1
. LSI-ETD experiments were obtained on a Thermo 
Fisher Scientific LTQ with ETD capabilities using the same LSI source configuration 
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described in Chapter 2.2 as well as the ETD conditions as described elsewhere [58]. For 
intact sequencing of ubiquitin, ETD mass spectrum was obtained in single scan 
acquisition. Proton transfer reaction was applied to simplify the fragment ions.[93]  
Results and Discussion 
Lysozyme was chosen as a well-studied protein for initial experiments. A typical 
FF-TG AP-MALDI mass spectrum for lysozyme is shown in Figure 4.1A and can be 
compared with the ESI spectrum shown in Figure 4.1B, also acquired on the Orbitrap 
Exactive from the same 1 µM solution at 100,000 resolution and using 1-s acquisition. 
Observation of efficient production of such highly charged ions (up to 13+) in MALDI is 
unprecedented. As with ESI, the higher charge states allow AP-MALDI mass spectra to 
be obtained for compounds with molecular weights beyond the m/z limit of the 
instrument (4000). The capability to produce highly charged ions in high abundance in 
AP-MALDI and ESI strongly suggests that these ions are formed via related mechanisms. 
Process for Producing Highly Charged Molecular Ions by MALDI - Here, we 
provide a brief description of mechanistic implications as well as the conditions that are 
necessary to observe highly charged ESI-like ions in MALDI-MS. In ESI, the ionization 
mechanism is thought to involve highly charged solvent/analyte droplets [51-53]. In 
MALDI, the most accepted model is a two-step ionization process that occurs in the 
expanding plume that is created by absorption of the laser energy by the MALDI matrix 
[82,86]. Primary photochemical ionization is followed by ion-molecule reactions similar 
to chemical ionization, leading primarily to singly charged analyte ions.  
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Figure 4.1. (A) LSII (1 pmol in 2,5-DHB loaded on a glass microscope slide) and (B) 
ESI mass spectra (1 pmol injected into 1:1 ACN/water infused at 2 µL min
-1
) of a 1 pmol 
µL
-1
 solution of lysozyme (1-s acquisitions, 100,000 resolution (m/m, full-width half-
height at m/z 200)). Insets show the isotope distributions for the most abundant peaks and 
charge 10 in each spectrum. 
 
Alternatively, a cluster model has been proposed in which charged clusters 
produce multiply charged ions in a MALDI process by a mechanism similar to ESI 
[54,56,57]. To explain the dominant observation of singly charged ions, a “lucky 
survivor” mechanism was postulated in which highly charged positive ions, of e.g. 
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proteins, were reduced to singly charged ions, presumably by ion-electron 
recombination.[54] This mechanism was later modified to formation of singly charged 
ions directly from clusters.[55] Others have also suggested that clusters are a source of 
ions in MALDI, including background ions [85,87,94]. However, the validity of a cluster 
mechanism as a significant source of ions in MALDI MS has been questioned [35,82]. 
Given our observation of abundant, highly charged ions in FF-TG AP-MALDI, the 
potential mechanistic commonalities between ESI and MALDI must be reassessed. 
In analogy to ESI [1,51-53] and the cluster (liquid droplet) model for MALDI 
[54,56,57], we propose a mechanism in which the laser-induced gas-phase clusters are 
highly charged. Similar to ESI, evaporation of solvent, but not charge, produces an 
unstable surface charge density, resulting in formation of smaller particles and eventually 
ion emission (Scheme 1.1IA). Unlike ESI in which an electric field induces excess 
positive or negative charges on solvent droplets, in the AP-MALDI experiments 
discussed here, cluster charging occurs in the absence of an electric field. Field-free 
production of charged clusters can occur at cluster birth by a statistical charge separation 
mechanism [53], photoionization, or electron loss from the cluster surface [35,55]. 
Provided a threshold laser fluence is achieved [56,57], cluster formation in 
MALDI is expected [36,38,54,82-87,94], and mechanisms exist for at least some of the 
clusters to become charged [35,53-55]. However, detection of higher charge state ions 
has remained elusive in MALDI until now. We propose that the highly charged clusters 
are initially produced during the explosive deposition of energy into the MALDI matrix 
in either AP- or vacuum MALDI at least with solvent-based matrix preparation using 2,5-
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DHB. However, for field emission of multiply charged ions, it is necessary to evaporate 
sufficient matrix, but not charge, from the clusters to achieve a surface charge density > 
~109 V m
-1
 [95]. One possibility for the absence of observable highly charged ions under 
vacuum conditions is that evaporative cooling quenches the initial rapid cluster 
evaporation process prior to achieving the necessary charge density. 
In support of a requirement of desolvation for observation of multiply charged but 
not singly charged ions, the AP to vacuum ion transfer capillary (Scheme 1.1IA) 
temperature was varied for angiotensin I (molecular weight, 1295.7) using solvent-based 
and solvent-free 2,5-DHB sample preparation. Barely detectable 2+ and 3+ molecular 
ions were observed with the transfer capillary temperature set as low as 150 °C (no 1+ 
ions were observed). The 2+ and 3+ ion abundances increase rapidly above 275 °C, and 
at 350 °C they dominate the mass spectrum (Figure 4.2).  
 
 
Figure 4.2. Ion count vs. ion transfer tube temperature plot for the 1 through 3 charge 
states of angiotensin I. The 2 and 3 ions are produced by the solvent-based and the 1 ions 
are produced by the solvent-free MALDI sample preparation methods. The plot suggests 
two distinctly different ionization mechanisms, one of which (multiply charged ion 
formation) is highly dependent on the ion transfer tube temperature. 
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Using the same matrix and analyte but prepared under solvent-free conditions 
[96,97], 1+ molecular ions are exclusively produced, and little change in ion abundance 
is observed over the same temperature range, strongly implying that an entirely different 
ion formation mechanism is being sampled. This and other evidence suggest that the 
singly charged ions produced using the solvent-free sample preparation method are 
formed near the sample surface by the two-step chemical ionization mechanism normally 
observed in MALDI but that the multiply charged ions are produced from clusters far 
downstream from the initial laser/matrix interaction (Scheme 1.1IA) and are enhanced by 
improved desolvation conditions (higher ion transfer tube temperature). Interestingly, 
Figure 4.2 suggests that higher sensitivity will be achieved by increasing the ion transfer 
tube temperature beyond 350 °C. 
The unique configuration of the FF-TG AP-MALDI arrangement (Scheme 1.1IA) 
may also provide improved ion sampling by the combination of the forward momentum 
of the laser-generated plume and the flow-dominated entrapment by gas diffusing from 
AP to vacuum through the instrument orifice. The absence of an electric field is expected 
to minimize loss of ions at the entrance to the ion transfer tube [24] and favor sampling of 
higher mass and thus higher momentum species such as clusters relative to free analyte 
ions created in the expanding plume region near the sample surface. Thus, the high 
efficiency of producing multiply charged ions may partially be the result of preferential 
sampling at the capillary inlet orifice. 
As noted, either singly or multiply charged ions can be selected in FF-TG AP-
MALDI by choice of matrix or matrix/analyte preparation conditions. Thus, using 2,5-
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DHB and dried droplet solvent-based sample preparation, multiply charged mass 
spectra of peptides and proteins nearly identical to those in ESI are produced, whereas 
solvent-free sample preparation [96,97] produces MALDI-like singly charged mass 
spectra for peptides. One difference in these distinct MALDI sample preparation methods 
is that analyte incorporation in the matrix (solid solution) is believed to occur for solvent-
based preparations [98] but not in the solvent-free case [72,99]. Consistent with this 
concept, the addition of a drop of ACN/water solution to the solvent-free prepared sample 
on the glass slide and evaporation of the solvent resulted in the mass spectrum changing 
from all singly charged with solvent-free preparation to dominantly multiply charged 
peptide ions after addition of solvent. 
Further support for the importance of analyte incorporation into the matrix is 
derived from solvent-based experiments using Cyt. c and various DHB positional  
isomers. Highly charged ions of Cyt. c were observed only for the 2,5-DHB isomer. 
Previous work [98] reported quantitative incorporation of Cyt. c only into the 2,5-DHB 
isomer. Importantly, changes only in the matrix/analyte conditions alter the selected 
charge state population, thus assuring that the observed multiply charged ions are related 
only to the matrix and not instrument parameters. The ability to select different ionization 
pathways provides a unique opportunity to study fundamental processes related to 
formation of gas-phase ions from nonvolatile compounds as well as entire new 
applications. 
Finally, it is unlikely that the multiply charged ions are a result of the ion source 
geometry because FF-TG MALDI has previously been used without such observations 
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[26]. This is demonstrated by changing the angle of the laser beam relative to the 
instrument orifice from 180° (Scheme 1.1IA) to 135°, making it possible to use FF 
reflective geometry so that the laser beam strikes the matrix/analyte mixture without 
passing through the glass plate. Multiply charged (2+) ions of angiotensin II were 
observed with FF reflective geometry AP-MALDI, thus demonstrating that TG alignment 
is not necessary for laser-generated multiply charged ion formation. 
Analytical Applications of Highly Charged MALDI Ions - The ability to produce 
multiply charged ions by AP-MALDI has advantages relative to ease and speed of 
analysis, mass range enhancement, and fragmentation and potentially in tissue imaging 
studies [27]. The speed of the method is shown by the ability to obtain a complete high 
resolution mass spectrum of a peptide or protein in 1 s. Because in AP-MALDI ionization 
occurs at atmospheric pressure, the time requirement for loading samples is also greatly 
reduced relative to vacuum MALDI, making high throughput analyses a reality. 
Sensitivity is also an important issue as it is commonly believed that AP-MALDI 
is significantly less sensitive than vacuum MALDI. As with any new technology, the 
optimum parameters for the FF-TG AP-MALDI method have likely not been achieved, 
and sensitivities much greater than reported here can be expected. Nevertheless, the limit 
of detection, defined here as the signal necessary to observe the triply charged molecular 
ion and its three 
13
C isotope peaks for angiotensin I (molecular weight, 1295.7) using 2,5-
DHB as matrix and the solvent-based sample preparation method, was determined to be 
~0.3 fmol applied to the glass slide (data not shown). The actual amount of sample 
consumed is estimated to be a less than 50 amol. A more meaningful gauge of sensitivity 
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for most analyses is the amount of material required to produce a recognizable full-range 
mass spectrum. The mass spectrum obtained from 40 fmol of insulin in 2,5-DHB applied 
to the glass slide using the solvent-based dried droplet method is shown in Figure 4.3. 
 
Figure 4.3. The FF-TG AP-MALDI mass spectrum obtained at 100,000 mass resolution 
from 40 fmol of bovine pancreas insulin loaded on the glass slide MALDI target plate in 
2,5-DHB using the solvent-based dried droplet method. The insets show the 
13
C isotopic 
distribution of the 4 and 5 charge state ions. Rel. Abund., relative abundance. 
 
The ability to obtain enhanced fragmentation in a MALDI process is another 
advantage of multiply charged ions. Important new fragmentation methods based on 
either electron capture [80,81] or ETD [58] have been applied to sequence termination of 
peptides and even proteins. Ubiquitin (molecular weight, 8561) was selected because it 
had been previously sequenced using ETD fragmentation.[100] Fluoranthene was used as 
the electron transfer reagent as described previously.[100] In initial experiments using 
FF-TG AP-MALDI, 2,5-DHB, and solvent-based conditions, ~5 pmol of ubiquitin was 
placed on the glass slide, and mass selecting the 11+ (m/z 779) charge state ion 
produced the single scan mass spectrum shown in Figure 4.4A. The single acquisition 
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ETD spectrum is shown in Figure 4.4B and consists of numerous fragment ions of 
various charge states. Making use of the proton transfer reaction method [93] simplifies 
the fragment ion spectrum as previously demonstrated using ESI, thus allowing easier 
sequence interpretation (Figure 4.4C). These results represent the first MALDI-ETD 
mass spectra and provide sequence coverage of the protein as previously presented using 
ESI-ETD [93]. The capability to observe either multiply or singly charged molecular ions 
by a MALDI process allows new experimental information that fills a gap in the long 
standing controversy regarding ionization mechanisms in MALDI and additionally 
provides a unique opportunity to study such processes as laser-induced cluster formation, 
charging, and desolvation as well as charge reduction mechanisms [54]. The 
commonality with ESI also provides a means to probe the mechanisms by which analyte 
ions are released from highly charged droplets. Finally, these findings have significant 
analytical utility in areas such as high throughput analyses at high sensitivity, tissue 
imaging  at  AP  using  high  resolution  instrumentation,  and identifying and  
characterizing proteins  using  fragmentation processes such as ETD.  
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Figure 4.4. (A) The FF-TG AP-MALDI mass spectrum of a single scan acquisition from 
5 pmol of ubiquitin in 2,5-DHB loaded onto the glass slide. (B) The single scan ETD 
acquisition from the mass-selected 11 charge state (m/z 779) ions. (C) The summed (40-s 
acquisition) proton transfer spectrum of the m/z 779 ion with the sequence coverage 
shown. 
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CHAPTER 5 
LASERSPRAY IONIZATION (LSI) ION MOBILITY SPECTROMETRY (IMS)                                               
MASS SPECTROMETRY (MS) “Springer and the original publisher (J. Am. Soc. 
Mass Spectrom., 21, 2010, 1260-1264, Inutan, E.D., Trimpin, S.) is given to the 
publication in which the material was originally published with kind permission from 
Springer Science and Business Media.” 
 
Introduction 
Laserspray ionization (LSI) mass spectrometry (MS) was recently introduced on 
a Thermo Fisher Scientific Orbitrap Exactive [27-29].  The principle of this ionization 
method is that the matrix/analyte sample is ablated by the use of a laser operating at 
atmospheric pressure (AP) and ions are subsequently formed from highly charged 
matrix/analyte clusters during a desolvation process.  The free choice of charge state 
selection demonstrates the utility of LSI for the analysis of complex mixtures.  Singly 
charged ions similar to those obtained with matrix-assisted laser desorption/ionization 
(MALDI) or multiply charged ions similar to those produced by electrospray ionization 
(ESI) [28] can be selected using LSI.  Multiply charged ions are especially beneficial for 
providing the ability to ionize by laser ablation larger molecules such as proteins and 
synthetic polymers on high-performance but mass range limited mass spectrometers such 
as the Orbitrap Exactive [28,29].  Full range mass spectra of bovine insulin were obtained 
on as little as 40 fmol when applying ion transfer capillary temperatures of ~350 °C [29]. 
The unique feature of LSI to produce highly charged ions using direct laser 
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ablation of a solid surface enhances fragmentation as was demonstrated by obtaining 
nearly complete protein sequence coverage of ubiquitin using electron-transfer 
dissociation (ETD) technology on a LTQ mass spectrometer [29].  Initial laserspray 
applications demonstrated the ability to produce singly charged lipid ions from mouse 
brain tissue under ambient conditions [27].  Using transmission geometry, the matrix 
treated tissue sections were passed free-hand through the focused laser beam in front of 
the mass spectrometer orifice (Orbitrap Exactive) obtaining a spatial resolution of < 100 
µm [27].  The objective is to observe proteins from tissue. 
Ion mobility spectrometry (IMS) MS has many advantages compared with even 
high-resolution mass spectrometers because of its ability to extend the dynamic range and 
separate isomeric composition [64-67].  This is possible because ions are separated in the 
IMS dimension according to charge and cross-section (size and shape) [101-105].  One 
key benefit of this solvent-free gas-phase separation by IMS is that when combined with 
solvent-free sample preparation [96] achieves total solvent-free analysis by MS entirely 
decoupling ionization, separation, and mass analyses from the use of any solvent 
[10,27,30]. 
We rationalized that to produce LSI multiply charged ions from the proposed 
highly charged matrix/analyte clusters [29], a device is required that efficiently 
desolvates the 2,5-dihydroxybenzoic acid (2,5-DHB) matrix to produce the highly 
charged molecular ions. One function of the Waters Company (Manchester, UK) ESI z-
spray source design used with the IMS-MS SYNAPT G2 is to reduce the background 
arising from cluster ions. However, this arrangement is not satisfactory as a means of 
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desolvating clusters in which the matrix (serving as solvent) is 2,5-DHB.  We, therefore, 
fabricated a simple device that is mounted on the z-spray ESI source and provides the 
thermal conditions necessary for desolvation and multiply charged ion production using 
the LSI method.  The benefits of IMS-MS in combination with direct LSI ambient 
ionization for the efficient separation and characterization of a protein mixture is 
demonstrated. 
Experimental  
Materials and sample preparation are included in Chapter 2.1 and the LSI set-up 
using the SYANPT G2 mass spectrometer with the fabricated desolvation device is 
described in Chapter 2.2. Bovine insulin (50 pmol µL
-1
) was used to test the fabricated 
desolvation device. For the protein mixture, ubiquitin and lysozyme were premixed using 
the stock solution in a 1:1 volume ratio. One µL was  used  to  prepare  the  LSI  sample  
on  the microscope slide employing solvent-based sample preparation protocols using 
2,5-DHB matrix [3], prepared in 50:50 ACN/water, and then dried to completeness.  The 
dried LSI sample was placed in front of the desolvation device in a distance of about 1 to 
3 mm (Scheme 2.2), similar to studies in which the dried sample was placed directly in 
front of the mass spectrometer orifice of the Orbitrap Excative [27-29]. LSI-IMS-MS was 
acquired using the Waters SYNAPT G2 as described in details in Chapter 2. 
Results and Discussion 
A maximum ion source temperature of 150 °C is available on the z-spray ESI 
source of the SYNAPT G2.  This was insufficient to produce any meaningful ion current 
even for low molecular weight peptides such as angiotensin 1 (MW 1296) using 2,5-DHB 
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matrix and the identical laser and configuration used in previous work [27,28,29].  
Applying the fabricated temperature device (Scheme 2.2), multiply charged ions of 
peptides and proteins are produced.  A typical example is shown in Figure 5.1 using 
bovine insulin (MW 5731). The total ion current (Figure 5.1a) shows the continuous ion 
production when moving the sample stage over unablated areas of the sample showing an 
increase when  heat (1-84 s) and a decrease when no heat (850-115 s) were applied.  The 
charge state distribution (Figure 5.1b) is similar to that previously observed using the 
commercially available heated transfer capillary of the Thermo Fisher Scientific Ion Max 
ESI source of the Orbitrap Exactive and the LTQ mass spectrometers [28,29].   
 
Figure 5.1. LSI-IMS-MS of bovine insulin (MW 5731): (a) The total ion current and (b) 
mass spectrum obtained using 2,5-DHB matrix incorporating the solvent-based sample 
preparation method. 
 
Larger proteins such as ubiquitin (MW 8561) and lysozyme (MW 14,304) also 
produced multiply charged ions in good abundance (Figure 5.2.1) using the simple 
desolvation chamber. Myoglobin (MW 16,951), however, produced less abundant ions 
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ranging from charge state +10 to +16 possibly suggesting a mass range limit for this 
particular desolvation device. All experiments incorporated ion mobility separation. In 
ion mobility measurements, three-dimensional (3-D) information is acquired; td, m/z, and 
signal intensity.  Frequently, the intensity of a signal is embedded in a 2-D plot of td vs. 
m/z (Figure 5.2.2) and visualized by the use of a color-code. The 2-D IMS-MS plots of 
ubiquitin, lysozyme, and a mixture of ubiquitin and lysozyme are shown, respectively, in 
Figure 5.2.2. LSI ions of proteins fall into families depending upon their sizes and charge 
states as previously reported for biopolymers using ESI-IMS-MS [101].  Further, one can 
readily observe the elongated features indicating con- formational differences within each 
charge state of each protein.  Similar observations have been reported, especially for 
ubiquitin, using a homebuilt ESI-IMS-MS instrument [106-109]. 
Many features become noticeable in a 2-D plot.  Without data extraction and 
time-intensive analyses, the pictorial snapshot [66] determines readily the presence of 
both proteins (Figure 5.2.2c).  By selecting the specific part of the 2-D plot using the 
DriftScope, it is possible to extract m/z and/or td information for any ion or inset region of 
interest.  This removes most of the background interference, especially those at lower 
m/z. Most importantly, charge state families of different proteins can be extracted, 
providing the respective mass spectrum for each protein. 
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Figure 5.2. LSI-IMS-MS using 2,5-DHB matrix and the solvent-based sample 
preparation method of (a) ubiquitin (MW 8561), (b) lysozyme (MW 14,304), and (c) a 
mixture of ubiquitin and lysozyme. (1) Total mass spectra (as if no IMS dimension is 
employed) and (2) two-dimensional plots of td vs. m/z ratio. 
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An example of extracting easily interpretable data from lower abundant ions is 
shown in Figure 5.3.  The mass spectrum of a mixture of ubiquitin and lysozyme, 
purposely designed to have a high signal to noise ratio and to be difficult to interpret, is 
shown.  It is not obvious from the mass spectrum that lysozyme is present, and it could 
easily be overlooked.  Because the mobility dimension provides clean separation of the 
multiply charged ions of these proteins (Figure 5.2.2c), mass spectra can be extracted for 
both proteins free of the other.  The extracted mass spectrum of lysozyme in the protein 
mixture is shown in Figure 5.3 and is similar to that of pure lysozyme (Figure 5.2.1b).  
The charge state distributions are essentially identical with the most abundant ions having 
charged state +9. 
 
Figure 5.3. The LSI-IMS-MS mass spectrum of the extracted lysozyme component 
from the two-dimensional IMS-MS plot displayed in Figure 5.2.2c. 
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CHAPTER 6 
LASERSPRAY IONIZATION-ION MOBILITY SPECTROMETRY-MASS 
SPECTROMETRY: BASELINE SEPARATION OF ISOMERIC AMYLOIDS 
WITHOUT THE USE OF SOLVENTS DESORBED    AND IONIZED DIRECTLY 
FROM A SURFACE “Reprinted (adapted) with permission from (Inutan, E.D.; 
Trimpin, S.  J. Proteome Res. 2010, 9, 6077-6081). Copyright (2010) American 
Chemical Society.” 
 
Introduction 
 No analytical method is available for detailed characterization of complex 
mixtures of closely related molecules present in tissue material. Challenges are related to 
many different factors associated with complexity including solubility, volatility, 
hydrophobicity, isobaric, and isomeric compositions.  Mass spectrometry (MS), with 
benefits that include high sensitivity, specificity, mass resolution and the ability to 
simultaneously characterize many constituents of a mixture, is a promising technique.  
Unfortunately, MS methods are limited to the separation of ions measured and displayed 
by m/z ratios and ion intensities.  Molecular structures, especially isomers, are inferred 
indirectly, if at all, through a combination of techniques such as liquid separation 
methods coupled with MS. Liquid based separation approaches perform poorly with 
solubility restricted materials [10,30] and can be inadequate for tissue analysis, especially 
if the need is to analyze the materials unadulterated and with a high spatial 
resolution.[110-113]  Further issues include the ionization efficiency, especially of 
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compounds with limited solubility, frequently complicating or preventing analysis. [96] 
Ion mobility spectrometry (IMS) MS has been noted for the ability to separate ions in the 
gas-phase according to the number of charges and cross-section defined by size and 
shape.[59-67] 
 Laserspray ionization (LSI) shows advantages relative to other MS based 
methods, especially for tissue imaging, and include improved spatial and volume 
resolution, more relevant atmospheric pressure conditions, faster analyses, extended mass 
range for analysis of high-mass analytes that are beyond the mass range limitations of 
high performance AP ionization mass spectrometers, and improved fragmentation using 
electron transfer dissociation.[28-29,31,41]  The desolvation conditions to obtain the 
highly charged protein ions from the charged matrix/analyte clusters are critical, 
especially for protein analysis, and are accomplished using 2,5-dihydroxybenzoic acid 
(2,5-DHB) matrix by heating the AP to vacuum ion transfer capillary to >400 C for 
good sensitivity.[29]  Unfortunately, most AP ionization mass spectrometers do not use a 
heated capillary for ion transfer from AP to vacuum. 
 Recently, LSI has been retrofitted to an IMS-MS instrument (SYNAPT G2) by 
constructing a heated desolvation device in front of the ion entrance orifice of the 
nanoelectrospray ionization (nano-ESI) source for evaporation of the matrix from the 
highly charged matrix/analyte cluster to give the multiply charged LSI ions.[49]  This 
was, for example, shown for a mixture of ubiquitin and lysozyme.[49]  The temperature 
capability of this home-built device is >250 C.  The necessity for proper desolvation 
conditions was exemplified by turning off the heat entirely.  Without external heat 
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applied to the copper tube, the ion current was fully lost using 2,5-DHB as matrix even 
though the metal tube was connected to the inlet skimmer maintained at 150 C. 
 Here, we introduce the ability for efficient desolvation of the highly charged 
matrix/protein clusters by lowering the thermal requirements of the matrix. This allows 
the operation at 150 C cone temperature available with the SYNAPT G2 mass 
spectrometer without applying additional heat to the desolvation tube, and more 
importantly, under lower temperature conditions that retain the proteins’ structure. 
Experimental Procedure 
Materials and sample preparation are included in Chapter 2.1, and the LSI set-up 
using the SYNAPT G2 mass spectrometer with the fabricated desolvation device is 
described in Chapter 2.2. For LSI-MS, 5 pmol µL
-1
 of ubiquitin, cytochrome C, and 
lysozyme were prepared individually in 50:50 ACN/water with 0.1% TFA, and insulin in 
50:50 MeOH/water with 1% acetic acid. Solutions of 10 pmol µL
-1
 each of β-amyloid (1-
42), β-amyloid (42-1), and the mixture of β-amyloid peptides (1-42) and (42-1) were 
made in 50:50 ACN/water with 0.1% TFA to obtain the LSI-IMS-MS. One µL sample 
solution was placed on top of the microscopy glass slide after which 1 µL of 2,5-DHAP 
matrix prepared in 50:50 ACN/water was added on top, and briefly mixed with the tip of 
the pipet. Three more times, 1 µL of matrix solution was added but without further 
mixing. The matrix/analyte spot was then blow dried with warm air. For ESI-IMS-MS, a 
10 pmol µL
-1
 solution of the isomeric mixture in 50:50 ACN/water with 0.1% TFA was 
used and infused at a flow rate of 1 µL min
-1
. The capillary voltage was set at 3 kV, 
sampling cone at 40 V, and extraction cone at 4 V. The ion source temperature was set to 
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150 C to mimic conditions with LSI. Desolvation gas flow was set at 500 L h-1 at a 
temperature of 150 C.  
Results and Discussion  
 LSI produces mass spectra from proteins that are nearly identical to those 
produced by ESI but has the advantages of fast analyses at high spatial resolution directly 
from surfaces. Thus, the method is potentially a powerful new approach to imaging. 
While the mass spectra seem very similar to ESI in charge state and relative charge state 
abundances, the method is considerable different in the approach to ion formation leaving 
questions relative to the softness of this ionization method. Concerns relate to possible 
destruction of the protein structure by the deposited laser energy and the applied heat for 
desolvation of the matrix/analyte cluster [29,31,49] which is necessary to obtain the ESI-
like multiply charged ions by laser ablation.[27] A new LSI matrix, 2,5-
dihydroxyacetophenone (2,5- DHAP), was shown to produce multiply charged ions using 
only the 150 C provided by the source heater supplied with the SYNAPT G2 Z-spray 
ion source. Typical mass spectra obtained for proteins using 2,5-DHAP and only the 
energy from the 150 C ion source temperature are shown in Figure 6.1. As noted above, 
the mass spectra appear very similar to ESI mass spectra. Multiply charged ions as high 
as +17 for cytochrome C (Figure 6.1C) are produced without the high temperature 
applied to the desolvation region that was required when using 2,5-DHB as an LSI 
matrix.[28] Further, when the desolvation device is removed entirely and the experiment 
performed with only the 150 C skimmer cone temperature, similar results related to ion 
abundance and charge state distribution of these proteins are obtained (Appendix A 
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Figure S10); however, significant low mass chemical background and contamination of 
the source are then observed.  
 
Figure 6.1. LSI-MS mass spectra of (A) insulin (MW 5731) in 50:50 MeOH/water with 
1% acetic acid, (B) ubiquitin (MW 8561), (C) cytochrome C (MW 12361), and (D) 
lysozyme (MW 14300) prepared in 50:50 ACN/water with 0.1% TFA using 2,5-DHAP 
matrix in 50:50 ACN/water with ion source temperature of 150 °C.  
   
 The importance of a soft LSI ionization relates to the desire to obtain structural 
conformation information directly from the solid state from proteins as in tissue imaging 
experiments. An advantage of the lower heat application is that mass spectra obtained 
under similar thermal conditions using ESI and LSI can be compared to determine the 
relative softness of the ionization methods. LSI using 2,5-DHAP generally produces 
lower charge states than ESI of the same proteins. The lower charge states have been 
shown to relate to more compact protein structures while higher charge states are 
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frequently elongated  by  Coulombic  repulsion  of  the  ions  subject  to conditions used 
for mass spectral acquisition such as sample preparation,  the  choice  of  solvent,  
skimmer  voltage,  and trapping times.[106,114,115]  The lower thermal conditions used 
with 2,5-DHAP  are  expected  to  be  beneficial  in  retaining  the proteins’ structure. To 
examine the validity of intact protein structure and the practical utility by LSI-IMS-MS, 
we studied β-amyloid (1-42),[10,96,116-118]  reversed β-amyloid (42-1), and the 
isomeric mixture of β-amyloid (1-42) and (42-1). β-Amyloid (1-42) is known to have low 
solubility in common ESI solvents.  
 Figure 6.2 shows the mass spectra (left panel) and the 2-D plots (right panel) of 
drift time vs. m/z for isomeric mixture (A) and the pure β-amyloids (B, C) obtained by the 
LSI method using 2,5-DHAP matrix prepared in 50:50 ACN/water and spotted on a glass 
microscope slide as described above and dried to completeness before laser ablation. The 
mass spectrum alone cannot distinguish one isomer from the other because of the same 
charge states and similar abundances (Figure 6.2.1), but the IMS-MS pictorial 
‘snapshot’14 readily shows separation and identification of the charge states from the 
isomeric mixture (Figure 6.2A2). The separation of the two isomers was then verified by 
analyzing the individual isomer samples (Figure 6.2B2 and C2). Thus, solvent-free IMS-
MS gas-phase separation successfully separated and clearly showed both components of 
the isomeric mixture. From the drift times shown in Figure 6.2.2, the β-amyloid (1-42) 
reveals a much more compact structure than the reversed β-amyloid (42-1) as one would 
expect from the aggregation tendency.[119]  
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Figure 6.2. LSI-IMS-MS of (A) an isomeric mixture of β–amyloid (1-42) and reversed β-
amyloid (42-1), (B) β-amyloid (1-42), and (C) β-amyloid (42-1) prepared in 50:50 
ACN/water with 0.1% TFA acquired using 2,5-DHAP matrix in 50:50 ACN/water. The 
(1) mass spectrum does not distinguish one isomer from the other, but the (2) 2-D plot of 
drift time vs. mass-to-charge (m/z) ratio snapshot clearly shows separation of the two 
components. 
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 Using the DriftScope, it is possible to extract m/z and drift time information for 
any ion or inset region of interest and give a much better insight to drift time separation. 
The extracted drift time distributions for the individual charge states +3 to +5 are shown 
in Figure 6.3A. Charge state +3, the lowest charge state and most compact structure of β-
amyloid (1-42) and (42-1), shows the least difference in shape as can be seen by some 
degree of overlapping drift time distributions for ions. Baseline separation without the 
use of any solvent is achieved for charge states +4 and +5 of this isomeric, solubility 
restricted protein mixture. Using 2,5-DHAP as matrix and the ion source temperature set 
to 150 C allows very similar instrumental conditions for  LSI- and  ESI-IMS-MS of  the  
 
Figure 6.3. Extracted drift times of an isomeric mixture of β-amyloid peptides (1-42) and 
(42-1) prepared in 50:50 ACN/water with 0.1% TFA acquired with the ion source 
temperature set to 150 °C by (A) LSI using 2,5-DHAP matrix in 50:50 ACN/water, and 
(B) by ESI obtained at a flow rate of 1 μL min-1. The drift times in (A) and (B) are nearly 
identical demonstrating similar or identical gas phase ion structures by the two ionization 
methods. 
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isomeric β-amyloid mixture. The results of such a comparison between ESI and LSI is 
shown in Figure 6.3 where the drift times for each charge states of the protein mixture 
were extracted and compared. The drift times of the ions for the isomeric mixture are 
essentially identical between LSI (Figure 6.3A) and ESI (Figure 6.3B) with the minor 
exception that the LSI drift distributions are frequently sharper and therefore produce 
improved baseline separation of the different isomeric structures. This is evidence that 
both ESI and LSI are energetically similar and temperature effects observed for ion 
structures studied by ESI might occur after the ions are released into the gas phase and 
not in the charged droplets.  
 Although ESI is the MS technique predominately used for amyloid peptide 
detection, for investigating cleavage sites for specific amyloid peptide interaction,[117]  
and to study mechanisms  of  initial  oligomerization  reactions,[118]   the  solubility 
issues [116] make LSI an alternative method to ESI. Hyphenated with IMS-MS, LSI is a 
suitable analytical method for characterizing complex mixtures and possible molecular 
conformations present in tissue material. In case of isomeric composition, IMS separation 
is reduced from separation according to the number of charges, size, and shape to the sole 
separation according to shape. The baseline separation achieved for the isomeric protein 
composition by solvent-free gas-phase separation using IMS-MS demonstrates the utility 
of soft desorption directly from a surface combined with soft desolvation for ion 
production by LSI in retaining the protein structure (shape).  
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CHAPTER 7 
LASERSPRAY IONIZATION - A NEW METHOD FOR PROTEIN ANALYSIS 
DIRECTLY FROM TISSUE AT ATMOSPHERIC PRESSURE AND WITH 
ULTRA-HIGH MASS RESOLUTION AND ELECTRON TRANSFER 
DISSOCIATION SEQUENCING “This research was originally published in Molecular 
and Cellular Proteomics (Inutan, E.D.; Richards, A.L.; Wager-Miller, J.; Mackie, K.; 
McEwen, C.N.; Trimpin, S. Mol. Cell. Proteomics 2011; 10:1-8) © the American Society 
for Biochemistry and Molecular Biology.” 
 
Introduction 
Tissue imaging by mass spectrometry (MS) is proving useful in areas such as 
detecting tumor margins, determining sites of high drug uptake, and mapping signaling 
molecules in brain tissue [111,120-,121,122,123,124,125,126]. Imaging using secondary 
ion mass spectrometry is well established but is only marginally useful with intact 
molecular mass measurements from biological tissue [127-129]. Matrix-assisted laser 
desorption/ionization (MALDI)-MS operating under vacuum conditions has been used 
for tissue imaging with success, especially for abundant components such as membrane 
lipids, drug metabolites, and proteins [113,130,131]. Spatial resolution of ~20 µm has 
been achieved [132], and the MALDI-MS method has been applied in an attempt to shed 
light on Parkinson disease [13,15], muscular dystrophy [133], obesity, and cancer 
[130,134]. 
Unfortunately, there are disadvantages in using vacuum-based MS for tissue 
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imaging in relation to analysis of unadulterated tissue. Also, the mass spectrometers used 
in these studies frequently have much lower mass resolution and mass accuracy than are 
available with atmospheric pressure ionization (API) instruments and are not as widely 
available. Because the vacuum ionization methods produce singly charged ions, mass-
selected fragmentation methods provide only limited information, especially for proteins. 
In addition, no advanced fragmentation such as electron transfer dissociation (ETD) 
[58,100,135] is available for confident protein confirmation or identification. 
Atmospheric pressure (AP) MALDI can be coupled to high performance mass 
spectrometers but suffers from sensitivity issues for tissue imaging where high spatial 
resolution is desired [136]. AP MALDI also primarily produces singly charged ions [2,3]. 
Thus, mass and cross-section analysis of intact proteins has yet to be accomplished using 
AP MALDI because of intrinsic mass range limitations of API instruments, which 
frequently have a m/z limit of < 4000. Thus, new improved methods of mass-specific 
tissue imaging, especially at AP, are needed. 
The potential of laserspray ionization (LSI) (Scheme 1.1.IA) [27-
31,41,49,50,137,138] for protein tissue analysis is reported here. LSI has advantages 
relative to other MS-based methods, including speed of analysis, laser ablation of small 
volumes, more relevant AP conditions, extended mass range and improved fragmentation 
through multiple charging, and the ability to obtain cross-section data for proteins on 
appropriate instrumentation. The applicability of LSI for high mass compounds on high 
performance API mass spectrometers (Orbitrap Exactive and SYNAPT G2) has been 
demonstrated producing ESI-like multiply protonated ions [28,29,49]. The first 
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experiments showing sequence analysis by ETD using the LSI method were successfully 
carried out on a Thermo Fisher Scientific (San Jose, CA) LTQ-ETD mass spectrometer 
[29]. Nearly complete sequence coverage was obtained for ubiquitin, an important 
regulatory protein. Applying ETD fragmentation to LSI-MS analyses potentially provides 
a new method for studying biological processes, including the mapping of 
phosphorylation, glycosylation, and ubiquitination sites from intact proteins and directly 
from tissue. 
Furthermore, unlike ESI and related ESI-based methods such as desorption-ESI 
[139], the LSI method has been shown to allow analysis of lipids in tissue from ablated 
areas < 80 µm [27]. In comparison with literature reports for AP MALDI at the same 
stage of development [140], LSI is more than an order of magnitude more sensitive and is 
capable of analyzing proteins on high resolution mass spectrometers as was demonstrated 
by obtaining full-acquisition mass spectra at 100,000 mass resolution (FWHH, m/z 200) 
after application of only 20 fmol of bovine pancreas insulin in the matrix 2,5-
dihydroxyacetophenone (2,5-DHAP) onto a glass microscope slide [31]. The analysis 
speed of LSI was demonstrated by obtaining mass spectra of five samples in 8 s [137]. 
Here, we show the utility of LSI for intact peptide and protein analyses directly from 
mouse brain tissue. The ability to obtain a protein mass spectrum directly from mouse 
brain tissue in a single laser shot at 100,000 mass resolution and with ETD fragmentation 
is demonstrated.  
Experimental Procedure 
Analysis of Aged and Fresh Tissue Samples - The mouse brain tissue sections used in 
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this study were shipped in dry ice before being delipified according to published 
procedure [74] and then again shipped overnight in dry ice. The aged, delipified tissue 
sample was stored for approximately 2 months at -5 °C. The delipification was initially 
obtained on the aged tissue sample and verified by MALDI-TOF-MS analysis. The 
optimized delipification conditions were used for further study comparing results 
obtained from MALDI- and LSI-MS analysis. A second set of mouse brain tissue 
samples were cut, frozen, and immediately shipped overnight. Each microscopy glass 
slide, plain and gold-coated, was mounted with four to five tissue sections. On receipt of 
the frozen samples, delipification of the tissue on glass slides was performed as described 
below, and again the samples were immediately frozen and shipped overnight for prompt 
LSI-MS analysis on an Orbitrap Exactive mass spectrometer. These samples were again 
frozen and shipped overnight for microscopy and subsequent MALDI-MS and LSI LTQ 
Velos analysis. 
LSI-MS of Mouse Brain Tissue - The glass microscope slide mounted with mouse brain 
tissue was prepared with the LSI matrix (5 mg mL
-1 
of
 
2,5-DHB or 2,5-DHAP, saturated 
solution) dissolved in 50:50 ACN/water by placing a number of 0.2-µL drops on top of 
the tissue material and allowing them to air dry. After solvent evaporation, the glass slide 
containing LSI matrix applied to mouse brain tissue was placed 2-3 mm in front of the 
mass spectrometer ion transfer tube entrance, moved manually through the laser beam, 
and aligned 180° relative to the ion entrance orifice (transmission geometry) (Scheme 
1.1IA). The AP to vacuum ion transfer capillary was heated to 375 °C for 2,5-DHB and 
300 °C for 2,5-DHAP, and the laser fluence per pulse was about 0.5-1 J cm
-2
. Multiply 
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charged ions were observed in the absence of an electric field in the ion source region. 
Both plain and gold-coated glass slides were used. 
LSI-ETD  – An LTQ Velos mass spectrometer with ETD capabilities was used as 
described in Chapter 2. The reaction time was set at 120 ms using an isolation width of 3 
amu. The activation time ranged from 25 to 50 ms for the precursor ions’ 917.5 (2+), 
1491 (12+), and 1789 (10+). A supplemental activation of 20 V was used for the 2+ 
precursor ion. A single 0.33-s acquisition was selected to obtain the ETD fragment ion 
mass spectra for peptide identification; the total ETD acquisition time was set for 1 min.  
LSI Tissue Imaging - Mouse brain tissue mounted on a glass microscope slide and 
coated with a saturated solution of 2,5-DHAP in 50:50 ACN/water using 0.2-µL drops 
was controllably moved through the laser beam with ablation in transmission geometry 
(Scheme 1.1IA) using an eTrack series xy-stage (Newmark Systems, Mission Viejo, 
CA). Lanes were at 100-µm intervals, and each lane was 10 mm long from which 22 s of 
data were acquired. For these studies, three mass spectral acquisitions were obtained per 
second with the laser operating at ~12 Hz. The ablated diameter for each laser shot after 
microscopy was ~15 µm (neglecting the stray beam commonly observed), which 
converts to an area of about 4(15) x 15 µm
2
 ablated per MS acquisition.  
MALDI-MS of Mouse Brain Tissue - A MALDI-TOF Bruker Ultraflex mass 
spectrometer (Bruker, Bremen, Germany) equipped with a nitrogen laser (337 nm) was 
used to monitor the success of the tissue delipification and for comparison with LSI 
results. The MALDI sample preparation was performed according to published work 
[74]. After washing the tissue and drying in the desiccator, the tissue was spotted with 
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0.2-µL of either sinapinic acid matrix dissolved in 50:50 ACN/water in 0.1% TFA or 2,5-
DHAP in 50:50 ACN/water. The mass spectrum was acquired using the linear positive 
ion mode with an accelerating voltage of 20.16 kV, extraction voltage of 18.48 kV, lens 
voltage of 7.06 kV, and pulsed ion extraction of 360 ns. Delayed extraction parameters 
were optimized to have the optimal resolution and sensitivity for the MALDI range was 
12-kDa. An increment of 30 laser shots was used, and shots were positioned and moved 
within a single matrix spot to obtain a mass spectrum having a total of 120 laser shots. 
The mass spectrum was processed and base line-corrected using the Flex Analysis 
software. Both plain and gold-coated microscopy slides were used; only gold-coated 
microscopy slides are expected to provide the correct mass calibration.  
Data Analysis - MASCOT Distiller version 2.3.2.0 (Matrix Science, London, UK) [141] 
was used to interpret ETD mass spectra for peptide and protein identification obtained 
from the LTQ-ETD Velos. The Mass Spectrometry protein sequence DataBase (MSDB) 
was searched using the no enzyme setting to obtain the sequence analyses directly from 
mouse tissue. Parameters were set to include acetylation, deamination, oxidation, 
methylation, and phosphorylation. The peptide and protein masses had to be within the 
mass tolerance characteristic of the mass spectrometer used for data acquisition. Searches 
within 1-Da mass error were performed, but to consider a peptide as well matched, it had 
to be within < 5 ppm of the mass obtained from the Orbitrap Exactive.  
Results and Discussion 
Evaluation of Experimental Conditions on Aged Tissue Sample - Tissue fixation 
or washing with solvents to extract lipids enhances the signal quality of peptides and 
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proteins and slows enzymatic processes, thus extending the useful life prior to analysis 
[142]. The washing solvent was selected based on previously reported studies [74,143] as 
well as from results we obtained from MALDI-MS analyses of tissue extracted with 
recommended solvents, ethanol and isopropanol. Here, the ethanol wash was selected 
because it gave higher intensity protein MALDI-MS signals using SA as the matrix. The 
guidelines developed by Schwartz et al. [144] for the proper handling of tissue sections 
(tissue storage, sectioning, and mounting) for peptide and protein analyses were applied. 
The choice of matrix and its deposition onto the tissue have been shown to be important 
in determining the subset of proteins extracted from the tissue and detected using MALDI 
[143]. For the MALDI analysis of the delipified mouse brain tissue, peptide and protein 
signals were detected using SA as matrix from m/z 5000 to 19,000 (Appendix A Figure 
S11) which is within the range that Seeley et al. [74] presented; the mass calibration is 
expected to be somewhat off for results in which plain microscopy glass slides without 
conductive coating were used. Only a few of the proteins detected give significant signal 
intensity similar to previous studies [130]. 
Once a satisfactory procedure for handling and delipifying mouse brain tissue was 
established for MALDI analysis, that method was applied for LSI-MS. Using 2,5-DHB as 
matrix, only lipids were observed even with the delipified tissue, similar to a previous 
report [27]. However, for the delipified tissue using 2,5-DHAP, lipids were observed in 
low abundance if at all, and signals for multiply charged ions having masses as high as 5–
19 kDa (at ZS1) were detected. A mass spectrum obtained from the Orbitrap Exactive at 
100,000 (FWHH, m/z 200) mass resolution by summing 15 1-s acquisitions is shown in 
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Figure 7.1 and represents ablation of most of the tissue covered by a 0.2-µL solution of 
2,5-DHAP. Because the mass resolution of the Orbitrap Exactive provides 
13
C isotope 
separation even for proteins, a single 
13
C isotope distribution is all that is necessary to 
determine the monoisotopic protein molecular weight with high mass accuracy (Figure 
7.1, insets). Ions observed just above noise, for which the monoisotopic peak cannot be 
reliably identified, provide a more accurate average mass than obtained with linear 
MALDI-TOF instruments. Figure 7.1B is the inset region from Figure 7.1A with the 
mass range displayed between m/z 650 and 1000. The multiply charged ions range from 
3+ to 8+, representing ions having molecular masses from approximately 650 to 5000 Da. 
For this data set, most ions were from compounds below 10 kDa. Because of the long 
storage time for the aged sample, it is possible that some of the observed multiply 
charged ions are from post-mortem enzymatic digestion of proteins [74,130]. The use of 
gold-coated and plain microscopy glass slides provides comparable abundance LSI mass 
spectra of the delipified tissue. As expected, no mass shift was observed in the AP LSI 
results using conductive or non- conductive glass slides; matrix placed below the tissue 
increased the ion abundance at the expense of a larger ablated area. Experiments without 
the addition of the LSI matrix did not provide any useful analytical results. Microscopy 
images of the aged mouse brain tissue after LSI analysis showed a variety of ablated 
areas, including numerous areas where the laser beam did not appear to penetrate the 
tissue (Appendix A Figure S12).  
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Figure 7.1. LSI mass spectra from aged mouse brain tissue washed with ethanol and 
spotted with 2,5-DHAP matrix in 50:50 ACN/ water using an Orbitrap Exactive mass 
spectrometer. A, full mass spectrum with insets showing multiple charged protein and 
peptide ions. B, limited mass range between m/z 650 and 1000 is displayed with 
monoisotopic molecular weights of the various multiply charged ions presented. Rel. 
Abund., relative abundance. 
 
The areas in which the tissue was completely ablated ranged in dimensions from ~3 to 9 
µm x ~5 to 25 µm. Because the laser was fired at several hertz as the tissue was 
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constantly moved through the laser beam, each 1-s acquisition was the sum of several 
laser shots. The elongated features observed in the microscopy image may be the result of 
multiple laser shots producing continuous ablation as the tissue was moved slowly 
through the beam. Holes in the tissue that appear to be from a single laser shot were 
typically < 30 µm
2
 (Appendix A Figure S13). For the 10-µm tissue thickness used in 
this study, these microscopy data suggest that the tissue volume below the ablated area 
represents ~300 µm
3
  for a single laser shot. However, to achieve this spatial resolution 
will minimally require matrix preparation methods that result in no diffusion of 
compounds outside the boundary area and improved mass spectral sensitivity. 
Comparison of LSI-MS and MALDI-MS Analysis on Fresh Tissue Samples - 
Successful results with the aged tissue samples prompted us to examine fresh tissue 
sections that were maintained at or below -20 °C except for short times required for 
mounting the tissue to the glass slide, delipification, mass spectral analysis, and 
microscopy. The fresh delipified samples using 2,5-DHAP matrix and acquired on the 
Orbitrap Exactive showed an abundant doubly charged LSI ion at m/z 917.50 (molecular 
weight 1833.0) and numerous other multiply charged ions at higher m/z values (Figure 
7.2). The highest mass protein with at least two observed charge state distributions had a 
molecular mass (monoisotopic) of 17,882 Da, although a single low abundance isotope 
distribution was observed for an ion having an average molecular mass of ~19,665 Da. 
Some of the lower molecular weight proteins observed in the aged tissue sample (Figure 
7.1) were also observed in the fresh sample but in lower abundance, whereas the higher 
mass proteins were significantly more abundant in the fresh tissue sample. Appendix A 
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Figure S14 shows that in a single laser shot the most abundant proteins were observed 
from the fresh tissue using the 100,000 mass resolution set- ting of the Orbitrap Exactive. 
The mass spectra for the single laser shot, the sum of seven laser shots, and the sum of 
the full acquisition for a 0.2-µL matrix deposition are shown in Appendix A Figure 
S14B. Notable differences between gold-coated (Appendix A Figure S15) and plain 
glass slides (Figure 7.2) were again not observed. Appendix A Figure S15 shows three 
isotope distributions each for multiply charge ions representing proteins having molecular 
masses of 9908, 11,788, and 12,369 Da (monoisotopic mass). 
 
Figure 7.2. LSI-MS summed full and inset mass spectra of delipified fresh tissue on 
plain glass slide spotted with 2,5-DHAP matrix in 50:50 ACN/water showing multiple 
charged protein ions using Orbitrap Exactive mass spectrometer. Rel. Abund., relative 
abundance. 
 
A fresh tissue section from the same mouse was delipified and immediately mass-
measured on an LTQ Velos instrument. The multiply charged ions described above for 
fresh tissue were observed. The mass spectrum from summing multiple acquisitions on 
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the tissue slice is provided in Figure 7.3A. The distribution of multiple charged ions of 
the protein having molecular weight 11,788, however, could be observed in a single 
acquisition representing one laser shot (Figure 7.3B1). Single laser shots in different 
areas of the mouse brain tissue gave different results. For example, Figure 7.3B2, also 
from a single laser shot, shows the protein at molecular weight 17,882 in lower 
abundance than the first protein of molecular weight 11,788, and a peptide having a 
molecular weight of 1833 was observed more in the center than the edges of the tissue. 
The ability to acquire a mass spectrum from a single laser shot using a relatively 
inexpensive nitrogen laser suggests the potential for high speed tissue imaging. 
Potential of Tissue Imaging Using LSI - To evaluate the potential for tissue 
imaging using LSI, a crude experiment was performed using a glass  slide with mounted 
mouse  brain tissue that was coated with the matrix 2,5-DHAP by depositing 0.2-µL 
droplets of a saturated solution of 50:50 ACN/water over the tissue surface and allowed 
to air dry. This matrix deposition method is not suitable for tissue imaging because 
delocalization of compounds in the tissue and uneven matrix deposition are expected with 
this approach. An attempt at spray applying the matrix from solution, which is a more 
appropriate matrix deposition method, resulted in very low abundances  of peptide and 
protein   ions   (Appendix A Figure S16). Clearly, improved matrix preparation 
conditions for LSI imaging are needed. Nevertheless, attaching the glass microscope slide  
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Figure 7.3. LSI-MS spectra of delipified fresh tissue on plain glass slide spotted with 
2,5-DHAP matrix in 50:50 ACN/water using LTQ Velos. A, sum of the full acquisition. 
B1 and B2, single acquisitions at different tissue locations showing different protein 
abundances. The ions observed around m/z 760 are from lipids. 
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to a computer controlled xy-stage allowed a crude image of mouse brain tissue to be 
obtained. Mass-specific imaging for two charge states of the protein with MW 11,788 
and one charge state of the protein with MW 12,369 is shown in Appendix A Figure 
S17. Several other peptides and proteins gave sufficient signal intensities in single 
acquisitions to produce crude images. Obtaining higher shot-to-shot reproducibility and 
increased analyte ion abundances are areas that require further research. 
Microscopy images of the laser-ablated tissue after the imaging analysis are 
shown in Figure 7.4. Rows spaced at 100-µm intervals of single laser shots are readily 
seen. The individual laser-ablated areas in this experiment, as determined by optical 
microscopy, are ~15 µm in diameter.  
 
Figure 7.4. Optical images of laser-ablated areas obtained in im- aging experiment. A, 
20x magnification. B, 100x magnification. Arrow denotes 15 µm. 
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The mass spectrum shown in  Appendix A Figure S18 is of a single MS acquisition 
during which time four laser shots impacted the tissue in adjacent positions. Thus, each 
mass spectral acquisition was of a visibly ablated area of approximately 15 x 4 x 15 µm
2
. 
It is clear from these images that the laser beam frequently completely ablates the tissue 
and matrix producing sufficient ions to be detected. The 10-µm-thick tissue slices likely 
absorb a fraction of the laser energy before it is absorbed by the matrix.  
The LSI method introduces remarkable speed and simplicity of analysis compared 
with reflective geometry MALDI where frequently >100 laser shots are summed to 
provide each data point in the image [145,146]. For tissue imaging experiments, high 
repetition and therefore expensive lasers are required to keep the analysis time reasonable 
(hours vs. days). The ability to obtain mass spectra of proteins directly from tissue in a 
single or even a few summed laser shots using the LSI approach suggests the potential for 
using less expensive lasers to achieve comparable analysis speed relative to high 
repetition laser MALDI. For the crude imaging experiment reported here, the laser 
repetition rate was ~12 Hz, and each lane received 89 laser shots in 22 s. With 100-µm 
spacing between rows, 80 rows were required to image the mouse brain tissue. Thus, 
actual acquisition time was only about 30 min. This work demonstrates the potential 
speed of this method for tissue analysis or imaging.  
The ability to obtain mass spectra of proteins directly from tissue using LSI offers 
considerable potential in tissue analysis. However, difficulties that need to be addressed 
before tissue imaging becomes a reality using LSI are increased ion abundances from 
single acquisitions and higher shot-to-shot reproducibility. We expect reproducibility is 
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related to uneven tissue thickness, the condition of the tissue, matrix application, and the 
laser flux per unit area. Just as in MALDI imaging, matrix application in LSI is a crucial 
step. The dried droplet method of spotting matrix that was used in the present study is 
inappropriate for tissue imaging studies. We are currently beginning research aimed at 
improving solvent-based and solvent-free matrix preparation methods for tissue imaging 
using LSI. Future advances also need to incorporate solvent-free gas-phase separation for 
efficient simplification of complexity of the produced gas-phase ions [10,30,49].  
For comparison purposes, sequential tissue sections from the same mouse brain 
used for the fresh tissue studies mounted on gold-coated and plain glass slides were used 
for vacuum MALDI-MS analysis. One-half of each delipified tissue section was coated 
with 2,5-DHAP, and the other half was coated with SA applying several 0.2-µL matrix 
solutions. Interestingly, none of the observed molecular weights are common between 
LSI using 2,5-DHAP and MALDI using either 2,5-DHAP or SA. MALDI with the 2,5-
DHAP matrix gave poor results, which may help explain the different proteins observed 
between vacuum MALDI and LSI.  
ETD Fragmentation of Peptides Directly from Tissue - Because LSI produces ESI-like 
multiply charged mass spectra directly from tissue, it becomes possible to achieve ETD 
fragmentation of these ions. This  is demonstrated  for the doubly charged peptide ion 
that was observed at m/z 917.5 (molecular weight 1833) for a single ETD acquisition 
representing four single laser shots, each on fresh spots of the tissue obtained on the 
LTQ-ETD Velos mass spectrometer (Figure 7.5). Table I shows the result of the 
MASCOT search obtained from the single acquisition data. A MASCOT score of 73 (67 
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is considered to be significant) was achieved for the peptide having the sequence Ac-
ASQKRPSQRSKYLATA that also is well within the 5-ppm mass tolerance for this 
peptide acquired on the Orbitrap Exactive.  
 
Figure 7.5. LSI-ETD single scan acquisition mass spectrum at precursor ion 917.5 (+2) 
of delipified fresh mouse brain tissue on plain glass slide spotted with 2,5-DHAP matrix 
in 50:50 ACN/water using LTQ Velos. 
 
This sequence encodes for the myelin basic protein N-terminal fragment that is 
known to occur in mouse brain. The labeled masses in Figure 7.5 are the predicted “c” 
and “z” fragments expected from ETD fragmentation of this peptide. The only missing 
sequence ions are related to the proline residue. It is clear that synergy exists between 
accurate mass measurement and ETD for reducing the number of hits obtained by 
database searching. ETD fragment ions and accurate mass measurement were also 
obtained for m/z 1491 and m/z 1789, which are the 12+ and 10+ charge states, 
respectively, for the protein of molecular weight 17,889 (Appendix A Figure S19). We 
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are in the process of attempting to identify this protein. These first results demonstrate the 
potential of LSI for protein identification directly from tissue and are a significant 
advance over current methods in which the identity of the ions observed are made only 
from an approximate average mass value of the proteins known to be in the tissue.  
Table 7.1 LSI-ETD MASCOT scores for m/z 917.5. The Delta value is the difference 
between the calculated mass for the sequence shown and the accurate mass measurement 
obtained from the Orbitrap at 100,000 mass resolution. Only sequences with a Delta 
0.005 were within the mass tolerance of the mass. 
                    Table 7.1 LSI-ETD MASCOT scores for m/z 917.5. 
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CHAPTER 8 
COMMERCIAL INTERMEDIATE PRESSURE MALDI ION MOBILITY 
SPECTROMETRY MASS SPECTROMETER CAPABLE OF PRODUCING 
HIGHLY CHARGED LASERSPRAY IONIZATION IONS “Reprinted (adapted) 
with permission from (Inutan, E.D.; Wang, B.; Trimpin, S. Anal. Chem. 2011, 83, 678-
684). Copyright (2011) American Chemical Society.” 
 
Introduction 
Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (MS),  
for  over  20  years,  has  been  an important analytical method for a variety of ﬁelds, 
especially those related to analysis of synthetic and biopolymers.[2,3,10,147-150] The 
method has been extended from a vacuum technique in which time-of-ﬂight (TOF) mass 
analyzers provided nearly unlimited mass range to intermediate pressure (IP; ~0.2 Torr) 
and atmospheric pressure (AP) techniques interfaced to mass analyzers having limited 
mass-to-charge (m/z) range.[21,75,136] Production of singly charged ions on these m/z 
limited instruments eliminates the ability to mass analyze the singly charged ions of high-
mass compounds. Further, the most accepted ionization mechanism for MALDI involves 
ion molecule reactions occurring in the laser plume similar to atmospheric pressure 
chemical ionization (APCI).[82] An undeﬁned fraction of the analyte is available for 
ionization by this mechanism because a substantial fraction is ablated as matrix/analyte 
droplets or clusters.[31,36,37,94,151] Some reports have speculated that the singly 
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charged ions produced by MALDI originate from these clusters.[54,85,152] Several 
mechanisms by which the clusters become charged have been suggested.[35,54,55,82] 
Laserspray ionization (LSI) was the ﬁrst example of laser ablated matrix/analyte 
producing electrospray ionization (ESI)-like multiply charged ions.[27-31,41,48-
50,137,138]  Deﬁning features of LSI are AP conditions, the absence of applied ionizing 
voltage, the necessity of a heated region in the AP to vacuum interface, and the use of 
lasers and matrix compounds commonly employed in ultraviolet (UV)-MALDI (e.g., 2,5-
dihydroxyacetophenone, 2,5-DHAP and 2,5-dihydroxybenzoic acid, 2,5-DHB) 
[153,154]. Thus, LSI has the attributes of MALDI related to analysis of compounds 
directly from surfaces with high spatial resolution and the attributes of extended mass 
range and improved fragmentation associated with multiply charged ions in ESI. LSI is 
most commonly applied using transmission geometry (TG) where the laser beam strikes 
the matrix/analyte from the backside relative to the ion entrance oriﬁce of the mass 
analyzer. While TG is not a requirement for LSI,[41]  it is of practical importance for 
simplicity of alignment, reproducibility, speed of acquisition, and especially the potential 
of high spatial resolution imaging.[27,48]  MALDI, especially in vacuum, uses a laser 
ﬂuence near the ionization threshold to achieve ions with a low energy spread and, thus, 
improved mass resolution. Therefore, numerous laser shots are typically acquired and 
summed to produce a mass spectrum, while LSI can achieve ultrahigh resolution even at 
high laser ﬂuence, often providing good results from a single laser shot.[48,138] 
Nevertheless, vacuum MALDI has been shown to be more sensitive than either AP-
MALDI or AP-LSI.  
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Here, we report the ﬁrst example of producing highly charged LSI ions using 
vacuum conditions (ca. 0.16 Torr). The results were achieved on a commercial 
intermediate pressure (IP)-MALDI ion source interfaced to a Waters SYNAPT G2 ion 
mobility spectrometry (IMS) MS instrument using conditions common with AP-LSI. 
Multiply charged ions are also produced in MALDI under vacuum conditions, but the 
average mass-to-charge ratio is much higher than reported here. To our knowledge, the 
only similar charge state distribution achieved under vacuum conditions two orders of 
magnitude higher (~30 Torr) than here was with ESI operated under special conditions 
for the purpose of the use of ion funnel technology for ion focusing.[94] Besides the 
fundamental implications of this work, an important potential analytical advantage of IP-
LSI, other than use of a commercial instrument, is the potential for high sensitivity 
equivalent or better than AP-LSI and vacuum MALDI. We demonstrate that analysis of 
peptides directly from tissue produces nearly identical mass spectra and drift time 
distribution appearance observed with AP-LSI and from solution using ESI. 
Experimental Section 
Analyte solutions were prepared individually in 50:50 ACN/water with 0.1% TFA 
(ACTH), 50:50 ACN/water with 0.1% FA (N-acyl MBP fragment), 50:50 MeOH/water 
with 1% acetic acid (Ang I, GFP, BI), and 49:49:2 ACN/water/acetic acid (ubiquitin). 
The matrix solutions were prepared saturated (20 mg of 2,5-DHB in 100 μL of 50:50 
ACN/water with 0.1% TFA, 10 mg of CHCA in 2 mL of MeOH/ACN, and 5 mg of 2,5-
DHAP in 150 μL ACN, vortexed for a few minutes, then 150 μL water was added and 
vortexed again until a darker yellow solution is obtained). The matrix/analyte mixture 
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was prepared in 1:1 volume ratio to make the final concentration of the analyte 1 pmol 
μL-1 before deposition on the target plates. One microliter of the matrix/analtyte mixture 
was used and deposited on metal and glass plates using the dried droplet method.[3] The 
model mixture composed of 1 pmol Ang I, 2 pmol GFP, 2 pmol BI, and 2 pmol SM was 
prepared in 50:50 MeOH/water with 1% acetic acid. For the tissue sample, an aged 
delipified tissue slice prepared as described in a previous study,[48] was spotted with 0.2 
μL of the 2,5- DHAP matrix solution and allowed to air-dry prior to analysis.  
LSI at IP using the MALDI source of SYNAPT G2 - An IMS-MS SYNAPT G2 (Waters 
Corporation) with an IP-MALDI source operating using a Nd:YAG laser (355 nm) was 
employed in this study. Instrument parameters and acquisition conditions are included in 
Chapter 2.3.  
LSI at AP using the NanoESI source of SYNAPT G2 – The description of the set-up is 
included in Chapter 2.2. The LSI sample holder was slowly moved through the focused 
laser beam using the xy-direction of the stage.   
ESI-IMS-MS - The Waters SYNAPT G2 instrument was operated in mobility-TOF using 
positive ion sensitivity mode. A 1 pmol μL-1 solution of MBP in 50:50 ACN/water with 
0.1% TFA was infused at a flow rate of 1 μL min-1. The capillary voltage was set at 3 kV, 
sampling cone at 50 V, and extraction cone at 4.4 V. Desolvation gas flow was at 800 L 
h-1 and at a temperature of 150 °C. 
MALDI-TOF-MS - A MALDI-TOF Bruker Ultraflex mass spectrometer (Bruker, 
Bremen, Germany) equipped with a nitrogen laser (337 nm) was used to acquire the mass 
spectrum of the same mixture/analyte used in IP studies on the IMS-MS SYNAPT G2 
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mass spectrometer. The mass spectra were acquired using the reflectron positive-ion 
mode with a reflectron voltage of 20.30 kV and an ion source lens voltage of 8.85 kV. 
Laser repetition rate was set at 20 Hz and increments of 20 laser shots were used to 
acquire the mass spectrum with a total of 100 shots. The laser attenuation was set at 45%, 
55%, and 70% (highest laser fluence) for CHCA, 2,5-DHB, and 2,5-DHAP, respectively. 
Flex Analysis software was used to process the data and obtain the mass spectrum. 
Results 
The mass spectra obtained at IP on a commercial MALDI-IMS-MS (SYNAPT 
G2) are nearly identical in charge state to mass spectra obtained using ESI and LSI on the 
same instrument at AP. A number of parameters were explored for their inﬂuence to 
provide multiply charged peptide and protein ions with high abundance and good 
reproducibility. These include the sample support (glass and metal), matrixes (2,5-DHAP, 
2,5-DHB, CHCA), solvent (MeOH, water, ACN, and combinations thereof),  laser  
ﬂuence  (relative  values,  with  settings:  low  “50” to highest “500”), and pressure (IP 
and high vacuum MALDI instruments). Typical IP results are shown in Figure 8.1 for 
Ang I, BI, and ubiquitin, though with increasing molecular weight, the ion abundance 
decreases notably. As is the case in LSI at AP using laser alignment in reﬂective 
geometry,[41] both glass and metal plates can be used at IP (Appendix B Figure S1). 
The glass plate provided higher abundance than a metal target plate for multiply charged 
ions and less chemical background, a well-known issue in MALDI.[94] 
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Figure 8.1. IP-LSI-IMS-MS mass spectra using a glass plate, 2,5-DHAP matrix 
(50:50ACN/water), “200” laser power: (A) angiotensin I (methanol/water with 1% acetic 
acid), (B) BI (methanol/water with 1% acetic acid), (C) ubiquitin (49:49:2% acetic acid). 
  
90 
As with AP-LSI, the best results were obtained with 2,5-DHAP (vs. CHCA and 
2,5-DHB, Appendix B Figure S2). Also similar to previous studies [41] on a commercial 
AP-MALDI  source  on  an  Orbitrap  XL  using  2,5-DHAP  and reﬂection geometry, 
irreproducibility is encountered  at  relative low threshold laser ﬂuence by the inability to 
observe ions after a couple of laser shots at the same location. Moving to the next spot 
and increasing the laser ﬂuence improved the reproducibility. We relate this issue to the 
laser aligned in reﬂection geometry and not to IP conditions; in transmission geometry, 
this is not observed because the sample in the path of the laser beam is completely 
ablated in a single shot. [48,138]  In MALDI, ﬁrst shot phenomena have been reported 
for the analysis of molecular complexes.[155,156] 
Another interesting phenomena affecting the relative abundances of singly and 
multiply charged ions produced by IP is the sample preparation and morphology as 
determined for 2,5-DHAP using microscopy. The crystallized LSI matrix/analyte sample 
showed a ﬂat ﬁlm-like appearance around the edge and a center with a ﬂuffy crystalline 
appearance (Appendix B Figure S3). Mass spectral results showed that the center 
provided more abundant multiply charged ions (Appendix B Figure S4) while the outer 
ﬁlm produced more singly charged ions. The similarity to results obtained using AP-LSI, 
suggests that a similar ionization mechanism is active at IP, and thus, we refer to this new 
method as IP-LSI.  
The commercial MALDI source at IP allows for the ﬁrst time a precise 
assessment of the laser ﬂuence on the production of highly charged LSI ions. The effect 
of laser ﬂuence on the formation of multiply charged ions is notable for any of the 
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matrixes. Results are summarized in Appendix B Figure S5 for Ang I and Appendix B 
Figure S6 for MBP, a neuropeptide, using in both cases 2,5-DHAP matrix. At very low 
laser ﬂuence of “50” and “100” low abundant MBP ions are detected barely above the 
baseline. At “150”, highly charged ions are observed but in relative low abundance and 
with essentially no chemical background. At “200”, the ion abundances of the highly 
charged ions increase by a factor of 3 vs. “150”, also with essentially no chemical 
background signals. With increasing laser ﬂuence up to “500”, matrix signals start to 
show up and the relative intensity of the multiply charged ions increases for the lower 
charge states and formation of singly charged ions become much more evident. At the 
highest laser ﬂuence of “500”, the doubly charged ions are the base peak for both 
compounds but the triply charged ions are signiﬁcantly reduced in abundance. Further, 
the ion abundance of the background increases to the point of overwhelming the ion 
intensity of both the multiply and the singly charged ions present in the mass spectra. 
Increasing the laser ﬂuence to “500” provided only highly charged but no singly charged 
ions of BI (Appendix B Figure S7).  
Only singly charged ions (Ang I, GFP, ACTH, BI) are observed using the same 
matrix/analyte samples on a high vacuum commercial MALDI instrument (Appendix B 
Figure S8) with glass or metal sample plates using 55% and 70% laser ﬂuence for CHCA 
and 2,5-DHAP matrixes, respectively. Higher laser ﬂuence was necessary for 2,5-DHAP 
in comparison to CHCA and 2,5-DHB for the detection of singly charged analyte ions. 
2,5-DHAP produced low abundant doubly charged ions for ACTH and BI at high laser 
ﬂuence under vacuum MALDI conditions, whereas the other matrixes only produced 
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singly charged ions. These results suggest that matrix/analyte clusters are formed under 
vacuum conditions, similar to suggestions by Karas, Tabet, and others,[54,85,152] but 
multiply charged ions are only observed with proper desolvation conditions, which in this 
case are produced primarily by the choice of matrix and laser ﬂuence.  
The evaluation of parameters under our control on the SYNAPT G2 allowed 
extension of the mass range at IP to proteins as large as ubiquitin with charge states to 
+12 (Figure 1C, laser “200”, and Appendix B Figure S9, laser “500”). There are no 
provisions to provide heat in the pressure drop region between the IP source and the high 
vacuum of the mass analyzer. Previous AP-LSI studies  on a  LTQ  Velos  (Thermo  
Fisher  Scientiﬁc)  with  the capability of heating the ion inlet capillary to 450 °C 
produced highly charged ions of carbonic anhydrase (~29 kDa) with charge states up to 
+27.[138] Interestingly, with the SYNAPT G2, it appears that the helium gas associated 
with the IMS region is of critical importance. Only singly charged ions are observed, as 
expected from a MALDI process without added helium gas, but the addition helium gas 
results in observation of multiply charged ions (Appendix B Figure S10). We assume 
this is a result of desolvation of charged clusters and are currently developing methods to 
apply heat within the IP region with the expectation that similar sensitivity [29] and mass 
range [138] enhancements observed with AP-LSI will be observed at IP-LSI.  
The practical utility of this novel ionization method is shown for analysis of a 
mixture composed of a lipid (SM), peptides (Ang I, GFP), and a small protein (BI) using 
the common LSI matrix 2,5-DHAP, a glass plate sample holder, and the maximum laser 
ﬂuence provided by the manufacturer settings (Figures 2 and S11, Appendix B) metal 
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plate of mixture; Figures S12 and S13 (Appendix B) pure samples with low and high 
laser ﬂuence). Interestingly, the lipid and small peptide showed metal adducted singly 
charged ions especially with high laser ﬂuence.  Collision-induced dissociation can be 
used to characterize lipid compositions directly from tissue (Appendix B Figure S14). 
 
 
Figure 8.2. IP-LSI-IMS-MS of a model mixture of angiotensin I (Ang I), sphingomyolin 
(SM), [Glu1]-fibrinopeptide B (GFP), and bovine insulin (BI) using a glass plate, 2,5-
DHAP matrix (50:50 ACN/water), and “500” relative laser power: (A) 2-D plot of drift 
time vs. m/z and extracted drift time for +4 BI, +2 and +1 Ang I ions; (B) total mass 
spectrum and inset spectrum of +4 BI ion. 
 
Figure 2A shows the 2D data set of drift time vs. m/z separations of the IP-LSI-
IMS-MS measurement of this model mixture at a laser ﬂuence of “500”. In the total mass 
spectrum (Figure 2B), the most abundant signal is from Ang I observed with charge 
states +1 and +2. The other components of the model mixture, especially the higher 
charge states of the protein, are not very noticeable because of the low signal intensity as 
compared to the higher abundant Ang I. Because of the exquisite sensitivity for the entire 
sample composition, the IMS-MS 2-D display allows these ions to be readily visualized 
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(Figure 2A).  
Singly charged ions of lipids and peptides fall nearly on the same diagonal 
indicating little separation in the IMS dimension. However, the charge states +1, +2, and 
+3 are well separated from each other and readily observed individually. The highly 
charged bovine insulin ions +4, +5, and +6 fall on a diagonal line that is well separated 
from lower charge states +3, +2, and +1. The relative drift times of the diagonal lines 
drawn through the different components in the sample are highly charged protein ions +6, 
+5, and +4 < multiply charged peptide and protein ions +3 and +2 < singly charged 
matrix ions < singly charged peptide and lipid ions. The separation trend is in accord with 
previous studies using vacuum MALDI-IMS-MS.[157-162] Here, the extent of 
separation between the highly charged and the singly charged ions is of notable analytical 
utility.  
Comparison of the results obtained with IP-LSI to those obtained with AP-LSI 
(Appendix B Figure S15) shows that, at IP using low laser ﬂuence of “200”, the results 
closely resemble those obtained with unattenuated laser ﬂuence at AP. Increasing the 
laser ﬂuence at IP to “300” increases the abundance of the singly charged lipid and 
peptide ions at the expense of a notable increase in matrix background and decrease of 
the abundance of higher charged ions. 
A second set of comparison experiments was applied to obtain data directly from 
mouse brain tissue using IP-LSI-IMS-MS (Figure 3). This same tissue section was 
previously analyzed using AP-LSI-MS in combination with ultrahigh mass resolution and 
electron transfer dissociation (ETD) enabling identiﬁcation of an endogenous 
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neuropeptide directly from its native and complex environment.[48] At IP, charge state 
families similar to the model mixture in Figure 2 were observed ranging from charge 
state +1 to +3. Extracting diagonal slices through the 2D data set in Figure 3 provide 
mass spectra that deconvolute the different charges states, as is exempliﬁed by the 
extracted mass spectrum and inset mass spectra for charge state +2 shown in Figure 
8.4A. 
 
Figure 8.3. IP-LSI-IMS-MS of a delipified mouse brain tissue (analyzed previously,[31]) 
using a glass plate, 2,5-DHAP matrix (50:50 ACN/water), and “500” relative laser 
power: (A) 2-D plot of drift time vs. m/z and extracted drift time for +3 peptide and +1 
lipid ions; (B) total mass spectrum and inset spectrum of +3 ion and the ion (+2) with the 
largest MW 3216. 
 
 The highest molecular weight peptide observed is 3216 Da. Previous studies of 
the same tissue using AP-LSI-MS on LTQ Velos and Orbitrap mass spectrometers 
showed low abundant protein ions up to MW ca. 19,665 Da.[48] The extracted slices 
from the 2-D data set permit examining in detail the different charge-state distributions 
(+2, Figure 8.4A) and drift time distributions (Figure 8.4B; Figures S16 and S17, 
Appendix B, for lipids and peptides) even of low-abundant ions that would otherwise be 
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diffcult to extract (e.g., charge state +2 vs. charge states +1 or +3).  
 
 
 
Figure 8.4. Extracted data from Figure 3: (A) mass spectrum of chargestate family +2 
and respective inset mass spectra; (B) drift time distributions of charge states +1 to +3: 
(1) N-acetylated fragment of myelin basic protein (characterized previously by ETD,[8]) 
and (2) from the synthesized neuropeptide (+1, +2, and +3, MW 1833). 
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Drift time distributions can be extracted for speciﬁc m/z values from which cross 
sections can be determined using a calibration approach.[163] These values can give 
insight into structures when combined  with  computer  modeling  approaches [164-176]   
or aid identification when standards are available.[50,66] For example, Figure 8.4B 
shows the drift time distributions obtained for +1, +2, and +3 charge states for the N-
acetylated fragment of myelin basic protein with a MW of 1833 Da. Narrower drift time 
distributions are observed with increasing charge state. The drift time distributions of the 
singly charged ions are, however, unexpectedly broad, as is the case for any of the 
peptides that showed singly and doubly charged ions (Appendix B Figure S16). The 
singly charged ions obtained from the deﬁned lipid, peptides, and protein mixture 
analysis (Appendix B Figure S17) also showed notably broader drift time distributions 
relative to the multiply charged ions. The width of the drift time distributions may 
indicate more than one ionization mechanism for singly charged ion production.  
For further insight, we obtained the custom synthesized neuropeptide that was 
previously identiﬁed directly from tissue by a MASCOT search of LSI data from a LTQ-
ETD and Orbitrap Exactive.[48] The extraction of the drift times of the IP-LSI-IMS-MS 
measurements of singly charged ions (Figure 8.4B) again showed the unusual broad drift 
time distributions as compared to the multiply charged ions. Importantly, the endogenous 
neuropeptide and the standard sample provide identical drift time distributions for charge 
states +1 to +3 obtained by IP-LSI-IMS giving further conﬁrmation of the structure 
present in the tissue. We noted earlier that the charge state and drift time distribution 
appearance is nearly identical for the synthetic neuropeptide sample to that observed in 
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AP-LSI or ESI IMS-MS (Appendix B Figures S18-S19) but with the important 
difference that singly charged ions are not present under AP conditions even though AP-
LSI uses signiﬁcantly higher laser ﬂuence than those used with IP-LSI. Previous 
investigations of isomeric beta amyloid peptide mixtures showed baseline separation 
using a LSI-IMS-MS (SYNAPT G2) approach,[50] strongly suggesting that even rather 
small differences in the structures of the peptides would be observed using the IMS-MS 
approach. 
Discussion 
The production of highly charged ions using a commercial IP-MALDI source has 
important analytical implications but is also of fundamental interest. As noted previously, 
a number of authors have suggested ion formation in MALDI occurs from charged 
matrix/analyte clusters or droplets.[54,55,85,94,152]  Garrison and co-workers ﬁrst 
modeled formation of matrix droplets by vacuum laser  ablation  of  a  solid  
matrix.[36,38]   Tabet  and  co-workers postulated on the basis of Karas's lucky survivor 
model [152] that two energy-dependent processes exist for ion formation from 
matrix/analyte clusters: hard desolvation leading to low charge states (+1) by emission of 
charged matrix molecules and soft desolvation leading to multiply charged ions (+2) by 
emission of neutral matrix molecules in a process similar to the mechanism proposed for 
ESI. This study was based primarily on relative abundances of +1 and +2 ions produced 
at different laser ﬂuences. If, in fact, MALDI ions are produced from charged clusters, 
then the results presented here are the logical extension of this process as would be the 
case with AP-LSI. However, both AP-LSI and the work presented here have almost 
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identical outcomes for various matrix compounds tested and, thus, we refer to the 
methods as AP-LSI and IP-LSI rather than MALDI methods. Not only do these methods 
produce highly charged ions not previously observed with MALDI but also the out- come 
of all experiments to date is nearly identical to matrix assisted ionization inlet (MAII) 
results.[39] MAII requires no laser and, thus, is outside the deﬁnition of MALDI. 
However, it is not clear yet if ions can be produced at IP with MAII, at least without a 
source of thermal energy. The laser ﬂuence in IP-LSI may provide the energy that the 
heated inlet provides in AP-LSI and MAII for the initial ionization. The ability to extend 
the LSI/MAII methods to vacuum conditions also poses new questions relating to the 
MALDI mechanism and has the potential to even shed new light on the ionization 
mechanism in ESI. 
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CHAPTER 9 
LASERSPRAY IONIZATION IMAGING OF MULTIPLY CHARGED IONS 
USING A COMMERCIAL VACUUM MALDI ION SOURCE “Reprinted (adapted) 
with permission from (Inutan, E. D.; Wager-Miller, J.; Mackie, K.; Trimpin, S. Anal. 
Chem. 2012, 84, 9079–9084). Copyright (2012) American Chemical Society.” 
 
Introduction 
Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (MS) 
produces abundant singly charged ions of peptides from the solid state under low 
pressure, intermediate pressure, and atmospheric pressure conditions.[3,21,75] Time-of-
ﬂight (TOF) is the common mass analyzer used with low-pressure MALDI and in 
principle provides unlimited mass range for detection of large molecules.[177] A 
limitation of the production of primarily singly charged ions is that high-mass compounds  
cannot  be  analyzed  using  high-performance instruments  with  only  a  limited  mass  
range  such  as  Fourier transform ion cyclotron resonance, Orbitrap, or ion mobility 
spectrometry (IMS) (SYNAPT G2) mass spectrometers. MALDI imaging mass 
spectrometry has provided information on spatial distributions of lipids,[162,178] 
peptides,[179] and proteins [180] directly from biological tissue sections, and MALDI-
IMS-MS imaging has been applied for lipids [113,162] and peptides [162] as well as 
studying protein changes related to several diseases such as Alzheimer’s   and   
Parkinson’s [13,15,16] as   well   as   cancer.[124,181,182] Secondary ion mass 
spectrometry (SIMS) has also been used to map the distribution of cancer 
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chemotherapeutic agents in tissues and cells,[183,184] lipids,[185-187] and  later, matrix-
enhanced SIMS to enhanced subcellular imaging of tissue samples.[188-190] Desorption  
electrospray  ionization  is  promising  for  imaging living  tissue  without  sample  
preparation.[191-193] 
Laserspray ionization inlet (LSII) [27-31,41,48-50,137,138] and matrix assisted 
ionization inlet (MAII) [39,194] are two  new  ionization  methods  in MS operating 
from atmospheric pressure to produce highly charged ions similar to electrospray 
ionization (ESI). Both LSII and MAII have attributes in common with MALDI allowing 
analysis of compounds directly from the solid state by using a solid matrix material 
composed of a small organic compound.[40] The application of heat and the presence of 
an atmospheric pressure to vacuum pressure drop region are two important factors in 
producing abundant highly charged ions in the inlet of the mass spectrometer.[29,31,45] 
In LSII, the laser alignment is not  important  because  multiply  charged  ions  are  
formed without the use of a laser,[39,40,44] as well as with the use of a laser aligned  in  
transmission [27-31,48-50,138] or  reﬂection  geometry.[41] For example, a commercial 
atmospheric pressure MALDI source with   the   laser   aligned   in   reﬂection   geometry   
produced abundant highly charged protein (e.g., lysozyme) ions on a Thermo Orbitrap 
mass spectrometer.[41] Critical is that sufficient heat is provided to the inlet of the mass 
spectrometer which directly depends on the matrix used.[29,40] Multiply charged ions 
produced by LSII and MAII using 2-nitrophologlucinol (2- NPG) matrix extend the mass 
range of detection to at least bovine serum albumin (~66 kDa).[194] LSII was also shown 
to produce sufficient ion abundance directly from tissue to identify an endogenous 
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peptide, a fragment of N-acetylated myelin basic protein  (MBP)  (amino acid (aa) 1−16),  
using  electron  transfer  dissociation (ETD) and high-accuracy mass measurement [48] 
and has been successfully introduced on a mass spectrometer with a heated inlet to 
perform imaging of lipids.[50,138] The laser aligned in transmission geometry provides 
ease of operation [27-31,48-50,138] and offers the potential for high spatial resolution 
imaging. [48,195,196]. 
Initial studies on matrixes [138] enabled us to introduce LSI technology operating 
from vacuum, LSIV, using a commercial intermediate pressure MALDI ion source 
interfaced to a Waters IMS-MS SYNAPT G2 mass spectrometer.[42] In the absence of a 
heated inlet region, abundant multiply charged analyte ions are formed by laser ablation 
using a matrix that efficiently evaporates.[40] 2-NPG  matrix  is  the  ﬁrst  matrix  to  
produce highly charged ions at atmospheric pressure, intermediate pressure, and low 
pressure.[44,45,194] The mechanism proposed [45] for the LSI inlet and vacuum 
ionization process is laser ablation producing highly charged matrix/analyte droplets 
which upon matrix evaporation releases ions by a similar process to that proposed for 
ESI.[51,52] The impact of a laser has been experimentally and theoretically shown to 
form molten droplets of  matrix/analyte,  and  the  existence  of  clusters  was  veriﬁed 
recently  for  LSII.[31,36,197] 2,5-Dihydroxyacetophenone  (2,5-DHAP),[48,50] a 
matrix that requires a lower  inlet  temperature than, for example, 2,5-dihydroxybenzoic 
acid (2,5-DHB), produces abundant multiply charged ions at intermediate pressure under 
LSI tuning conditions.[39,42] However, the use of higher laser power [42] and voltages 
[45] increase the abundance of singly charged ions. Using a higher laser power makes 
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only minor contribution to the production of singly charged ions. It is primarily the 
higher voltages of the MALDI settings that allow switching from multiply charged using 
ESI-like settings to singly charged ions either at atmospheric pressure [41] or 
intermediate pressure.[45] The practical utility of LSIV on a commercial vacuum 
MALDI source in combination with IMS-MS was demonstrated using 2,5-DHAP as 
matrix for the mixture analysis of lipids, peptides, and proteins.[42] Various families of 
compounds are well-separated from each other. Imaging applications are an extension to 
these tissue analysis developments. Here, we show the applicability of LSIV using a 
commercially available vacuum MALDI   source   operating   at   intermediate   pressure   
(~0.16  Torr) for tissue imaging of multiply charged peptide ions achieved without any 
physical instrument modiﬁcations. 
Experimental Section 
2,5-DHAP and 2-NPG matrix solutions were prepared by dissolving 5 mg in 150 
μL of 50:50 ACN/water (warmed), and 100 and 300 μL of 50:50 ACN/water (with and 
without 0.1% FA), respectively. The matrix:analyte mixture was prepared in 1:1 volume 
ratio before depositing 1 μL of the analyte/matrix mixture on a glass plate using the dried 
droplet method.[42] Mouse brain tissue sections were obtained as previously described 
[48,113,195,196] and included in Chapter 2.1. The tissue sections were mounted on 
plain and precoated glass plates with CHCA matrix using a tissue box [195] and 
delipiﬁed with ethanol as previously described.[48] The delipiﬁed tissue slices were 
spotted separately with several 0.5 μL of 100% 2,5-DHAP and 100% 2-NPG matrix in 
50:50 ACN/water for direct analysis and spray-coated with 2-NPG for imaging. A binary 
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mixture of 10%   2-NPG   and   90%   2,5-DHAP   by   volume   composition matrix 
solutions was also used for tissue imaging. 
Laserspray Ionization Vacuum (LSIV) – A commercial IP-MALDI source of SYNAPT 
G2 mass spectrometer was employed in this study as described in Chapter 2.3. In the 
analysis of standards (MBP, galanin, bovine insulin), the laser power used ranged from 
4.2 to 7.3 J cm
-2
 as previously reported,[45] at a ﬁring rate of 200 Hz and a scan rate of 1 
scan s
-1
 acquiring a sum mass spectrum of 1-2 min. For tissue imaging, the instrument’s 
MALDI imaging pattern creator software was used as one would use for MALDI 
imaging. The sampling resolution was set at 100 μm × 100 μm x,y laser step size, similar 
to MALDI imaging. Acquisition was set at a scan time of 2 s, laser power of 12.5 J cm
-2
 
at a ﬁring rate of 200 Hz, and 1 scan time per pixel. The total imaging acquisition time 
was ~5 h to image the entire tissue section. Laserspray  Ionization  Inlet  (LSII) - A  
Nanolockspray source  of  the  SYNAPT  G2  was  used  LSII comparison as described in 
Chapter 2.2 using a  home-built skimmer cone with a fabricated copper inlet tube 
attached, and the laser was aligned at 180° to the inlet tube, focused onto the 
matrix/analyte  sample  on a  glass  plate,  and ablated  in transmission geometry  
(Scheme 2.1)  relative  to  the  inlet  of  the  mass  spectrometer.  The source temperature 
was set at 150 °C, and acquisition was obtained in resolution mode using 100 and 4 V 
sample cone and extraction cone voltages, respectively, with a scan time of 1 s for 2 min. 
Data Processing - MassLynx version 4.1 was used to process the mass spectra, 
DriftScope version 2.2 was used to extract the two-dimensional (2-D) plot of drift time 
vs. mass-to-charge (m/z) ratio, and mobility extractor was used to obtain the drift time vs. 
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m/z selected data set and convert into an MSI ﬁle using the MALDI imaging converter. 
BioMAP 3.8.0.1 was used from Novartis Institutes for Biomedical Research, Basel, 
Switzerland, to extract from the MSI ﬁle the images of the peptides. 
Results and Discussion 
The endogenous N-acetylated MBP peptide (Ac-ASQKRPSQRSKYLATA), 
previously sequenced by LSII (Scheme 1.1IA) using high-performance 
fragmentation,[48]  was the initial focus for obtaining MS images of multiply charged 
ions using LSIV (Scheme 1.1IIA) on a commercial IP-MALDI source of the SYNAPT 
G2 mass spectrometer. The use of a suitable matrix material and appropriate settings and 
acquisition conditions such  as  laser  power  and  voltages  for  ion  acceleration  and 
transmission are important factors inﬂuencing the formation of the highly charge ions at 
intermediate pressure.[40,42,45] The direct analysis of MBP peptide from delipiﬁed 
mouse brain tissue was ﬁrst achieved by spotting 2,5-DHAP matrix onto the tissue. 
Multiply charged peptide ions up to charge state +3 were detected with the largest MW of 
~3.2 kDa (Appendix B Figure S20). Exceptional ion abundance is obtained for the MBP 
peptide with m/z 917.39 using 2,5-DHAP, but only when the matrix is directly spotted on 
the tissue (Appendix B Figure S20A). With LSII, spotting 2,5-DHAP matrix on 
nondelipiﬁed mouse brain tissue allowed detection of lipids as well as multiply charged 
ions of the N-acetylated MBP fragment peptide (Appendix B Figure S21). However, 
spray-coating of the matrix, necessary for good spatial resolution in tissue imaging, 
provided poor ion abundance using 2,5-DHAP operated from atmospheric pressure or 
vacuum.  
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2-NPG, a more volatile matrix than 2,5-DHAP, produced abundant multiply 
charged ions of up to charge state +4 from a synthesized MBP peptide standard (Figure 
9.1I.A) at low laser power applying “LSI settings” [42,45] on the commercial IP- 
MALDI  source  without  any physical instrument modiﬁcations. The analyte ion 
intensity increased as did the chemical noise background with increasing laser power 
(Figure 9.1I.B). The chemical background could be removed using  the  IMS  dimension,  
especially  because  the  different charge state ions are well-separated in the IMS 
dimension, identical to ESI-IMS-MS.[59-63,67] Only singly charged ions are produced 
when the default “MALDI settings” [45] are applied (Figure 9.1II). The ion abundances 
observed are similar for the multiply charged ions (“LSI settings”) (Figure 9.1I) and the 
singly charged ion (“MALDI settings”).[45] For a number of peptide and small-protein 
standards using “LSI settings” [42,45] (Appendix B Figure S22): (A) MBP, MW 1833 
Da; (B) galanin, MW 3150 Da; and (C) bovine insulin, MW 5731 Da), 2-NPG matrix 
allows detection of higher charge states than 2,5-DHAP matrix. 2-NPG requires less laser 
power (ca. 4.2 J cm
-2
) than 2,5-DHAP (ca. 7.3 J cm
-2
) to obtain good ion abundance 
while maintaining higher charge states (Appendix B Figure S23). However, the ion 
abundance near the respective threshold for ion formation is then slightly lower with 2-
NPG relative to 2,5-DHAP (Appendix B Figure S22). The laser power dependence is in 
agreement with a previous study that found a higher laser power induces lower charge 
states using 2,5-DHAP matrix.[42]  
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Figure 9.1. LSIV-IMS-MS (1) total mass spectra and (2) two dimensional plot of drift 
time vs m/z of N-acetylated MBP peptide (MW ∼1833 Da) with 2-NPG matrix acquired 
using (I) “LSI settings” [42,45] at (A) low “4.2 J cm−2” and (B) higher “7.3 J cm−2” laser 
power with an inset of the isotopic distribution of +4 ion and (II) commercial “MALDI 
settings” [45] on a Waters SYNAPT G2 MALDI source. Insets in parts 1 and 2 show 
isotopic distributions and drift times of MBP ion. 
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Figure 9.2 shows the LSIV analysis of delipiﬁed mouse brain tissue using “LSI 
settings” with 2-NPG matrix applied to the tissue by different deposition methods. By 
directly spotting 100% 2-NPG matrix on the tissue and the use of a relatively high laser 
power (12.5 J cm
-2
), abundant multiply charged ions from peptides and proteins are 
obtained (Figure 9.2I.A) and are well-separated by IMS from the singly charged lipid 
ions (Figure 9.2I.B). Ions are observed from proteins that are present in the tissue having 
molecular weights up to ~8.6  kDa (Appendix B Figure S24) on a high-performance 
mass spectrometer with a mass range of 8000. As noted above, spotting the tissue with 
100% 2,5-DHAP matrix only detected up  to  ~3.2  kDa (Appendix B Figure S20). 
Unfortunately, 100% 2-NPG matrix spray-coated on a mouse brain tissue section 
required the application of a laser power of 12.5 J cm
-2
 to obtain sufficient ion abundance 
(Figure 9.2II) for good images. Using “LSI settings”, as described above, under these 
higher laser ﬂuence conditions, only +2 and +1 ions are detected (Figure 9.2II.A) from 
mouse brain tissue. However, the IMS dimension separating +2 from the +1 charge state 
allows extraction of the +2 peptide ions with good ion abundance (Figure 9.2II.B). 
Just as in MALDI imaging, sample preparation is important with LSI imaging. 
Thus, a number of sample preparation protocols were explored. For example, mouse 
brain tissue sections mounted on a CHCA precoated glass slide, similar to previous 
protein studies,[31] and spray-coated with  a binary mixture of 90% 2,5-DHAP and 10% 
2-NPG allowed observation of higher molecular weight peptides  and  proteins ions 
(Appendix B Figure S25) but with notably less ion  abundance  relative  to  100%  2-
NPG  (Figure 9.2I). Thus,  in the absence of the heated inlet,[27−40] the volatility of the 
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matrix composition  in  vacuum  deﬁnes  the  outcome  of  the  tissue analysis and is 
especially restrictive to imaging for which direct matrix  spotting  cannot be  employed  
because of delocalization of  the  tissue  composition,  as  is  also  the  case  with  
MALDI. Clearly, further developments in sample preparation will be necessary to 
advance LSIV imaging just as it was for MALDI.  
 
Figure 9.2. LSIV-IMS-MS (A) total mass spectra and (B) two-dimensional plot of drift 
time vs. m/z of delipified mouse brain tissue (I) spotted and (II) spray-coated with 100% 
2-NPG matrix. Insets show (A) isotopic distributions of +2 charge state ion of the 
identified peptide N-acetylated MBP fragment, (I.B) drift times of charge state +4 and +1 
ions, and (II.B) isotopic distribution of the +2 ions. Insets of higher charge states in part I 
are included in Supporting Information Figure S24. 
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The drift time and m/z values of an area of choice can be selected  in  the  2-D  IMS-MS  
plot,  which  becomes  possible because of the two dimensionality of the data set,[66,67] 
allowing investigation of any ion of interest, while disregarding others. Here, using the 
ion mobility embedded mass spectral data set from the 100% 2-NPG spray-coating 
approach in Figure 9.2II.B, images were created for three peptides. This ion at m/z 
917.40 had previously been sequenced using ETD fragmentation of the doubly charged 
N-acetylated MBP peptide (1−16) ion.[48] The image (Figure 9.3A) relates well with the 
known location of the myelin basic protein (Figure 9.3D),[54]  validating  our  tissue 
imaging MS approach of multiply charged ions at vacuum. Using similar procedures, 
images of two additional doubly charged peptide ions are obtained, m/z 831.35 and 
795.81 (Figure 9.3, parts B and C), respectively. All three peptide images have the 
same location as the myelin basic protein in the mouse brain tissue (Figure 9.3D).[198] 
Using  the  amino  acid  sequence information  obtained  from  the  identiﬁed  peptide  
MBP fragment with a MW of 1832.8 Da [48] (aa residues (1−16), Figure 9.3A), images  
of  MWs  1660.7  Da  (aa  residues  (1−14), Figure 9.3B), and 1589.6 Da (aa residues 
(1−13), Figure 9.3C), then correspond to MBP peptides with two and three amino acid 
truncations (Figure 9.3, parts B and C) of the C-terminal end.  
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Figure 9.3. LSIV at intermediate pressure images of endogenous peptides from delipified 
mouse brain tissue spray-coated with 100% 2-NPG matrix: (A) m/z 917.40 (+2) MW 
1832.8, (B) m/z 831.35 (+2) MW 1660.7, and (C) m/z 795.81 (+2) MW 1589.6. (D) 
Coronal section of the mouse brain [198] at a level similar to those analyzed in panels 
A−C. Arrowheads in panel D indicate heavily myelinated fiber tracts. Insets show 
molecular weight and amino acid sequence of the images relative to the identified peptide 
N-acetylated MBP fragment. The highest ion intensities are m/z 917 = 1.02 e
4
, m/z 831 
=1.27 e
4
, and m/z 795 = 1.06 e
4
, respectively.  
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CHAPTER 10 
MATRIX ASSISTED IONIZATION VACUUM, A NEW IONIZATION METHOD 
FOR BIOLOGICAL MATERIALS ANALYSIS USING MASS SPECTROMETRY 
“This research was originally published in Molecular and Cellular Proteomics (Inutan, 
E.D.; Trimpin, S. Mol. Cell. Proteomics 2013; 12:792-796) © the American Society for 
Biochemistry and Molecular Biology.” 
 
Introduction 
The conversion of large and nonvolatile compounds such as proteins into gas-
phase ions is of immense fundamental and practical importance. The 2002 Nobel Prize in 
Chemistry was awarded for the accomplishment of this conversion via electrospray 
ionization (ESI) [1] and matrix-assisted laser desorption/ionization (MALDI) [2] 
interfaced with mass spectrometry (MS) to obtain the molecular weights of proteins with 
high accuracy. These methods employ high voltage or a laser to form gaseous analyte 
ions from a wide variety   of   compounds   in   solution   or   a   solid   matrix, 
respectively.  
MALDI interfaced with a time-of-flight (TOF) mass spectrometer produces gas-
phase analyte ions in vacuum and is the method of choice for the molecular imaging of 
biological surfaces. Ionization in vacuum provides excellent ion transmission [23], as 
well as good spatial resolution achieved using a focused laser beam. However, the 
analysis of protein complexes is very challenging with MALDI, requiring strategies such 
as first-shot phenomena [199] and chemical crosslinking [200]. The necessity of a laser 
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also makes MALDI less soft than ESI and produces background ions, which can hinder 
the analysis of small molecules [94,201]. MALDI is also of limited utility on high 
performance mass-to-charge (m/z) analyzers because of mass range issues related to the 
formation of singly charged ions, which also produce few fragment ions for structural 
characterization [202].  
Multiple charged ions produced directly from solution in ESI bring the m/z ratio 
within the range of high performance mass spectrometers, allowing the analysis of high-
mass compounds. These instruments have advanced features for structural 
characterization, such as ion mobility spectrometry (IMS) for gas-phase separations 
[42,45,50], ultra-high mass resolution and mass accuracy [27-29,48], and advanced 
fragmentation such as electron transfer dissociation (ETD) [29,48]. However, ESI is 
limited for surface characterization, requiring approaches such as desorption-ESI [139] 
and laser ablation ESI [203], ionization methods that produce multiply charged ions but 
are not compatible with analyses of larger proteins or fragile complexes.  
A softer ionization approach is needed in order to observe fragile molecules and 
molecular complexes in living organisms at low levels directly from tissue and cell 
cultures, without extensive sample preparation, while retaining spatial information. 
Ideally, this approach would be compatible with mass spectrometers having advanced 
capabilities to aid structural characterization directly from surfaces. The new ionization 
method described here, in which molecules are transferred from solid-phase to gas-phase 
ions through the simple exposure of a material of interest in a suitable matrix to vacuum, 
is an advance toward this goal and is of fundamental interest. 
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Experimental Procedures 
Analyte solutions were diluted with water to make concentrations ranging from 1 
to 5 pmol uL
-1
, 20 pmol uL
-1
 for BSA, and 50 fmol uL
-1
 for ubiquitin. For the 
noncovalent complex, stock solutions of lysozyme and penta-N-acetylchitopentaose were 
individually diluted in 25 mMol ammonium acetate buffer with 10% methanol according 
to published procedures [204]. The molar ratio of the protein-ligand mixture was 
optimized, and a premixed noncovalent complex mixture of 1:285 protein:ligand molar 
ratio was used. The blood sample was diluted in water at a 1:10 volume ratio. 3-NBN was 
dissolved in 50 uL of 100% ACN with 0.1% formic acid and 150 uL of 50:50 ACN/water 
with 0.1% formic acid (positive mode measurements), and 150 uL of 50:50 ACN/water 
was mixed with 0.1% NH4OH for peptides and 1% NH4OH for proteins (negative mode 
measurements). The matrix/analyte solution was prepared at 1:3 and 1:1 volume ratios 
for positive and negative mode measurements, respectively, and 1 uL was spotted on the 
target plate. Mouse brain tissue, obtained using a protocol described elsewhere 
[48,195,196], was donated by Professor Ken Mackie (Indiana University). The delipified 
mouse brain tissue [48] was coated with several 0.5-uL spots of 3-NBN matrix in 50:50 
ACN/water with 0.1% formic acid. The matrix deposition on brain tissue sections from 
mouse brain tissue was miniaturized by spotting, on the same area, a total of 1 uL in five 
increments of 0.2 uL, covering a ~400 µm x 150 µm area on the tissue. Blood was 
extracted from Band-Aid using water. After solvent evaporation of the matrix/analyte 
spot, the target plate was introduced into the vacuum of the mass spectrometer.  
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Matrix Assisted Ionization Vacuum (MAIV) on a Commercial Vacuum MALDI Source 
– IMS-MS SYNAPT G2 (Waters Co., Milford, MA) with a commercial intermediate-
pressure MALDI source conventionally operated with an Nd:YAG laser (355 nm) was 
employed with the laser off as described in Chapter 2.4. Analyte ions were observed 
with as little as 1 V applied between the sample plate and the extraction lens. Some 
voltage is necessary to accelerate ions into the hexapole ion guides and to the mass 
analyzer.  
MAIV on Commercial Atmospheric Pressure ESI Source of Waters Co. SYNAPT G2 – 
The skimmer cone of the z-spray was modified as described in Chapter 2.4 using a wider 
outer (~4.5 mm) and inner (~3 mm) cones.  
MAIV on Commercial Atmospheric Pressure ESI Source of Thermo Scientific LTQ 
Velos – The transfer capillary was modified by inserting a ferrule on the outer opening of 
the inlet tube to hold the glass plate as described in Chapter 2.4.   
Results and Discussion 
The MAIV method described here, using 3-NBN as matrix, produces ions when 
placed in vacuum. Similar to ESI [204], multiple charging, even of protein complexes, is 
observed, but it occurs directly from the solid state. For example, the MAIV mass 
spectrum of the 14.3 kDa lysozyme protein using the vacuum MALDI source of the 
SYNAPT G2 is shown in Figure 10.1A, and its complex with penta-N-
acetylchitopentaose, separated from both the lysozyme and the peptide ions via IMS, is 
shown in Figure 10.1B. A challenge in analyzing molecular complexes via any MS 
approach is that the sample preparation must keep the complex intact under conditions 
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suitable for ionization. These mass spectra are obtained simply by placing the 
matrix/analyte sample in vacuum. Ions are continuously formed until the matrix 
completely sublimes, which, depending on the applied conditions, can take a few seconds 
to tens of minutes (Figure 10.1C). No laser, voltage, or heat is used to initiate the 
ionization process. The “hot spot phenomenon” [205-207], an intrinsic limitation for 
quantitation in MALDI, is not an issue because the entire matrix/analyte sample is 
analyzed by simply summing mass spectra acquired during complete matrix sublimation. 
 
 
 
Figure 10.1. MAIV mass spectra of (A) lysozyme, 14.3 kDa, (B) noncovalent complex 
of lysozyme/penta-N-acetylchitopentaose (PNAP) extracted from the IMS-MS two-
dimensional dataset, (C) total ion current of A, (D) bovine serum albumin, 66 kDa. Red 
numbers indicate the charge states, and blue numbers in the upper right corner of each 
spectrum provide relative ion abundances. 
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3-NBN has no acidic protons needed for ionization, so the protons must be 
supplied by the solvent, analyte, or acid during sample preparation. Typically, the matrix 
is dissolved in organic or water-organic solvents, with or without 0.1% formic acid, and 
the analyte in water/organic solvent or, for complexes, water buffered with ammonium 
acetate. The matrix and analyte solutions are mixed in the same way as the sample 
preparation used in MALDI, dried, and placed in vacuum or, for labile compounds, 
immediately placed in vacuum without drying. Astonishingly, MAIV produces ions from 
proteins at least as large as BSA (~66 kDa) (Figure 10.1D).  
As with ESI, small molecules are detected as singly charged with little matrix-
related chemical background (e.g. leucine enkaphelin; Figure 10.2IA), and larger 
peptides (e.g. acetylated N-terminal fragment peptide of myelin basic protein; Figure 
10.2IB) as multiply charged ions. Mass spectra are obtained using the SYNAPT G2 mass 
spectrometer vacuum MALDI source, consuming low femtomoles of small proteins such 
as ubiquitin (50 fmol) (Figure 10.2IC). Good negative ion abundances of, for example, 
ubiquitin (Figure 10.2IIA), the hirudin (55– 65) peptide (Figure 10.2IIB), and the 
phosphorylated peptide cholecystokinin (10 –20) (Figure 10.2IIC) are also observed 
with MAIV.  
Peptides and proteins are detected by applying 3-NBN in an appropriate solvent 
onto the surface of a mouse brain tissue section (Figure 10.3A) and subjecting the 
sample to the vacuum of the mass spectrometer (Figure 10.3B). Selected areas of interest 
of a tissue can be exposed to matrix, and even if the entire tissue section is placed in 
vacuum, only molecular ions from compounds in those specific areas are observed 
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(Figure 10.3C). Miniaturizing the matrix deposition area to ca. 150 µm x 400 µm using a 
micropipette enables enhanced spatial resolution analyses without the need for a laser, as 
is required with MALDI [208]. The high signal-to-noise obtained for this analysis 
suggests that much smaller spot sizes can be analyzed with appropriate matrix deposition 
methods and faster introduction of the sample into vacuum. The multiple charging in  
 
Figure 10.2. MAIV mass spectra acquired in (I) Positive ion mode: (A) 1 pmol leucine 
enkephalin (molecular weight (MW) 555 Da), (B) 1 pmol MBP peptide (MW 1833 Da), 
and (C) 50 fmol ubiquitin (MW 8559 Da) and (II) Negative ion mode: (A) ubiquitin, (B) 
phosphorylated peptide cholecystokinin (10 –20) (MW 1332 Da), and (C) hirudin (55– 
65) peptide (MW 1411 Da). 
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MAIV aids the separation of the compound classes (proteins, peptides, and lipids) by 
size, shape, number of charges, and m/z using IMS-MS.  
 
Figure 10.3. MAIV-IMS-MS of a mouse brain tissue section using a commercial vacuum 
MALDI source with the laser off: (A) photograph of application of matrix solution to a 
section of mouse brain on a glass microscope slide, (B) two-dimensional IMS-MS plot of 
drift time vs. m/z of ions showing separation of compound classes by charge, size, and 
shape of lipids, peptides, and proteins. Insets show isotopic distributions of lipid and 
protein ions, and (C) microscopy photograph of the mouse brain tissue before and after 
ionization. Circled area shows the area on the tissue analyzed in B, and small arrows are 
included to guide the eye for a better relative comparison of the photographs. 
 
Mass spectrometers with vacuum MALDI sources are not a requirement for 
MAIV, as ESI sources can be reversibly modified for MAIV operation. Figure 10.4A 
shows a glass microscope slide (Appendix C Figure S1) onto which a microliter of 
blood, diluted 1 part in 10 of water, mixed with 3-NBN matrix in ACN:water, and dried, 
is held against the inlet of a modified ESI source of the SYNAPT G2 mass spectrometer 
by the atmospheric-pressure-to-vacuum differential. Unlike with ESI, which detects 
predominantly the α-subunit of hemoglobin [209], both the α- and β-subunits are detected 
in good ion abundance from the blood spot using MAIV. Figure 10.4B shows the IMS-
MS plot of the gas-phase drift-time separated α- and β-subunit multiply charged 
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molecular ions. The extracted mass spectrum of the β-subunit is shown in Figure 10.4C. 
These results correlate well with blood spot results obtained with MAIV using the 
SYNAPT G2 vacuum MALDI source, indicating the universal utility of this ionization 
method with vacuum and atmospheric pressure ion sources.  
 
Figure 10.4. MAIV-IMS-MS of a solvent-extracted blood spot from a Band-Aid using a 
commercial atmospheric pressure ESI source with a modified skimmer cone to provide a 
larger inlet aperture. (A) photograph of the device showing the isolation valve in the open 
position with a glass microscope slide held by the pressure differential against the 
skimmer opening, with the matrix– blood spot sample exposed to the vacuum initiating 
ionization; more details on source modifications are provided in supplemental Appendix 
C Figure S1. (B) two-dimensional IMS-MS plot of drift time vs. m/z of ions showing 
separation of compound classes by charge, size, and shape: α-globin (MW 15,126 Da) 
and β-globin (MW 15,866 Da) chains of hemoglobin. Both and chains of hemoglobin are 
detected with MAIV in good ion abundance (mass spectral details in supplemental 
Appendix C Figure S2), something that has been reported [209] to be problematic with 
ESI (1). Extraction of the mass spectral information from the two-dimensional display in 
B provides the individual mass spectra of the proteins, and (C) extracted full range mass 
spectrum of the β-globin chain. 
 
Using MAIV, sufficient ion abundance is obtained with the modified ESI source 
to perform sequence characterization. ETD fragmentation of the quadruply charged 
molecular ions of the acetylated N-terminal peptide fragment of myelin basic protein 
provides complete sequence coverage (Figure 10.5) using the modified ESI source, 
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identical to the principle shown in Figure 10.4A, of a linear ion trap LTQ Velos. An 
expansion of the region between m/z 450 and 900 is shown in the inset, graphically 
demonstrating the degree of fragmentation obtained with this method. ETD is more 
applicable to the fragmentation of peptides and proteins than collision-induced 
dissociation, but only with ionization methods that produce abundant multiply charged 
ions [13, 14]. 
The similarity of the charge states of ions produced via MAIV and ESI suggests 
similar mechanisms for their formation. A requirement for producing bare ions in ESI is 
solvent evaporation from highly charged droplets, and MAIV may require matrix 
sublimation from highly charged particles. A special property of 3-NBN, beside its ability 
to sublime at ambient temperature when placed in vacuum [68], is triboluminescence 
[69,70] producing unusually strong dinitrogen discharge emission under conditions in 
which crystal fracturing occurs. This discharge is believed to result from a high electric 
field created between fractured crystal surfaces having opposite charge [26]. In vacuum, 
the fracturing would be driven by sublimation of the matrix or residual solvent, producing 
charged particles that, upon sublimation of matrix, release analyte ions. 3-NBN matrix 
particles are observed leaving the surface in vacuum. Other matrices have been found to 
produce ions via MAIV, but none as well as 3-NBN.  
This contribution represents the first example of a new ionization phenomenon 
demonstrating that small and large molecules are transferred as ions from the solid phase 
to the gas phase under vacuum conditions, without the application of external energy or  
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Figure 10.5. MAIV using the LTQ Velos ESI source to perform ETD fragmentation of 
the MBP peptide +4 charge state ion (m/z 459). Top, total fragment spectrum; bottom, 
inset m/z 400–900. Sequence coverage is increased relative to previous ETD studies of 
this peptide [48]. Red numbers indicate the charge state, and blue numbers the ion 
abundance. Sequence coverage is provided (top). 
 
fields, apparently via a sublimation-driven process. Multiply charged ions are produced 
from the solid state with high sensitivity, giving MAIV advantages of both ESI and 
MALDI. Analyses of surfaces of biological tissue, thin layer chromatography plates, and 
one- and two-dimensional gels are logical applications. MAIV, requiring only the 
vacuum necessary for the proper functioning of the mass spectrometer, might be 
applicable with common electron/chemical ionization mass spectrometers, with the 
filament used for ionization turned off. The simplicity and wide applicability of MAIV 
also might prove useful in clinical settings and in field portable instruments.   
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CHAPTER 11 
MATRIX ASSISTED IONIZATION IN VACUUM, A SENSITIVE AND WIDELY 
APPLICABLE IONIZATION METHOD FOR MASS SPECTROMETRY “Springer 
and the original publisher (J. Am. Soc. Mass Spectrom., 24, 2013, 722-732, Trimpin, S., 
Inutan, E.D.) is given to the publication in which the material was originally published 
with kind permission from Springer Science and Business Media.” 
 
Introduction  
Vacuum ionization coupled to mass spectrometry (MS) is highly sensitive and has 
enormous potential [23], but relative to ambient ionization methods, progress in this area 
has been relatively slow since the introduction of matrix-assisted laser 
desorption/ionization (MALDI) [2,3]. Important developments include intermediate 
pressure vacuum MALDI [75,136], solvent-free MALDI [30,72], surface enhanced LDI 
[210], the application of MALDI in imaging [111,146], soft laser desorption [211-213], 
and cluster beam methods [214-217], all of which produce singly or low charge state 
ions. However, the ability to produce high charge state ions under vacuum conditions 
would expand analytical capabilities to high performance mass spectrometers that have 
limited mass ranges, would enable advanced fragmentation technology for improved 
characterization, and would have the potential to maximize signal-to-noise in complex 
samples [23,202]. Vacuum ionization approaches are promising in terms of applications 
because ion transmission losses inherent with atmospheric pressure ion sources are 
eliminated [24], thus, potentially enhancing sensitivity [23]. 
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Highly charged quasi-molecular ions have been observed under sub-ambient 
pressure using electrospray ionization (ESI) [218], and in low abundance, using an 
explosive matrix with plasma desorption MS [219,220]. Inlet ionization was described, in 
which multiply charged ions were produced under sub-ambient conditions inside a heated 
inlet tube connecting the atmospheric pressure ionization region and the first vacuum 
region of a mass spectrometer. Mass spectra nearly identical to those produced in ESI 
were obtained by laser ablation of matrices common to MALDI [28,29], or by using 
physical forces to dislodge the matrix/analyte into the inlet from a surface [39,194]. 
Introduction of solubilized analyte into the heated inlet also produced multiply charged 
ions [221,222]. Concepts learned from these inlet ionization methods enabled discovery 
of methods for producing highly charged ions of peptides, proteins, and polymers at 
intermediate [42] and low pressure [44] using laser ablation of certain matrix compounds. 
Here, we report the rather astonishing discovery [46] of matrix compounds that 
produce positive or negative analyte ions simply by placing the matrix/analyte sample 
directly in vacuum in the absence of a laser, high voltage, or even added heat. We have 
termed this method matrix assisted ionization vacuum (MAIV). MAIV has been shown 
to operate in the positive and negative ion modes and to produce ions from a variety of 
compound classes including drugs, lipids, peptides, and proteins with high sensitivity. 
Besides the analytical utility of MAIV, this work demonstrates that a laser is not a 
requirement for ion formation in vacuum, just as it was not required for inlet ionization 
using matrices common with MALDI [40,45]. 
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Experimental Procedure 
Analyte solutions were diluted with water, with the following exceptions: 
lysozyme was diluted using 25 mM ammonium acetate in 10 % MeOH, 50:50 
ACN/water with 0.1 % TFA was used with β-amyloid (1-42) for positive mode 
measurements and 50:50 MeOH/water was used for negative mode measurements. Final 
concentrations of all analyte solutions ranged from 1 to 10 pmol μL-1. PEG-DME 2000 
was doped with LiCl (10 % by volume from a 1 M LiCl solution). The small molecule 
model mixture composed of 5 pmol μL-1 each of clozapine, Leu-enkephalin, 
sphingomyelin, angiotensin II, ACTH, and bovine insulin was prepared in water. The 
large molecule model mixture in addition contained Leu-enkephalin, sphingomyelin, 
galanin, bovine insulin, and ubiquitin. The higher mass protein mixture contained 
5 pmol μL-1 each of lysozyme (added from 25 mM ammonium acetate in 10 % MeOH) 
and ubiquitin, and 10 pmol μL-1 of myoglobin. 
For testing the different compounds for use as MAIV matrix, solutions were 
prepared by dissolving 5 mg of the matrix compound in 100 μL of 50:50 ACN/water. The 
3-nitrobenzonitrile (3-NBN) matrix was also dissolved in 150 μL of 50:50 ACN/water 
with 0.1 % formic acid and 50 μL 100 % ACN with 0.1 % formic acid. For positive mode 
measurements, the matrix/analyte mixture was prepared (1:3 v:v) using 3-NBN in 100 % 
ACN with 0.1 % formic acid; for negative mode, the ratio was 1:1 v:v using 3-NBN in 
50:50 ACN/water with 1 % ammonium hydroxide. Coumarin was also prepared by 
dissolving 5 mg in 50 μL of 50:50 ACN/water with 0.1 % formic acid and 2,5-DHAP in 
150 μL of 50:50 ACN/water with 0.1 % formic acid (warmed). 
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From a given matrix/analyte mixture, 1 μL was typically spotted on the target 
plate using the dried droplet method. For matrix assisted ionization inlet (MAII) and 
MAIV using a custom modified ESI source, 1 μL of the analyte was spotted on a glass 
plate and 2 μL of 3-NBN matrix was added and air-dried, as previously described [40]. A 
similar procedure was used with 2,5-DHAP and coumarin. For the glass capillary 
experiments, the capillaries were partially filled with acidified 3-NBN matrix containing 
an equal volume of analyte solution. The sample was allowed to dry before taping the 
capillary to a modified MALDI sample plate.  
A number of surfaces were analyzed by taping different materials (e.g., currency, 
filter paper, KimWipe (Kimberly-Clark Professional, Roswell, GA USA) tissue, plastic, 
aluminum foil, and thin layer chromatography (TLC) plates) onto a MALDI modified 
plate; each surface was spotted with 1 μL of matrix/analyte. Solvent-free sample 
preparation was employed as previously described using angiotensin I [223]. In brief, 
metal beads (1.3 mm, BioSpec Products, Inc., Bartlesville, OK, USA) and matrix powder 
were combined in a vial in which analyte had been added in solution and completely 
dried. Homogenization/transfer of the matrix/analyte to the glass plate was accomplished 
using a TissueLyser II (Qiagen Inc., Valencia, CA, USA) with a 30 Hz frequency and a 
duration of 10 minutes. Binary matrices were prepared according to published procedures 
[40,44] using 3-NBN and α-cyanohydroxycinnamic acid (CHCA). Partially dry and wet 
samples were introduced to the vacuum of the mass spectrometer in a glass capillary and 
on a metal plate. Some 3-NBN/analyte samples were frozen in the wet state on the 
MALDI plate at -80 °C and immediately placed in vacuum for analysis. 
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Matrix Assisted Ionization Vacuum (MAIV) - MAIV-MS was performed on IMS-MS 
SYNAPT G2 mass spectrometer (Waters Co.) operated in the positive, negative and 
sensitivity (V) modes. For MAIV using the commercial vacuum MALDI source, the 
source was operated without firing the laser (Scheme 1.1.IIB and 2.3) as described in 
details in Chapter 2.4. The dried and in some cases slightly wet matrix/analyte mixtures 
were individually loaded into the source vacuum (0.226 mbar) requiring ∼2 min to load. 
Glass tubes and other surfaces, such as a currency bill, were introduced to the vacuum 
source using the commercial MALDI plate holder and moving stage. Ionization from the 
cold (from -80 °C) and glass tube experiments lasted for 10 and 30 min, respectively. For 
MAIV using the commercial ESI source, the skimmer cone of the z-spray was first 
modified by inserting a small ferrule to the normal outer cone of the skimmer. The glass 
plate with the matrix/analyte spot was placed tight to the ferrule facing the source 
entrance. The matrix/analyte crystals were drawn by the pressure differential between the 
atmospheric pressure and the instrument vacuum. Ions were observed once the 
matrix/analyte crystals were drawn by the vacuum of the mass spectrometer. The ESI 
source block temperature was set to 80 °C and was operated with default ESI settings. In 
the second version as described in Chapter 2.4, the inner cone opening was widened to 
about ~3 mm and the outer cone was widened to about ~4.5 mm with a ferrule inserted 
forming vacuum seal between the glass plate and the inner cone; in this case, the vacuum 
was protected by keeping the isolation valve closed until the sample was loaded (Scheme 
2.4). For sensitivity comparison between MAIV and ESI, 5 fmol clozapine in 50:50 
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MeOH/water was used depositing 1 μL in 3-NBN for MAIV and for ESI using an 
infusion flow rate of 1 μL min-1 for 1 min. 
Matrix Assisted Ionization Inlet (MAII) - MAII-MS was performed on a LTQ Velos 
mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) with commercially 
available inlet temperature control using inlet temperatures of 50 to 450 °C as previously 
reported (Scheme 1.1.IB).[40] 
Results and Discussion 
Introduction of analyte, incorporated in the matrix 3-NBN into the vacuum of the 
mass spectrometer produces ions from small molecules as well as proteins without the 
need of a laser voltage, other than that necessary for ion transmission, or heating the 
sample. A typical example using the SYNAPT G2 vacuum MALDI source is shown in 
Figure 11.1a where multiply and singly charged ions, similar to ESI, are observed with 
good resolution and abundance from a mixture containing the lipid sphingomyelin, 
peptides Leu-enkaphelin, and galanin, and small proteins insulin and ubiquitin. This 
example demonstrates the breadth of the MAIV method to ionize differing compound 
classes over a wide mass range. Ions were produced until the matrix was no longer 
observed on the commercial sample plate. The MAIV mass spectrum of lysozyme is 
shown in Figure 11.1b, but using a binary matrix mixture containing only 20% 3-NBN in 
CHCA matrix solution, corresponding to a molar ratio of 1.6:1 molar ratio of 3-
NBN:CHCA. By incorporating a less volatile matrix with the more volatile 3-NBN, the 
time over which ions are observed was increased. Snapshots of the plate taken about 2 
and 3 min after introduction to vacuum shows loss of matrix from the surface with 
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increasing time (Appendix C Figure S4). A video of the ionization process is provided 
online as Supplemental (‘MAIV on MALDI source video I’). 
 
Figure 11.1. MAIV mass spectra using the vacuum MALDI source of: (a) a mixture of 
sphingomyelin (molecular weight, MW 703 Da), leu-enkephalin (MW 555 Da), galanin 
(MW 3156 Da), bovine insulin (MW 5731 Da), and ubiquitin (MW 8561 Da), (b) 
lysozyme (MW 14.3 kDa) using binary matrix mixture of 3-NBN and CHCA in 1.6:1 
molar ratio using the SYNAPT G2 intermediate pressure MALDI source, and (c) is the 
same sample obtained on the SYNAPT G2 modified ESI source. Isotopic distributions 
are shown in Appendix C Figure S3. Blue numbers in upper right corner of each 
spectrum provide relative ion abundance and red numbers the charge states. 
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The MAIV matrix, 3-NBN, was discovered while testing compounds having 
characteristics similar to 2-nitrophloroglucinol (2-NPG), the best matrix found to 
produce multiply charged analyte ions using MAII [40,194], and one that requires a 
relatively low inlet temperature for ion production [45]. Importantly, 2-NPG was also 
shown to produce multiply charged ions using laser ablation under vacuum conditions 
[44,45]. Of the compounds tested (Table S1.I, Scheme 1.1.IB), 3-NBN was found to 
produce highly charged ions of acidified insulin by MAII at an inlet temperature of 50 °C 
and with maximum abundance at ca. 100 °C (Appendix C Figure S5). This is contrary to 
other matrix compounds (>100) useful for inlet ionization for which good ion abundance 
is only obtained at much higher inlet temperature [40] using the same mass spectrometer. 
Thus, the thermal requirement for 3-NBN matrix to produce abundant analyte ions from 
atmospheric pressure is low. 
This matrix was therefore deemed to be a potential matrix for producing highly 
charged ions on atmospheric pressure ionization mass spectrometers lacking a heated 
inlet as well as with vacuum MALDI ion sources which are postulated to need matrix 
volatility to produce multiply charged ions through desolvation of charged matrix 
droplets/clusters that are produced by laser ablation [45]. 3-NBN was therefore employed 
with a homebuilt modification to the SYNAPT G2 skimmer cone inlet, which allowed 
rapid testing of matrices using laser ablation of the sample under vacuum conditions. In 
this approach, a connecting ferrule was constructed at the inlet skimmer cone of the ESI 
source (Scheme 2.4), which made a sufficient vacuum seal to hold a glass microscope 
slide. Matrix/analyte was placed on the vacuum side of the glass slide with the intention 
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of ablating the sample using a focused beam from a nitrogen laser fired in transmission 
geometry. 
Surprisingly, a mass spectrum of insulin was obtained without the laser. A larger 
inner and outer cone opening was subsequently shown to provide improved vacuum 
when sealed using the glass slide, as judged by the force with which the slide is held to 
the modified mass spectrometer entrance (Appendix C Figure S6). The larger opening 
also achieves substantially improved ion abundance (Figure 11.1c) and more rapidly (a 
few seconds, Appendix C Figure S6) than the smaller opening. A video of the process is 
provided online in the Supplemental (‘MAIV on ESI source video II’). Introducing the 
same matrix/analyte sample composition into the intermediate pressure vacuum MALDI 
source of the SYNAPT G2 produced very similar mass spectra to those observed with the 
sealed atmospheric pressure inlet but requires longer introduction time and 
sublimation/evaporation of the matrix/analyte sample is slower. This, to our knowledge, 
is the first example of matrix assisted ionization requiring only vacuum conditions, which 
are available with any mass spectrometer. 
A number of compounds similar to 3-NBN were also examined for their potential 
as MAIV matrices to ionize insulin and ubiquitin. Using the same acquisition settings and 
insertion of the matrix/analyte into a vacuum MALDI source without the use of a laser, 3-
NBN performed exceptionally well, 2-NBN showed reasonable analyte ion abundance, 
and 4-NBN produced no ions (Appendix C Figure S7). A visually apparent difference is 
that 3-NBN sublimes quickly in the SYNAPT G2 MALDI source and is completely 
removed from the sample plate after roughly 5 min followed by 2-NBN, and then 4-
  
132 
NBN, which could still be observed on the plate with no visual differences after 1 h. Even 
with laser ablation, 4-NBN does not produce the desired analyte ions. Of the isomers of 
NBN and nitrobenzaldehyde, 3-NBN and 4-nitrobenzaldehyde are reported to sublime 
under vacuum conditions [68]. Of the nitrobenzaldehyde isomers (Appendix C Figure 
S8), only 1,3-nitrobenzaldehyde produces ions of angiotensin I under the conditions 
employed, but with low ion abundance. The best results with this matrix were obtained 
when the matrix:analyte was prepared solvent-free. Morphology changes during the 
prolonged grinding of matrix/analyte in the solvent-free preparation [223] may be related 
to matrix melting aiding incorporation of analyte. 
With 3-NBN matrix containing insulin on the MALDI sample plate, multiply 
charged quasi-molecular analyte ions are detected with the mass spectrometer while 
simultaneously observing the matrix through the optical microscope camera display 
available with the SYNAPT G2 MALDI source. The footprint of the matrix decreases 
with time due to sublimation and the detected ion abundance similarly decreases. No ions 
are observed once there is no visible matrix. The ability of the matrix to sublime or 
evaporate is apparently critical for producing ions of nonvolatile analyte molecules, but 
can also be a hindrance because the matrix must not sublime/evaporate too rapidly or it 
will not survive the ca. 2 min introduction period from atmospheric pressure to vacuum 
of the commercial MALDI source. There are a number of ways to partially circumvent 
the rapid sublimation besides use of binary matrix mixtures (Figure 11.1b), including 
cooling the sample plate to -80 °C before insertion to vacuum (main ion abundance 
postponed to ~2.5 min, Appendix C Figure S9b), and placing the sample in capillaries 
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which restricts the rate of sublimation by reducing the matrix surface exposed to vacuum 
(ion abundance extended to ~30 min, Appendix C Figure S10). A problem with current 
vacuum MALDI sources is that, because of sublimation, only one sample can be placed 
into vacuum at a time. However, a modified atmospheric pressure ionization source 
(Scheme 2.4) allows rapid analysis of samples by MAIV (Figure 11.1c). 
Mechanistic Considerations 
Under vacuum conditions, the matrix, as noted above, appears to sublime from 
the surface until it is no longer observed. However, placing a glass plate near 3-NBN 
under low pressure conditions does not result in a thin even layer of matrix collecting on 
the surface as would be expected for sublimation, but in numerous small particles, which 
can be observed using an optical microscope at 50× magnification. One possibility for the 
observed ejection of particles is the cooling of the surface in vacuum due to the latent 
heat of sublimation causing surface splintering, and may be similar to charged ice 
particles observed to be ejected from freezing water droplets [224]. Alternatively, 
sublimation/evaporation of the matrix, or trapped solvent, under vacuum conditions may 
contribute to ejection of matrix particles from the surface. 
Charged solvent droplets in ESI and solvent assisted ionization inlet (SAII) 
[221,222] and charged matrix droplets/particles in MAII are proposed to be responsible 
for producing similar charge state distributions to those observed with MAIV. Producing 
charged droplets or particles is common in nature. For water droplets and ice crystals, it 
has been shown that a cold subliming/evaporating surface has an excess of positive 
charge and a warm condensing surface an excess negative charge [224]. The dislodging 
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of the surface of ice crystals [225] carrying excess surface charge is believed to be the 
source of electrification of thunderclouds [224]. Thus, the observed 3-NBN particles, by 
a similar mechanism may be ejected having an excess of the surface charge. Such a 
charging mechanism occurring from the surface rather than individual particle is 
problematic for explaining continuous ionization and observation of both positive and 
negative ions. 
Another characteristic of 3-NBN that could lead to charging of the ejected 
particles is dinitrogen discharge emission (triboluminescence) during crystal fracturing 
[69,70]. Triboluminescence [226,227] is known to occur when 3-NBN undergoes a 
fracturing process [69,70]. The emitted light, referred to as lightening, is caused by 
electric charge of opposite sign being produced on opposing surfaces of a crack in the 
crystal. The electric field caused by these charges is sufficiently high to initiate a 
discharge at atmospheric pressure, and thus it seems reasonable that the process of 
splintering matrix particles from the 3-NBN surface could create charges. The particles 
ejected from the matrix surface could also splinter, creating smaller charged particles. In 
the case of 3-NBN, once the charged particles are formed, matrix sublimation, similar to 
solvent evaporation in ESI, would also be required to release the bare analyte ions. 
Sublimation/evaporation of the charged solid particles could release analyte ions by the 
charge residue mechanism [51], or possibly a modified ion evaporation mechanism [52]. 
However, without addition of thermal energy, it seems unlikely that the matrix could 
convert to molten droplets [31] or molten clusters [197] as previously observed for LSII 
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and modeled for vacuum MALDI [36,37]. Thus, multiply charged ions must be produced 
directly from the solid state. 
Sublimation/evaporation of the charged particles appears to be rapid based on 
similar ion abundances with and without the use of the IMS TriWave Technology of the 
SYNAPT G2 mass spectrometer (Appendix C Figure S11). Thus, with 3-NBN, the bare 
ions are already formed before they reach the TriWave device. This was not the case for 
laser ablation of 2,5-DHAP matrix, where desolvation appears to occur as late as the IMS 
region [42]. 
According to the above scenario, a successful MAIV matrix requires both a 
fracturing mechanism that produces charged particles and either sublimation or 
evaporation to release bare ions. Conditions of pressure and temperature will affect both 
charge generation and ion release. Therefore, the number of successful MAIV matrices 
may be restricted in the absence of heat and proper vacuum conditions. A means of 
supplying thermal energy under vacuum conditions may increase analyte ion abundance 
and expand the compounds that act as MAIV matrices. This hypothesis is based on the 
fact that heating the mass spectrometer inlet tube in MAII to 450 °C produced multiply 
charged ions for peptides and proteins with well over 100 small molecules tested as 
matrices [40]. 
A number of compounds tested show sublimation (Table S1.I) but no analyte 
ions are formed using MAIV conditions. Several compounds that triboluminescence were 
also examined, but did not sublime visually from the surface of the sample holder and 
produce no ions by MAIV (Table S1.II). However, like 3-NBN, coumarin is a 
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triboluminescence compound [228] that sublimes [229] in vacuum and produces multiply 
charged analyte ions in the SYNAPT G2 MALDI source and ESI source (Appendix C 
Figure S12) similar to 3-NBN. On the other hand, 2,5-dihydroxyacetophenone (2,5-
DHAP) matrix does not produce ions in the intermediate pressure vacuum MALDI 
source without laser ablation and requires added heat to produce analyte ions using the 
modified ESI source (Appendix C Figure S13). Based on these results, we hypothesize 
that MAIV is a sublimation/evaporation-driven triboluminescence process leading to 
analyte ionization. 
Fundamentally interesting is that larger proteins are efficiently ionized with 
MAIV, with and without acidifying the matrix or analyte solutions, and, because of 
multiple charging, can be analyzed on a mass range limited mass spectrometer having a 
commercial MALDI source. Higher charge state ions are obtained when the 
matrix:analyte sample is introduced to the vacuum source with some solvent still present. 
Myoglobin (Figure 11.2a) is found to produce up to +22 charges and carbonic anhydrase 
(Figure 11.2b) up to +31 charges. Observation of multiply charged ions of proteins using 
matrix assisted laser ablation in a vacuum MALDI source (Scheme 1.1.IIA) was limited 
at high mass to ionization of ubiquitin using 2,5-DHAP as matrix [42]. However, the 
MAIV results for carbonic anhydrase are similar to those obtained with MAII [194] or 
LSII [138] (Scheme 1.1.I). This seems to indicate a similar ionization mechanism, but in 
MAII and LSII ionization occurs in a heated inlet to the mass spectrometer, whereas in 
MAIV ions are produced under cold vacuum sublimation conditions. ESI and SAII also 
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produce similar mass spectra of proteins [221] demonstrating that ion formation from 
charged droplets and charged particles produce similar results. 
 
Figure 11.2. MAIV-IMS-MS of (a) myoglobin (MW ∼17 kDa) and (b) carbonic 
anhydrase (MW ∼29 kDa) with 3-NBN matrix using the intermediate pressure vacuum 
SYNAPT G2 MALDI source. Blue numbers in upper right corner of each spectrum 
provide an indication of ion abundance and red numbers the charge states. 
 
Applications 
The sensitivity of MAIV is demonstrated by a comparison using ESI and MAIV 
of 5 fmol consumed of clozapine, a schizophrenia drug (Figure 11.3). The isotopic 
distribution is readily discerned for MAIV but not ESI because of the chemical 
background observed with ESI. Cooling the plate slows matrix loss during the ca. 2 min 
sample plate introduction period allowing observation of sub-fmol of clozapine using 
MAIV on the vacuum MALDI source (Appendix C Figure S14). 
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Figure 11.3. Mass spectra of 5 fmol clozapine (MW 326 Da) using: (a) MAIV on an 
intermediate pressure vacuum MALDI source with 3-NBN matrix and (b) an ESI source 
in 50:50 MeOH:water. Insets show isotopic distribution of clozapine and its chemical 
structure. Numbers in red are clozapine ions reflecting the expected chlorine isotopic 
distribution. Blue numbers in upper right corner of each spectrum provide an indication 
of ion abundance and red numbers indicate the isotopic distribution. 
 
MAIV is also broadly applicable to a wide range of compounds. Because of 
multiply charging, MAIV works well with advanced methods such as IMS. The two-
dimensional dataset of drift time vs. mass-to-charge (m/z) separations for the MAIV-IMS-
MS measurement of a mixture of compounds is shown in Figure 11.4Ia.  
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Figure 11.4. MAIV-IMS-MS of a mixture of (I) clozapine (MW 326 Da), sphingomyelin 
(MW 702 Da), leu-enkephalin (MW 555 Da), angiotensin II (MW 1040 DA), ACTH 
(MW 2465 Da), and bovine insulin (MW 5731 Da), and (II) ubiquitin (MW 8561 Da), 
lysozyme (MW ∼14.3 kDa), and myoglobin (MW ∼17 kDa) in 3-NBN matrix using the 
SYNAPT G2 intermediate pressure vacuum MALDI source: (a) two-dimensional plot (2-
D) of drift time vs. m/z, (b) total mass spectrum, and (c) extracted mass spectrum from 
the 2-D plot of the least abundant component from (b). Other extracted mass spectra are 
displayed in Appendix C Figure S15. Blue numbers of each spectrum provide an 
indication of ion abundance; other colors indicate the charge states. 
 
The charge states +1 (clozapine MW 326, sphingomyelin MW 702, Leu-enkephalin MW 
555), +2 (ACTH MW 2465, angiotensin II MW 1040), and +3 (ACTH, insulin MW 
5731) are well separated from each other and from the higher charge states (+4 and +5) 
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from bovine insulin. The mass spectrum of this mixture (Figure 11.4Ib) show 
exceptional quality both in terms of ion intensity across the mass range for all mixture 
components and low chemical background. Making use of the two-dimensionality of the 
dataset allows clean mass spectra to be extracted for any of the component of the mixture 
(e.g., ACTH, Figure 11.4Ic). IMS-MS can also be used to separate proteins that are 
beyond the m/z range of the instrument. Figure 11.4II demonstrates this capability with a 
mixture containing the proteins ubiquitin (~8.5 kDa), lysozyme (~14.3 kDa), and 
myoglobin (~17 kDa). The cleanly extracted mass spectrum for the least abundant 
component, lysozyme, is shown in Figure 11.4IIc. 
A variety of other compounds have been analyzed using the MAIV method on the 
commercial vacuum MALDI source of the SYNAPT G2 without the use of the laser. For 
example, the low solubility β-amyloid (1-42) peptide produces abundant multiply 
charged ions using MAIV in the positive (most abundant charge state +4, Figure 11.5a) 
and negative (most abundant charge state -3) modes (Figure 11.5b). Arachidonic acid 
produces abundant negative singly charged ions (Figure 11.5c). PEG-DME 2000 doped 
with LiCl produces multiply cationized molecular ions (Figure 11.5d). Similar to ESI, 
small molecules such as the illicit drug cocaine (Appendix C Figure S16a), the pesticide 
foramsulfuran (Appendix C Figure S16b), and the D-mannopyranose derivative 
(Appendix C Figure S16c), produce singly charged ions with MAIV from the solid state 
in vacuum and with relative little chemical background ions. The background ions 
observed in MALDI-MS at every mass has been shown to be related to charged matrix 
clusters [94]. The low background in MAIV-MS may be related to the absence of laser 
  
141 
ablation. Ions related to the matrix and, possibly, matrix and solution impurities are 
observed in MAIV, but only at a relatively few masses (e.g, m/z 328 and 415). 
 
Figure 11.5. MAIV-IMS-MS of beta-amyloid (1-42) (MW 4511 Da) (a) positive and (b) 
negative mode measurements, (c) arachidonic acid (MW 304 Da) in negative mode, and 
(d) PEG DME 2000 doped with 10 % 1 M LiCl in positive mode using the intermediate 
pressure vacuum SYNAPT G2 MALDI source. Insets show isotopic distributions. Red 
numbers indicate the charge states of the negatively and positively charged analyte ions. 
 
Other applications show MAIV to be useful for the analysis of molecules from 
native surfaces such as mouse brain tissue [46]. Synthetic surfaces can also be sampled in 
this manner (e.g., TLC plate, tissue, and filter paper, Appendix C Figure S17). 
Characterization of cocaine from paper currency using MS (Figure 11.6a), IMS 
(Figure 11.6b), and MS/MS (Figure 11.6c) was achieved by application of 2 μL of 
matrix solution on the eye of President Jackson and introducing the $20 bill folded and 
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attached to the sample plate into the intermediate pressure vacuum MALDI source of a 
SYNAPT G2 mass spectrometer. 
 
 
Figure 11.6. Surface analysis by MAIV (a) MAIV mass spectrum from a $20 bill spotted 
with 3-NBN matrix and acquired using the intermediate pressure vacuum SYNAPT G2 
MALDI source, (b) extracted drift time, and (c) collision-induced dissociation mass 
spectra of illicit drug cocaine (MW 303 Da) detected from (1) $20 bill and (2) standard 
cocaine. MS/MS fragmentation pattern is essentially identical to [298]. The other major 
component detected from the surface of the bill with a repeat unit of 58 indicates 
polypropylene glycol. Blue numbers of each spectrum provide an indication of ion 
abundance and red numbers the charge state. 
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The results were compared with those obtained from a cocaine standard prepared on a 
glass slide and with MS/MS results described in the literature [230]. Cocaine has been 
analyzed directly from currency by a number of ambient ionization methods [231,232], 
but with MAIV, the location sampled is readily defined by the matrix application. 
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CHAPTER 12 
THE POTENTIAL FOR CLINICAL APPLICATIONS USING A NEW 
IONIZATION METHOD COMBINED WITH ION MOBILITY 
SPECTROMETRY-MASS SPECTROMETRY “Springer and the original publisher 
(Int. J. Ion Mobility Spectrom., 16, 2013, 145-159, Inutan, E.D.; Wager-Miller, J.; 
Narayan, S.; Mackie, K.; Trimpin, S.) is given to the publication in which the material 
was originally published with kind permission from Springer Science and Business 
Media.” 
 
Introduction 
Identifying clinically relevant health and disease biomarkers is often like 
searching for the proverbial needle in a haystack. Mass spectrometric approaches are well 
suited for such a search because they can interrogate complex biological matrices at the 
molecular level with superb sensitivity, mass resolution, and mass accuracy. However, 
improved sensitivity and dynamic range, as well as reproducibility from sample to 
sample, are required for many clinically relevant applications. The extreme complexity 
that comes with clinical samples combined with the pressure of accuracy, time and cost 
constraints requires that operator involvement be limited as much as possible. While 
tandem mass spectrometry (MS) targeted screening has been very successful, it requires 
expertise in operation, data interpretation, and is time consuming because it is usually 
preceded by liquid chromatography (LC) or gas chromatography (GC), methods that can 
be prone to column fouling, and additionally the targeted approach does not detect non-
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targeted molecules. LC-MS has significantly impacted analyses of complex biological 
materials such as tissue, plasma, and urine [233-246]. However, this technology has had 
only limited success in clinical applications. It is generally accepted that clinical MS 
analysis needs more efficient and simple ionization, and ideally, real time separation 
orthogonal to MS for additional specificity. Ion mobility spectrometry (IMS), especially 
combined with MS, has emerged as a powerful method for separating ions, without the 
use of a solvent, according to number of charge, size, and shape. Near real time 
separation is achieved and molecular shape information is available using cross-section 
analysis [61,64,67,247-262]. Additional characterization technologies can be applied 
such as MS/MS using collision induced dissociation (CID) or electron transfer 
dissociation (ETD) [58,100,263,264]. 
MS ionization methods are powerful, but problematic for many clinical 
applications for reasons including cost, robustness, degree of difficulty, and interference 
from the generation of high background ions. In the past decade, numerous ‘ambient 
ionization’ sampling strategies have been implemented using established ionization 
methods to circumvent some of these issues [139,232,265-267]. Heretofore unknown 
ionization methods for MS have recently been discovered and fundamental studies are 
starting to define physical underlying processes [29,31,40,45,197]. These new ionization 
methods encompass inlet ionization with a laser, laserspray ionization inlet (LSII) 
[28,49], and without a laser, matrix assisted ionization inlet (MAII) [39,194], or with a 
solvent, solvent assisted ionization inlet (SAII) [221,222,268,269], as well as 
the vacuum ionization methods of laserspray ionization vacuum (LSIV) [42-44], and 
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matrix assisted ionization vacuum (MAIV) [46,47,]. These methods are sensitive, operate 
from atmospheric pressure or vacuum, and are applicable for low and high mass analytes 
in the solid phase or in solution. Charge states similar to electrospray ionization (ESI) are 
produced, and on high performance mass spectrometers yield high resolution, accurate 
mass measurement, charge state resolved IMS-MS, and/or advanced fragmentation for 
structural characterization. Of these new ionization methods, MAIV stands out as being 
exceptionally simple, requiring no high voltage or laser, and operates at room 
temperature or with heat, ionizing a variety of different compounds from fatty acids to a 
protein complex [46,47]. We previously hypothesized that the underlying mechanism of 
MAIV may be a sublimation driven triboluminescence like process [46,47]. Four 
different MAIV matrix compounds have been discovered, 3-nitrobenzonitrile (3-NBN), 
2-nitrobenzonitrile, 3-nitrobenzaldehyde, and coumarin [47], but none work nearly as 
well as 3-NBN. Here we show initial results to analytical utility using MAIV in 
conjunction with real-time separation by IMS, MS, and MS/MS, which suggests a future 
of this methodology in clinical applications. 
Experimental Methods 
Materials and sample preparation are included in Chapter 2.1. Nicotine and its 
metabolite standards and the smoker’s urine were provided by DMC (Detroit, MI). 
Cetirizine, an allergy medication, was purchased as tablets from a pharmacy and taken 
orally (human) and subsequently used for urine analysis. Dilutions from stock solutions 
were made in water for most of the analytes, in 50:50 methanol/water for clozapine, and 
in 25 mM ammonium acetate in 10 % methanol for lysozyme to make 1 to 5 pmol μL-1 
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concentrations. The analyte concentrations in the model mixture of lipids, peptide, and 
proteins ranged from 1 pmol μL-1 (sphingomyelin, leucine enkephalin, angiotensin II) to 
5 pmol μL-1 (galanin, bovine insulin, ubiquitin) and the small molecule mixture ranged 
from 1 to 8 pmol μL-1. The protein mixture contained 5 pmol μL-1 lysozyme and 
10 pmol μL-1 myoglobin. The mixture for negative mode measurements contained bovine 
insulin (2 pmol μL-1), beta amyloid (1–42) (5 pmol μL-1) and ubiquitin (10 pmol μL-1). 
Clozapine, angiotensin I, and ubiquitin were diluted in 1 M NaCl for the salt studies. 
Clozapine was diluted in water and 50:50 methanol/water for solvent and pH studies of 
small and large molecules with 3-NBN added with and without formic acid. 3-NBN 
matrix was prepared by dissolving 5 mg in 50 μL 100 % ACN with and without 0.1 % 
formic acid, 150 μL 50:50 ACN/water with 0.1 % formic acid (mixing and deposition on 
tissue), and 50 μL 50:50 ACN/methanol with 0.1 % formic acid (small molecule mixture) 
for positive mode measurements, and 150 μL 50:50 ACN/water with 1 % NH4OH 
(MAIV and ESI comparison) and 50:50 ACN/methanol with 1 % NH4OH for negative 
mode measurements. 
The dried droplet method was used to prepare 1 μL spots of analyte:matrix 
mixture in 3:1 and 2:1 volume ratio for positive and negative measurements, respectively. 
For tissue analysis, sections of a non-drug and drug treated mouse brain tissue were 
collected and mounted on a glass microscope slide as previously described in Chapter 
2.1 and in previous studies.[48,195] The mouse received clozapine (50 mg kg
−1
, 
intraperitoneal) 90 min before it was sacrificed. Clozapine plasma was obtained by 
centrifugation of heparinized blood collected by cardiac puncture from treated mouse 
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after euthanasia. A 25 μL volume of the plasma was concentrated by evaporation in the 
biodryer without heat and redissolved in 10 μL water. A total of 1 μL of 3-NBN matrix in 
50:50 ACN:water with 0.1 % formic acid was spotted in 0.2 μL increments. Small 
sections of tissue removed from the glass plate were also dipped in 3-NBN matrix 
solution and spotted directly on the sample target plate. For the human body fluids 
analysis, separately 10 μL of the drug dosed urine and blood (extracted with water from 
an adhesive bandage) was diluted to 100 μL with water. The smoker’s urine (5 μL) was 
directly combined with the 3-NBN solution. Isomeric mixture of 5 pmol μL-1 beta-
amyloid (1–42) and 2 pmol μL-1 (42–1) was prepared in 50:50 ACN/water with 0.1 % 
TFA. For the matrix assisted laser/desorption ionization (MALDI) comparison, 5 mg of 
CHCA was dissolved in 1 mL of 50:50 ACN/water with 0.1 % formic acid and mixed 
with the analyte in 1:1 volume ratio. For ESI comparison, 10 pmol μL-1 of beta-amyloid 
(1–42) in 50:50 MeOH/water was used at an infusion flow rate of 4 μL min-1 for 30 s. 
Ion mobility spectrometry (IMS)-MS - An IMS-MS (SYNAPT G2) mass 
spectrometer (Waters Co., Manchester, UK) was used in this study. The mass 
spectrometer was operated in the positive, negative and sensitivity (‘V’ optics of the 
time-of-flight mass analyzer) modes. The IMS drift cell pressure was set at ~3.7 mbar. 
Argon was used as the collision gas for MS/MS in the transfer region. MassLynx 4.1 
software was used to extract the mass spectrum and DriftScope version 2.2 for the IMS 2-
dimensional (2-D) display of drift time (td ) vs. mass-to-charge (m/z) using a color 
background of hot metal or emerald forest and square root display. Nested datasets of 
drift(flight)time in units of td(m/z) were used as previously defined [67,270]. BayesSpray 
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from MaxEnt methods [271] was used to deconvolute the multiply charged ions to mass 
values. 
Matrix assisted ionization vacuum (MAIV) -  
MALDI source SYNAPT G2 - The IP-MALDI source of SYNAPT G2 was used 
to perform MAIV using a vacuum source as described in Chapter 2.4. Unless otherwise 
noted, the data were acquired using ‘LSI settings’ as previously reported [42,45] similar 
to those used with ESI with the extraction lens at a lower voltage than used with the 
default ‘MALDI settings’. The default ‘MALDI settings’ [45] of the vacuum MALDI 
source were used to obtain comparison mass spectra and proteins from tissue. In both 
operation modes, no laser was used and acquisition times were set at a scan time of one 
second for a period of 1 to 2 min. ESI source SYNAPT G2 - The interlocks of the ESI 
source of SYNAPT G2 were overridden using the connecting flange available with the 
MALDI source of the instrument to allow open access to the Z-spray skimmer cone; 
however, MAIV acquisition can also be obtained using the nano-ESI source as previously 
described for LSI [49,50]. The Z-spray skimmer cone was modified as described in 
Chapter 2.4 to perform MAIV on an ESI source. The source temperature was set at 
50 °C with a sample cone voltage of 40 V and extraction cone voltage of 4 V, similar to 
ESI source settings. 
Conventional ionization methods 
MALDI - The intermediate pressure MALDI source of SYNAPT G2 was 
operated using a Nd:YAG laser (355 nm, 200 Hz). Default ‘MALDI settings’ [45] were 
used in sensitivity mode with 20 V on sample plate holder and a laser power of setting of 
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‘225’ or ca. ~12.5 J cm-2. ESI - Acquisition conditions were set similar to MAIV using 
the MALDI source but with capillary voltage of 2.5 kV, desolvation gas flow of 
500 L hr−1, and 80 °C source temperature. 
Results and Discussion 
The MAIV method depends only on an appropriate matrix and the vacuum 
conditions common to mass analyzers. Thus, this method is applicable on either a 
commercial intermediate pressure MALDI source (Appendix C Figure S18.I) or an ESI 
source with minor modifications (Appendix C Figure S18.II). MAIV sample 
preparation can be the same as MALDI but produces multiply charged ions essentially 
identical to ESI. The MAIV procedure to generate a mass spectrum is amazingly simple. 
A solution of the MAIV matrix compound, e.g. 3-NBN, is pipetted onto the sample in a 
manner that is identical to MALDI sample preparation protocols. The matrix:analyte 
sample is then exposed to the vacuum of the mass spectrometer (Appendix C Figure 
S18.Ia). The total ion current (TIC) exemplifies the ion production during the time 
required for the matix:analyte to be removed from the sample plate surface, which is 
approximately 2 min for sample introduction and an additional 1 to 5 min, depending on 
the sample preparation, during which time analyte ions are observed (Appendix C 
Figure S18.Ib). Matrix apparently sublimes when exposed to vacuum. As long as the 
matrix is on the sample plate (Appendix C Figure S18.Ia, Inset), analyte ions are 
observed even for proteins (Appendix C Figure S18.Ic). Similarly, the nicotine standard 
and its diagnostic metabolite cotinine, which is predictive of recent tobacco smoking, are 
readily observed with MAIV using an ESI source (Appendix C Figure S18.IIa). Analyte 
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ions are observed in high abundance with little chemical background (Appendix C 
Figure S18.IIc). The ion formation in MAIV is continuous until the sample is depleted. 
Using the ESI source (Appendix C Figure S18.IIb) the analysis time is considerably 
compressed relative to MAIV operated on the intermediate pressure vacuum MALDI 
source (Appendix C Figure S18.Ib). From visual observations at atmospheric pressure, 
the matrix:analyte sample under favorable conditions is entirely removed within a few 
seconds, which accounts for the more rapid ionization process. Samples can be 
completely dry or still in solution when presented to the vacuum (Appendix C Figure 
S19) because the vacuum assists in drying the sample. The ready sublimation of 3-NBN 
under vacuum conditions is expected to eliminate instrument contamination by this 
matrix. 
The MAIV method is sensitive as is demonstrated by the mass spectra of 50 fmol 
of levofloxacin, an antibiotic drug, and bovine insulin shown in Appendix C Figure S20. 
MALDI mass spectra (Appendix C Figure S20.I) were acquired with the same 
levofloxacin sample (50 fmol applied) using the common matrix CHCA. The abundant 
chemical background observed with MALDI dominates the mass spectrum, and is likely 
related to photoionization of the matrix [94]. MAIV also fairs better than MALDI 
because without the use of a laser, ‘hotspot’ issues are not observed. Only 5 fmol of 
clozapine in the presence of 20 pmol of bovine insulin allow identification of clozapine 
using the extracted mass spectrum (Appendix C Figure S20.III). This is accomplished 
through the use of the IMS real time separation, which increases the dynamic range of the 
experiment, allowing minor components to be detected in the presence of abundant 
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components. Previous studies on pure clozapine standard showed mass spectra 
consuming only 5 fmoles in MS, and in MS/MS only 900 attomoles [47]. The use and 
application of IMS are discussed below. 
MAIV is also tolerant of salts which often add difficulty when directly analyzing 
biological samples using MS. High levels of salt (1 M NaCl, Appendix C Figure S21) 
added to samples had minimal deleterious effects as is demonstrated for clozapine, 
angiotensin I, and ubiquitin, all of which are detected as protonated ions. Only with 
increasing size of the protein is sodium adduction detected. Initial experiments suggest 
that pH has little influence on the charge state distribution. The ion abundance is best 
near neutral pH conditions for small and large molecules (Appendix C Figure S22), 
however, different solvents systems show different degrees of chemical background 
(Appendix C Figure S22.I). For smaller molecules, more volatile solvents seem to aid in 
ionization; visual observations suggest that crystal formation of matrix:analyte is more 
favorable. Although MAIV is a soft ionization method, fragmentation can be induced by, 
for example, increasing the extraction voltage in the intermediate pressure MALDI 
source. Using the low extraction voltage of LSI settings the drug clozapine is detected 
intact or with little fragmentation (m/z 270) (Appendix C Figure S23a), however, using 
the higher extraction voltage of the default MALDI settings with the same 
matrix:clozapine sample, abundant fragment ions are observed (Appendix C Figure 
S23b). Interestingly, the softer MAIV ionization conditions using LSI settings provide 
simplicity of data interpretation (Appendix C Figure S24.I) whereas MAIV using 
commercial MALDI settings (Appendix C Figure S24.II), but without the use of a laser, 
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form gas-phase dimers of lipid aggregates commonly observed in MALDI [272] and ESI 
analysis [273], especially when using laser irradiation or increased concentrations. These 
aggregates are readily visualized incorporating IMS [67,157,166], as is the case here 
(Appendix C Figure S24.IIB). All compounds tested to date have produced less 
chemical background, fragmentation, or aggregation, and improved ion abundance of the 
multiply charged ions using ‘LSI settings’. In the following examples, LSI settings were 
therefore used for analyte ionization with the exception for proteins from tissue. These 
ionization trends of high salt and pH tolerance allow direct analysis of small and large 
molecules from their native and complex environments by simply exposing the analyte or 
just the area of interest to 3-NBN and the vacuum of the mass spectrometer. Small and 
large molecule analyses using MAIV in combination with IMS real time separation 
technologies are discussed for potential use as a direct analysis platform in clinical 
applications using MS. 
Small molecules 
Drugs such as clozapine (MW 326), and levofloxacin (MW 361) as well as 
commonly abused drugs (cocaine MW 303, fentanyl MW 336, benzoylecgonine MW 
289) (Figure 12.1.Ia) can rapidly be analyzed using MAIV on an ESI source without the 
low-mass matrix background ions common at every mass with MALDI [274,275]. The 2-
dimensional (2-D) plot of drift time vs. m/z (Figure 12.1.Ib) shows separation in the ion 
mobility dimension of the singly charged MAIV ions produced for each of the 
compounds in the mixture. Singly charged ions are detected with no fragmentation and 
little chemical background (Figure 12.1.I). The extracted drift times (Figure 12.1.Ib, 
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Insets) display well-resolved peaks, and the isotopic distributions (Appendix C Figure 
S25.I) and accurate mass assignments help in identifying the drugs in the mixture. Nested 
td(m/z) data information [67,270] from IMS and MS can be extracted and used for 
identification, e.g. levofloxacin 4.28(337). An example of this approach with direct 
ionization from a mouse brain tissue sample is provided below. For additional specificity 
and confirmation, MS/MS without precursor ion selection (Figure 12.1.Ia) is performed 
with IMS similar to MSe but without the alternating low and high collision energy [276], 
or LC separations [277-288]. In other words, the entire set of ions, both directly ionized 
by MAIV as well as separated by IMS, are fragmented in the transfer region without 
precursor selection of the ions. Figure 12.1.Ib shows the 2-D plot display of drift time 
vs. m/z of the fragment ions obtained for each of the analyte molecules in the mixture. 
With the IMS dataset, each of the MS/MS mass spectra can be extracted based on the 
drift time information. This is shown for cocaine in Figure 12.1.Ic and Appendix C 
Figure S25.II. The validity of the method is shown by comparison with conventional 
IMS-MS/MS using precursor selection in the quadrupole, as demonstrated for cocaine in 
Figure 12.1.III. Identical results were obtained for all mixture components without 
(Appendix C Figure S25.II) and with (Appendix C Figure S25.III) precursor selection 
so that nested data information applies for IMS-MS/MS, e.g., td(m/z→m/z) 
3.25(304→182). Obtaining specificity for all mixture components without the precursor 
selection has the advantage of potentially being a fast non-targeted approach. The 
collective IMS-MS and IMS-MS/MS dataset should be sufficiently specific for 
automated data interpretation of large datasets, even if molecular ions are not completely 
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baseline separated by IMS or MS, and without LC, which is important for robust, direct, 
and surface analyses methods. 
The direct characterization of drugs from tissue is illustrated for clozapine using 
IMS and MS (Appendix C Figure S26). The first dimension information, the drift time 
distribution, is identical to the synthesized standard (Appendix C Figure S16b, Insets 
bottom right). The second dimension information, the mass measurement and isotopic 
distribution, readily identifies the drug because of the uniqueness of the chlorine pattern 
and superimposes over the standard sample (Appendix C Figure S26b, Insets top left). 
Therefore the nested dataset, 3.26(327) for clozapine, is sufficiently distinctive for 
identifying a small drug molecule directly from complex biological matrix such as tissue, 
at least if a standard is available. However, MS/MS can be employed if improved 
specificity is desired (Appendix C Figure S27). This may require an additional minute 
of data acquisition and perhaps more user expertise to enable interpretation. As long as 
the fragmentation patterns are known, the procedures are similar to those employed for 
targeted analysis using triple quadrupole technology, but includes a MS profile of the 
sample composition. 
Ions are only observed from the section of the tissue (Figures 12.2 and S26, 
Appendix C) where matrix is applied, which can be substantially smaller than 1 mm2. 
Matrix solution added to minute amounts of tissue is shown in Figure 12.2c. Contary to 
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Figure 12.1. MAIV-IMS of small molecule mixture of clozapine (MW 326 Da), lavaquin 
(MW 361 Da), and common abused drugs cocaine (MW 303 Da), fentanyl (MW 336 
Da), and benzoylecgonine (MW 289 Da) with 3-NBN matrix using the custom modified 
ESI source of SYNAPT G2 mass spectrometer: (I) MS, (II) MS/MS without precursor 
ion selection, and (III) MS/MS with m/z 304 precursor selection (cocaine). a Total mass 
spectra, b 2-D plot of drift time (td) vs. m/z. Insets in I.b show extracted drift times 
labeled in a nested fashion as td (m/z) as described previously [67,270]. II.c show the 
extracted MS/MS mass spectrum of cocaine from II.b 
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established technology, location is frozen in time as only the tissue exposed to the 3-NBN 
is ionized (Figure 12.2a). A spatial analyses of about 500 μm diamater is readily 
obtained without the use of a laser or a (micro) dissecting knife. Using this approach, 
mouse brain tissue was readily analyzed only 30 min after receiving 50 mg kg
-1
 of 
clozapine (Figure 12.b). This approach is therefore sensitive enough for low abundance 
drug detection. The protocol can be repeated until the tissue has been consumed by the 
ionization event. Using a similar approach, a tissue piece dipped into the matrix solution 
and subsequently inserted into the mass spectrometer for analysis is shown in Appendix 
C Figure S28.I.  
 
Figure 12.2. MAIV-IMS-MS of clozapine treated mouse brain tissue spotted with 3-
NBN matrix: a total mass spectra, b 2-D plot display of drift time vs. m/z, and c 
microscopy photographs of the tissue (1) before and (2) after matrix deposition. Insets 
show (a) isotopic distribution fromthe total mass spectrum, (b) isotopic distribution 
extracted from the 2-D plot, and extracted drift times labeled in a nested fashion for 
clozapine. Data was acquired using LSI settings without the use of a laser on the 
intermediate pressure MALDI source of SYNAPT G2 mass spectrometer. 
 
This simple method holds great potential as a rapid means for (e.g.) biopsy assays. 
Further, blood taken from a mouse 30 min after receiving 50 mg kg
-1
 of clozapine was 
also analyzed in a straightforward manner (Appendix C Figure S28.II). Despite the 
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complexity of the sample composition, clozapine at m/z 327 is readily observed. Because 
no laser is used and hot spot issues are avoided, quantitation studies might be possible. 
Using MAIV-IMS-MS, diluted urine can be analyzed without sample desalting. 
Ample ion abundance to characterize the drug cetirizine hydrochloride (Figure 12.3.I) 
from the urine of an individual taking allergy medication is produced by simply diluting 
the urine 1:10 in water and mixing it with the 3-NBN matrix before placing in vacuum. 
Again, the nested dataset is sufficiently distinctive. Specificity gained through MS/MS 
data for the drug cetirizine confirms its presence in the urine sample (Appendix C 
Figure S29.I). Similarly, the diagnostic nicotine metabolites, cotinine and nornicotine, 
can be observed simultaneously from the urine sample from a smoker using MAIV-IMS-
MS (Figure 12.3.II). Interestingly, the isobaric compounds (Inset right) of nornicotine 
(accurate molecular weight 148.0995 Da), one of the metabolites of nicotine, and 3-NBN 
(accurate molecular weight 148.0267 Da) are baseline separated in the IMS dimension 
(Inset left). Nornicotinine (Inset top), present in relatively low abundance, is matched 
with its nested data against the pure standards discussed above (Appendix C Figure 
S18.IIc). Using the notably different drift times and MS/MS fragmentation in the transfer 
fragmentation region of the mass spectrometer verified the identities of the two different 
isobaric small molecules (Appendix C Figure S29.IIa). Both urine solutions and plasma 
samples have been directly analyzed from glass microscope slides requiring only dilution 
with water before mixing with the matrix and required no sample clean up. Typically, 
such complex mixtures can result in column fouling in LC/MS and GC/MS, but with 
MAIV nonvolatile, un-ionized compounds remain on the sample plate, while compounds 
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that are volatile under the vacuum, including the matrix, are pumped from the instrument, 
potentially reducing or eliminating instrument contamination. IMS-MS and, if need be, 
MS/MS provide a instantaneous means for separation, profiling and characterization with 
very little operator expertise needed for sample preparation and analyses. Unlike targeted 
 
 
Figure 12.3. MAIV-IMS-MS using 3-NBN matrix of (I) urine from drug dosed 
individual taking cetirizine, an allergy medication and (II) smoker’s urine: (a) total mass 
spectra and (b) 2-D plot display of drift time vs. m/z. Insets in b show extracted drift 
times labeled in a nested fashion and isotopic distributions. Data was acquired using LSI 
settings without the use of a laser on the intermediate pressure MALDI source of 
SYNAPT G2 mass spectrometer. 
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analysis, the entire material is profiled. An intrinsic limitation of targeted analyses using 
traditional clinical assays is that one can only interrogate analytes for which assays are 
established and must run many samples, if need be, until the ‘hit’ is determined. 
Large molecules 
An example of a MAIV mass spectrum of the peptide beta amyloid (1–42) 
(molecular weight 4511 Da) using 3-NBN on the intermediate pressure Waters SYNAPT 
G2 MALDI source with the laser ‘off’ (Appendix C Figure S18.Ia) is shown for both 
positive (Fig. 4.I) and negative (Figure 12.4.II) mode detection. For comparison, the 
same sample was analyzed using ESI (Figure 12.4.III) on the same mass spectrometer. 
The negative mode mass spectra are nearly identical in charge state and sensitivity to ESI 
as shown in Figure 12.4.II and III but the charge states are slightly lower relative to the 
positive mode (Figure 12.4.I). The successful ionization in the negative mode is in 
support of the triboluminescence particle charging hypothesis [46,47]. With the IMS 
dataset, the drift times of the multiply charged ions of beta amyloid (1–42) 
(Figure 12.4.b, Insets) can be extracted. The extracted drift time information using the 
MALDI source with MAIV in the negative mode measurements (Figure 12.4IIb, Insets) 
is essentially identical to the extracted drift time using traditional ESI (Figure 12.4IIIb, 
Insets) additionally to the same charge state distributions. This is of fundamental interest 
because two different methods and acquisition conditions are used; MAIV operates from 
the solid state and ESI from solution. This indicates that cross-section analyses are 
applicable for MAIV using conditions and methods established for ESI. Previous studies 
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Figure 12.4. IMS-MS (a) mass spectra and (b) 2-D plot display of drift time vs. m/z of 
beta-amyloid (1–42) (MW 4511 Da) using MAIV with 3-NBN matrix in (I) positive 
mode and (II) negative mode on the intermediate pressure vacuum MALDI source, and 
(III) ESI comparison in negative mode of the SYNAPT G2 mass spectrometer. Insets 
show extracted drift times. 
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using ESI-IMS-MS suggested that negative mode measurements for amyloid β-protein 
are more reliable than positive mode measurements relative to cross-section analyses 
[118]. The drift time distributions may give additional information to the relative 
structures of these analyte ions directly from their native surfaces in the future. 
Figure 12.5 shows the MAIV data obtained from a mixture of beta amyloid (1–
42) (molecular weight 4511 Da), bovine insulin (molecular weight 5730 Da), and 
ubiquitin (molecular weight 8560 Da) in 2.5:1:5 molar ratio, respectively, using 3-NBN 
as matrix in the negative mode on the custom modified ESI source. Good ion abundance 
is observed from this mixture. However, ubiquitin ions are observed in lower ion 
abundance in the total mass spectrum (Figure 12.5a1 ) compared to bovine insulin, 
which is in the lowest concentration in the mixture. Using the drift time dimension 
provided by IMS (Figure 12.5b), the mass spectrum of each protein can be extracted 
(Appendix C Figure S30). The cleanly separated mass spectrum for ubiquitin is 
exemplified in Figure 12.5a2. 
The ability of MAIV to analyze a variety of samples is demonstrated for a model 
mixture containing a lipid (sphingomyelin molecular weight 702 Da), peptides (leucine 
enkephalin molecular weight 555 Da, angiotensin II molecular weight 1045 Da), small 
proteins (galanin molecular weight 3156 Da, bovine insulin molecular weight 5730 Da) 
and ubiquitin (molecular weight 8560 Da) in the positive detection mode using the 
SYNAPT G2 MALDI source (Appendix C Figure S31). MAIV ionizes all the individual 
components of the mixture from lipids to proteins with good ion abundance and 
essentially no chemical background (Appendix C Figure S31a). The multiply charged 
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Figure 12.5. MAIV-IMS-MS a mass spectra: (1) total and (2) extracted from b 2-D plot 
display of drift time vs. m/z of model mixture of beta amyloid (1–42) (MW 4511 Da), 
bovine insulin (MW 5730 Da), and ubiquitin (MW 8560 Da) in negative mode using the 
custom modified ESI source of SYNAPT G2 mass spectrometer. 
 
peptide and protein ions are well separated from the singly charged ions in the IMS 
dimension (Appendix C Figure S31b) allowing extraction of the mass spectra for the 
individual components (Appendix C Figure S31c). 
A mixture of higher mass proteins comprising lysozyme (MW ~14.3 kDa) and 
myoglobin (MW ~17 kDa) using MAIV with the MALDI source is shown in Appendix 
C Figure S32a. Lysozyme is present in low abundance compared to myoglobin, and 
therefore its signal is not readily observed in the total mass spectrum. However, the 
multiply charged ions of lysozyme are well separated from myoglobin as can be seen in 
the 2-D plot (Appendix C Figure S32b) making it possible to extract the cleanly 
separated protein mass spectra (Appendix C Figure S33c). Without the inclusion of 
IMS, lysozyme could have been overlooked in the total mass spectrum (Appendix C 
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Figure S32a). The multiply charged ions allow this dataset to be observed using a 
MALDI source (Appendix C Figure S18.I and II) on an instrument that is limited 
to m/z 8000. Thus, the multiply charged ions produced by MAIV have the advantage that 
protein analysis can be implemented on mass range limited IMS-MS mass spectrometers. 
Programs previously introduced for ESI analyses [271] are available to convert mass 
spectra of multiply charged ions to the molecular weight, as demonstrated using MAIV-
IMS-MS in Appendix C Figure S33 for the total mass spectrum of the mixture 
compositions discussed above (Figures S14 and S15). This is also applicable to proteins 
directly analyzed from whole blood (Appendix C Figure S33c and S34). 
A mixture of beta amyloid (1–42), of biological significance in Alzheimer 
Disease [289,290], and the reversed peptide (42–1) is efficiently ionized using the 3-NBN 
matrix (Appendix C Figure S35a). The two isoforms are baseline separated as is shown 
for charge state +4 (Appendix C Figure S35b); the achieved separation is identical to 
LSII-IMS-MS [50]. Using MS/MS in the transfer region, as is shown in Figure 12.6, and 
thus after the isomers are cleanly baseline separated according to their apparent shape 
difference using IMS, provides good fragmentation yield and sequence information 
content as is shown for the m/z selected charge state +5. The fragmentation pattern is 
different for the two peptides as might be expected considering that the hydrophobic end 
of (1–42) is at the C-terminus and at the N-terminus for (42–1). Although the charge 
mostly resides on the hydrophilic amino acids of both peptides, the highest sequence 
coverage is from the hydrophobic end.  
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Figure 12.6. The 2-D display of an isomeric mixture of beta-amyloid (1–42) (in red) and 
(42–1) (in yellow) using MAIV-IMS-MS/MSwith 3-NBN acquired on the intermediate 
pressure vacuum MALDI source of SYNAPT G2 mass spectrometer shows the IMS 
separated ions fragmented in the transfer region of the IMS TriWave using CID 
fragmentation. The charge state 5+ precursor ion was selected in the quadruple. The 
fragment ion mass spectra and sequence coverage of both isomers are overlaid on the 2- 
D plot. MAIV-IMS-MS results are provided in Appendix C Figure S35 and, for 
comparison, the same characterization approach was obtained using MAIV on the ESI 
source (Appendix C Figure S36). 
 
The fragmentation of the (1–42) peptide has previously been reported [291,292]. The 
MAIV-MS/MS of beta-amyloid (1–42) relates well with those observed with ESI-
MS/MS [292]. Another interesting observation is that MAIV on the vacuum MALDI 
source provided the better sequence coverage for both isoforms relative to those obtained 
with MAIV on the ESI source using the same matrix:analyte sample (Appendix C 
Figure S36). The apparent difference is better ion abundance of the parent ion using 
MAIV on the vacuum MALDI source. Expectedly, traditional ESI was cumbersome with 
the solubility restricted (1–42) relative to capillary clogging and MALDI only provides 
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singly charged ions with less resolved IMS separation and poorer fragmentation. MAIV 
combines the positive attributes of ESI and MALDI ionization methods for efficient 
ionization and characterization using high performance technology such as IMS and 
MS/MS. 
Application of 3-NBN to tissue is not limited to determining the location of small 
molecules. An example is shown in Figure 12.7 in which a specific area of a delipified 
mouse brain tissue (~500 × 600 μm) was exposed with 3-NBN matrix and analyzed 
(Figure 12.7a,b). The spatially resolved area depends on the matrix deposition; a 
delipification procedure is currently needed to observe proteins from tissue similar to 
MALDI-MS [74]. Information is obtained more rapidly without the laser by simply 
exposing the area of interest to matrix solution and placing the tissue into the vacuum of 
the mass spectrometer (Figure 12.7c). Proteins are detected with a molecular weight of 
5440 Da [46] and 16788 Da (Figure 12.7b). The deconvoluted masses for the extracted 
higher molecular weight are shown (Figure 12.7d). A literature search failed to confirm 
the identity of this protein and we found no report of it being observed in mouse brain 
tissue using MALDI of the higher abundant proteins such as myelin basic protein (MBP) 
[293]. This suggests that this novel ionization method may be complementary with 
MALDI as well as LSI [43,48]. Complementary information using laserspray ionization 
and MALDI was previously reported [48]. At the current development stage, sufficient 
ion abundance from tissue is obtained using MAIV on the vacuum MALDI source, but 
not on the ESI source. Therefore, ETD fragmentation, which is currently only available 
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on the ESI source, is not available to characterize these proteins directly from tissue as 
was achieved for laserspray ionization of peptides from tissue [48]. 
 
Figure 12.7. MAIV-IMS-MS of delipified mouse brain tissue spotted with 3-NBN 
matrix: (a) total mass  spectrum, (b) 2-D plot display of drift time vs. m/z, (c) microscopy 
photograph on the tissue after poking, and (d) deconvolved mass spectrum of protein. 
Data was acquired using the intermediate pressure vacuum MALDI source of SYNAPT 
G2 mass spectrometer. 
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CHAPTER 13 
CONCLUSIONS AND PROSPECTUS 
 
 The novel ionization methods presented at AP and vacuum produces multiply 
charged ions similar to ESI in a MALDI-like sample preparation. The production of 
multiply charged ions extends the mass range of high performance mass spectrometers 
that have limited mass-to-charge (m/z) range and enhances fragmentation. The 
incorporation of IMS to these new ionization methods provides separation of ions 
according to charge, size and shape or cross section.  Further compounds are ionized 
directly from surfaces. The laser-based ionization method at AP (LSII) has the speed of 
analysis beneficial for tissue imaging, and the TG approach produces smaller ablated 
areas to improve spatial resolution provided sufficient ion intensity is obtained. Single 
scan acquisition by LSII using a high performance mass spectrometer is sufficient to 
obtain good quality mass spectra with sensitivity as low as attomole amounts of the 
analyte. The observation of clusters and liquid droplets from the microscopy study of the 
collected ablated material and the heated inlet temperature study suggest that the multiply 
charged ions are formed by heating the inlet to desolvate the matrix in the clusters in a 
field-free environment.  The use of high performance mass spectrometer provides 
isotopic resolution and accurate mass measurement even for proteins and allows the 
characterization and identification of endogenous peptide directly from mouse brain 
tissue using advanced fragmentation such as ETD. The coupling of LSII with IMS-MS 
separates mixtures, including isomers directly from surfaces. LSII shows identical drift 
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times to ESI suggesting ion structure information occurs after formation of the gas phase 
ions. 
LSII extended its application using a vacuum MALDI source. In the absence of a 
heated inlet, multiply charged ions are formed by using a matrix that has low thermal 
requirements for evaporation or sublimation. The multiply charged ions observed are 
similar to LSI and is thus termed LSIV. No external energy is supplied except for the 
laser energy absorbed by the matrix and the pressure drop from IP to vacuum. The use of 
a suitable matrix, laser power, and proper acquisition and instrument settings are 
important factors in producing multiply charged ions using LSIV in a vacuum MALDI 
source. With IMS, drift time analysis directly from mouse brain tissue is achieved, and 
are identical to the drift times from the synthesized standard using LSII and ESI 
indicating similar structures are detected from the tissue. LSIV with IMS for tissue 
analysis improves the separation of singly charged lipids from multiply charged peptides 
and proteins. With the use of a suitable matrix, the proper sample preparation, and 
incorporation of IMS for tissue imaging, images of multiply charged endogenous peptide 
are obtained from the mouse brain tissue.  These compounds were characterized and 
identified previously by LSII. 
The fundamental understandings gained from LSII, the production of ions by 
tapping matrix:analyte into the inlet tube without the use of laser (MAII), and the 
observation of multiply charged ions in a vacuum MALDI source (LSIV) emboldened us 
to continue the search for matrixes that can produce multiply charged ions with very low 
thermal requirements. The aromaticity and/or functionality, as well as absorption of the 
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laser wavelength by the matrix, is not a requirement to produce multiply charged ions 
either with (LSII) or without the use of a laser (MAII). Astonishingly, one of these 
matrixes, 3-NBN has the highest ion abundance of multiply charged ions at very low 
temperature and produces ions in an IP-MALDI vacuum source without the use of a laser 
and was thus termed MAIV in analogy to MAII. MAIV using 3-NBN produces gas phase 
ions directly from the matrix/analyte crystals through a sublimation process, a 
characteristic property of 3-NBN. Both positive and negative ions are detected. A 
property of 3-NBN that may explain the production of charges is triboluminscence. 
MAIV produces ions from small and large molecules with little or no chemical 
background. Large molecules are observed as multiply charged ions in a vacuum MALDI 
source. Without the use of a laser, MAIV is applicable to fragile molecules and protein 
complexes. Biological fluids or tissue are ionized efficiently by just incorporating 3-NBN 
matrix into the sample and exposing the sample to the vacuum of the mass spectrometer. 
The sublimation process in the formation of ions makes it possible to miniaturize the 
matrix deposition on the tissue which is potentially useful for spatial and drug target 
analyses. The use of 3-NBN as the matrix and formation of the ions by exposing the 
matrix/analyte crystals to the vacuum of the mass spectrometer can be extended to ESI 
sources. This ionization process is rapid, robust, sensitive, and fast, making it potentially  
useful for clinical applications. The instantaneous ionization by MAIV, and the real time 
separation and characterization by IMS enhances the dynamic range, provides rapid 
analysis, separation of isomers and isobars, and cross section analysis directly from the 
surface important for biological applications. The laser based ionization methods LSII 
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improves spatial resolution and the vacuum condition LSIV enhances sensitivity useful 
for tissue imaging. 
  
  
  
172 
APPENDIX A 
Laserspray Ionization Inlet Supplementary information 
 
 
 
 
Figure S1: Chemical analysis of sphingomyelin (molecular weight [MW] 812.7): A) 
Total ion current: Ions are produced in a continuous fashion obtained by moving the 
sample holder through the focused laser beam. B) TG AP-MALDI mass spectrum with 
Inset region. Additionally, the [M2+H]
+
 dimers at > m/z 1500 are observed in accordance 
with previous studies (Trimpin, S., Tan, B., Bohrer, B.C., O’Dell, D.K., Merenbloom, S.I., 
Pazos, M.X., Clemmer, D.E., Walker, J.M. Profiling of Phospholipids and Related Lipid 
Structures usingMultidimensional Ion Mobility Spectrometry-Mass Spectrometry 2009, 
287, 58-69.  
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Figure S2: TG AP-MALDI mass spectra using 2,5-DHB: A) anandamide (MW 347.3); 
B) NAGly (MW 361.3); C) phosphatidyl glycerol (MW 770.5); D) phosphatidyl inositol 
(MW 886.6). 
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Figure S3: Solvent-based TG AP-MALDI mass spectrum of Leu-Enkaphelin (MW 
555.3) and 2,5-DHB. 
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Figure S4: TG AP-MALDI mass spectrum of angiotensin II (MW 1045.5) with a 
resolution 100,000 (solvent-based 2,5-DHB). The inset shows the doubly charged ion for 
a single laser shot obtained from the application to the glass slide of 0.1 μL of 400 
attomoles of angiotensin II solution. 
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Figure S5. TG AP-MALDI mass spectrum of a mixture of PEG 970 and PEG DME 2160 
in dithranol and NaCl prepared solvent-free. 
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Figure S6: TG AP-MALDI mass spectrum of (A) Met-Enkephalin (MW 573.2) and              
(B) beta-amyloid (33-42) (MW 914.5) in 2,5-DHB prepared solvent-free.  
  
[M+H]+
[M+Na]+
A
B
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Figure S7: TG AP-MALDI mass spectra (with Inset regions) of angiotensin II (MW 
1046.2) in a layered experiment by placing the analyte (1 μg) on the glass substrate, 
drying to completeness, and adding the 2,5-DHB matrix on top of the analyte using 
increasingly non-incorporating analyte/matrix conditions: A) aqueous, B) acetone, C) 
dichloromethane solution. 
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Figure S8: TG AP-MALDI mass spectrum of angiotensin II with A) 2,5-DHB: full mass: 
30 pmol μL-1; 50,000 resolution; 100,000 resolution. B) CHCA: 100,000 resolution with 
Inset regions. 
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Figure S9: TG AP-MALDI mass spectra (single shot) of angiotensin II (MW 1045.5; 30 
pmol μL-1) in (A) benzoic acid matrix and (B) o-chlorobenzoic acid matrix; resolution 
100,000; with Inset region. 
  
A
B
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Figure S10: LSI-IMS-MS total mass spectra of (A) β-amyloid (1-42), (B) β-amyloid (42- 
1), (C) an isomeric mixture of β-amyloid (1-42) and (42-1) prepared in 50:50 ACN:water 
with 0.1% TFA and (D) insulin in 50:50 MeOH/water with 1 % acetic acid obtained 
without the use of the desolvation device but with the source temperature set at 150 °C 
using 2,5-DHAP matrix in 50:50 ACN:water employing the thin layer sample 
preparation. 
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Figure S11: MALDI mass spectrum of delipified aged tissue on a plain glass slide using 
sinapinic acid as the matrix desolved in 50:50 ACN:water in 0.1% TFA. 
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Figure S12: Microscopy after laser ablation using LSI-IMS of delipified aged tissue 
on a plain glass slide spotted with 2,5-DHAP matrix in 50:50 ACN:water. (A1) and (B1) 
20x magnification and (A2), (A3), (B2), (B3) 100x magnification. 
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Figure S13: Optical microscopy image from delipified aged mouse brain tissue after 
LSI-MS analysis showing two ablated areas. The spatial resolution scale is shown in 
the lower right corner. 
 
  
  
185 
 
 
Figure S14: LSI mass spectra of delipified fresh tissue on gold coated glass slide spotted 
with 2,5- DHAP in 50:50 ACN:water using the Orbitrap Exactive. A) Total ion current; 
B1) Sum of 120 acquisitions; B2) single shot acquisition; B3) sum of 7 laser shot 
acquisitions. 
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Figure S15: Insets of LSI mass spectra: Isotopic distributions of the proteins 
detected from delipified fresh tissue on a gold-coated glass slide spotted with 2,5-
DHAP matrix in 50:50 ACN:water using the Orbitrap Exactive. 
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Figure S16: Optical images of laser ablated areas obtained in an imaging experiment 
on mouse brain tissue spray-coated with matrix using an airbrush: A) 20 X 
magnification and B) 100X magnification 
 
  
  
188 
 
 
Figure S17: Mass specific images for the same charge state +8 of two different proteins: 
A) MW 11788 and B) MW 12369. 
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Figure S18: Single scan acquisition on the LTQ Velos obtained in imaging 
experiment. The protein with monoisotopic mass 11788 Da as determined on the Orbitrap 
Exactive is labeled with +6 to +10 charges. 
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Figure S19: LSI-MS and MS/MS mass spectra using ETD obtained from delipified 
tissue spotted with 2,5-DHAP in 50:50 ACN:water. A) Full mass spectrum and ETD 
fragment ion mass spectra of B) m/z 1491 (+12) and C) m/z 1789 (+10) with Insets 
displaying the m/z range above the selected parent ions of (1) 1491 and (2) 1789. 
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APPENDIX B 
 
Laserspray Ionization Vacuum Supplementary information 
 
 
 
 
Figure S1. IP-LSI-MS mass spectra of peptides and proteins: (A) GFP, (B) ACTH, (C) 
insulin and (D) ubiquitin acquired using 2,5-DHAP matrix prepared in 50:50 ACN:water 
using laser energy of (a) “200” and (b) “500” on different target plates: (I) glass plate and 
(II) metal plate. 
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Figure S2. IP-LSI-MS mass spectra of angiotensin I (MW 1295) acquired from different 
matrixes: (A) 2,5-DHAP in 50:50 ACN:water, (B) CHCA, and (C) 2,5-DHB both in 
50:50 ACN:water with 0.1% TFA using laser energy of “500”. 
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Figure S3. Photographs of the microscopy of the analyte/matrix mixture spot of 
angiotensin 1 (A) before ablation and (B) after ablation using 200 laser energy. 
Analyte/matrix mixture prepared in 1:1 volume ratio using 2,5-DHAP matrix in 50:50 
ACN:water. The center spot (A) provides preferentially the multiply charged ions 
(Figure S4). 
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Figure S4. Comparison of the IP-LSI-MS mass spectra of angiotensin 1 (MW 1295) 
acquired using 2,5-DHAP matrix prepared in 50:50 ACN:water between (A) large and 
(B) needle-like crystals after deposition of analyte/matrix mixture (Figure S3). Laser 
energy used was “500”. 
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Figure S5. IP-LSI-MS mass spectra of angiotensin I (MW 1295) acquired using 2,5-
DHAP matrix prepared in 50:50 ACN:water from (I) glass plate and (II) metal plate with 
different laser fluence: (1) “200”, (2) “300”, and (3) “500”. (A) Full mass spectra and (B) 
insets of +3, +2, and +1. 
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Figure S6. IP-LSI-MS mass spectra of N-acetylated fragment of MBP (MW 1833) 
acquired using 2,5-DHAP matrix prepared in 50:50 ACN:water at different laser fluence 
from A) “50” to H) “500”. 
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Figure S7. IP-LSI-MS of bovine insulin using 2,5-DHAP matrix in 50:50 ACN:water 
acquired in full mass range. (A) Glass Plate and (B) Metal Plate. 
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Figure S8. MALDI-TOF-MS mass spectra of (A) Angiotensin I (MW 1295), (B) [Glu-
1]-fibrinopeptide B (MW 1569), (C) adrenocorticotropic hormone fragment (MW 2465), 
and (D) bovine insulin (MW 5731) acquired under high vacuum conditions using the 
same analyte/matrix mixture used to obtain the mass of spectra of IP-LSI-IMS-MS using 
2,5-DHAP matrix prepared in 50:50 ACN:water. 
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Figure S9. IP-LSI-MS mass spectrum of ubiquitin (MW 8561) acquired using 2,5-DHAP 
matrix prepared in 50:50 ACN:water using laser energy of “500”. 
 
  
m/z
  
200 
 
 
Figure S10. IP-LSI mass spectra of synthesized N-acetylated terminal fragment of 
myelin basic protein acquired using 2,5-DHAP matrix prepared in 50:50 ACN:water 
using low laser fluence: A) TOF (cooling gas 10 mL min-1 and trap gas flow (2.5 mL 
min
-1
) and B) IMS-TOF modes with He cell and IMS gas flow at 24 mL min
-1
; C) He cell 
(180 mL min
-1
), D) IMS cell (90 mL min
-1
) and E) both gas flows increased. 
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Figure S11. IP-LSI-IMS-MS of the model mixture (SM, Ang I, GFP, and BI) acquired 
using 2,5-DHAP matrix prepared in 50:50 ACN:water from (A) glass plate and (B) metal 
plate. (1) Total mass spectrum with an inset +4 charged state distribution of BI and (2) 2-
D plot of drift time vs. m/z and drift time distribution of +4 for BI. 
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Figure S12. IP-LSI mass spectra of the pure components in the model mixture using 2,5-
DHAP matrix prepared in 50:50 ACN:water using low laser energy of “200” from (I) 
glass and (II) metal plates.: lipid A) sphingomyelin MW 703, peptides B) angiotensin I 
MW 1295 and C) [Glu-1]-fibrinopeptide B MW 1569, and a protein D) bovine insulin 
MW 5731. 
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Figure S13. IP-LSI mass spectra of the pure components in the model mixture using 2,5-
DHAP matrix prepared in 50:50 ACN:water using laser energy of “500” from (I) glass 
and (II) metal plates: lipid (A) sphinomyelin (MW 703), peptides (B) Angiotensin 1 
(MW 1295), (C) [Glu-1]-fibrinopeptide B (1569) and a protein (D) bovine insulin (MW 
5731). 
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Figure S14. IP-LSI-MS/MS of lipid sphingomyelin (MW 703) using collision induced 
dissociation acquired directly from an aged mouse brain tissue section spotted with 2,5-
DHAP matrix prepared in 50:50 ACN:water. A collision energy of 32 V was applied in 
the trap cell to produce the choline fragment peak m/z 183. 
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Figure S15. Mass spectra of the model mixture (SM, Ang 1, GFP, and BI) acquired at (1) 
AP-LSI using a UV laser (Nitrogen 337 nm), and at IP-LSI (Nd:Yag 355 nm) using (2) 
“200” and (3) “300” laser power. (A) Full mass spectra; (B) Inset mass spectra from m/z 
400 to 2000. 
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Figure S16. Extracted drift times of the lipids detected from aged delipified mouse brain 
tissue section spotted with 2,5-DHAP matrix solution in 50:50 ACN:water using IP-LSI-
IMS-MS with a laser energy of “500”. 
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Figure S17. Extracted drift times of the +1, +2 and +3 charged states of peptides detected 
from aged delipified mouse brain tissue spotted with 2,5-DHAP matrix solution in 50:50 
ACN:water using IP-LSI-IMS-MS with a laser energy of “500”. 
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Figure S18. Extracted drift times of the individual component in the model mixture (SM, 
Ang I, GFP, and BI) acquired using 2,5-DHAP matrix in 50:50 ACN:water. (A) Glass 
plate and (B) Metal plate using a laser of 500. 
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Figure S19. Extracted drift times of the neuropeptide with charge states +2, +3, and +4 
(when present): (A) from mouse brain tissue section by AP-LSI-IMS-MS, and from the 
synthesized N-acetylated fragment of myelin basic protein obtained by (B) AP-LSI-
IMSMS and (B) ESI-IMS-MS. 
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Figure S20: LSIV-IMS-MS (A) total mass spectrum and (B) two-dimensional plot of 
drift time vs. m/z of delipified mouse brain tissue spotted with 2,5-DHAP matrix and 
acquired using ‘LSI settings’[42,45] on a commercial intermediate pressure MALDI 
source of the SYNAPT G2 mass spectrometer. Insets show (A) isotopic distribution of +2 
ions of the identified N-acetylated MBP peptide (m/z 917.39) and the highest MW 
detected, ~3.2 kDa (m/z 1616.12) (see *), and (B) drift times of +3, +2, and +1 ions.  
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Figure S21: LSII-IMS-MS (A) total mass spectrum and (B) two-dimensional plot of drift 
time vs. m/z of non delipified mouse brain tissue spotted with 2,5-DHAP matrix and 
acquired using the nanoESI source of the SYNAPT G2 mass spectrometer with a 
homebuilt skimmer cone to perform LSII in transmission geometry. Insets show in (A) 
isotopic distribution and (B) drift times of +3 charge state ion (m/z 612.36) of the 
identified N-acetylated MBP peptide and +1 drift time of a lipid (m/z 760.62). 
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Figure S22: LSIV-MS using (I) 2-NPG matrix at low laser power (4.2 J cm
-2
) and (II) 
2,5-DHAP matrix at higher laser power (7.3 J cm
-2
) of (A) N-acetylated MBP peptide 
(MW 1833 Da), (B) galanin (MW 3150 Da), and (C) bovine insulin (MW 5731 Da) 
acquired using ‘LSI settings [42,45] on a commercial  intermediate pressure MALDI 
source of the SYNAPT G2 mass spectrometer.  
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Figure S23: LSIV-MS of N-acetylated MBP peptide (MW 1833 Da) with 2-NPG matrix 
using different laser power: (A) 4.2, (B) 5.7, and (C) 7.3 J cm
-2 acquired using ‘LSI 
settings [42,45] on a commercial intermediate pressure MALDI source of the SYNAPT 
G2 mass spectrometer.  
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Figure S24: LSIV-IMS-MS of delipified mouse brain tissue spotted with 2-NPG matrix 
shown in Figure 2A. Shown here is the total mass spectrum of the multiply charged 
peptide and protein ions with the large molecular weight detected, an ~8.6 kDa protein 
(m/z 2855.84) with insets of the isotopic distributions of higher charge states: +3 (m/z 
1655.22) and +4 (m/z 1680.87) ions. Data acquired using ‘LSI settings [42,45] on a 
commercial intermediate pressure MALDI source of the SYNAPT G2 mass 
spectrometer.  
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Figure S25: LSIV-IMS-MS two-dimensional plot of drift time vs. m/z of delipified 
mouse brain tissue mounted on CHCA precoated glass plate spray coated with binary 
matrix mixture of 90% 2,5-DHAP and 10% 2-NPG and acquired using ‘LSI settings 
[42,45] on a commercial intermediate pressure MALDI source of SYNAPT G2 mass 
spectrometer. 
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APPENDIX C 
 
Matrix Assisted Ionization Vacuum Supplementary Information 
 
 
 
Figure S1. (I) Photographs of typical operation of MAIV on the ESI source: (A) vacuum 
valve closed, (B) glass on, (C) vacuum valve open, (D) matrix:analyte sample enters 
readily mass spectrometer by vacuum forces. This custom designed MAVI source 
operating from atmospheric pressure conditions is a means of rapid sample introduction 
to the vacuum of the mass spectrometer. (II) MAIV-MS of lysozyme (MW ~14.3 kDa) in 
25 mM ammonium acetate buffer in 10% MeOH on the ESI source of SYNAPT G2 
using (I) a modified skimmer cone with wider outer cone (~4.5 mm ID) and inner cone of 
(A) ~0.5 mm, (B) ~1 mm, (C) ~3 mm ID using 3-NBN in 50:50 ACN:water with 0.1% 
FA acquired with a source temperature of (II) 50 °C and (II) 80 °C. Red numbers 
indicate the charge state and blue numbers indicate the ion abundance. 
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Figure S2. MAIV-IMS-MS using ESI source of solvent extracted blood spot from a band 
aid (A) Total mass spectra and (B) extracted mass spectra of (1) α-globin ions (MW 
15126 Da) and (2) β-globin (MW 15866 Da) chain of hemoglobin. Data acquired on the 
SYNAPT G2 using a source temperature of 50 °C. 
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Figure S3. MAIV isotopic distributions from Figure 1A: (a) leucine enkephalin (+1), (b) 
sphingomyelin (+1), (c) galanin (+2), (d) galanin (+4), (e) bovine insulin (+5), and (f) 
ubiquitin (+9) in the model mixture with 3-NBN matrix. Blue numbers of each spectrum 
provide an indication of ion abundance and red numbers the charge states.  
556 557 558
8.86e4
556.28
557.28
558.29
704 705 706
2.09e5
703.58
704.57
705.57
m/z
790 791
1.75e5
790.12
789.88
790.38
790.63
790.88
791.13
791.38
791.63
1147 1148
1.17e5
1147.701147.49
1147.30
1147.10
1147.89
1148.08
1148.29
1148.50
1148.70
m/z
953
%
0
100 1.89e
5952.60952.49
952.37
952.26
952.71
952.82
952.93
953.05
953.17
m/z
1579 1581
2.23e4
1579.23
1578.73
1579.74
1580.23
1580.75 1581.22
1581.70
1582.21
%
0
100
%
0
100
%
0
100
%
0
100
%
0
100
a
b
c
d
f
g
+1            
Leu Enk
+1            
SM
+2            
Gal
+4            
Gal
+5            
BI
+9            
Ubi
  
219 
 
 
 
Figure S4. Picture snapshots of matrix:analyte spot with 3-NBN matrix using the 
MALDI source of SYNAPT G2: (a) 5 seconds after indexing sample plate that requires 
ca. 2 min and (b) after additional 70 seconds. Yellow and blue arrows point the areas of 
the spot where crystals sublimed after 70 seconds in the vacuum source. See online 
‘MAIV on MALDI source video I’ using the intermediate pressure vacuum MALDI 
source of SYNAPT G2 mass spectrometer. 
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Figure S5. MAII temperature study of 3-NBN in 50:50 ACN:water using acidified 
bovine insulin (MW 5731 Da) acquired using the LTQ Velos at (a) 450 °C, (b) 300 °C, 
(c) 200 °C, (d) 150 °C, (e) 100 °C, and (f) 50 °C inlet capillary temperature of the 
overridden ESI source. Blue numbers of each spectrum provide an indication of ion 
abundance and red numbers the charge states.  
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Figure S6. MAIV (I) total ion current (TIC) and (II) mass spectra of bovine insulin 
(MW 5731 Da) with 3-NBN matrix using a SYNAPT G2 mass spectrometer (a) on the 
commercial ESI source with the custom modified inner and outer cone (Scheme 1II) and 
(b) using LSI settings of a commercial SYNAPT G2 intermediate pressure vacuum 
MALDI source. (c) Lysozyme (MW 14.3 kDa) with 3-NBN matrix on custom modified 
commercial ESI source of SYNAPT G2 with a wider inner and outer cones. Blue 
numbers in upper right corner of each spectrum provide an indication of ion abundance 
and red numbers the charge states. See online ‘MAIV on ESI source video II’ using the 
custom modified ESI source of SYNAPT G2 mass spectrometer. 
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Figure S7. Mass spectra of nitrobenzonitrile (NBN) isomers: (a) 2-NBN, (b) 3-NBN, and 
(c) 4-NBN with (I) ubiquitin in water (MW 8561 Da) using solvent-based: (1) MAIV and 
(2) with laser, and (II) angiotensin I in water (MW 1295 Da) using solvent-free sample 
preparations acquired using LSI settings of a commercial SYNAPT G2 intermediate 
pressure vacuum MALDI source. Blue numbers in upper right corner of each spectrum 
provide an indication of ion abundance and red numbers the charge states.  
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Figure S8. Mass spectra of nitrobenzaldehyde isomers: (a) 2-nitrobenzaldehyde, (b) 3-
nitrobenzaldehyde, and (c) 4-nitrobenzaldehyde with angiotensin I (MW 1295 Da) using 
(I) solvent-based and (II) solvent-free sample preparations acquired using LSI settings of 
a commercial SYNAPT G2 intermediate pressure vacuum MALDI source. Blue numbers 
of each spectrum provide an indication of ion abundance and red numbers the charge 
states.  
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Figure S9. MAIV-MS of ubiquitin in water with 3-NBN matrix in 100% ACN with 0.1% 
formic acid acquired using LSI settings of a commercial SYNAPT G2 intermediate 
pressure vacuum MALDI ion source without the use of a laser with matrix:analyte 
crystals (a) wet when loaded in the MALDI source and (b) cooled at -80 C before 
loading into the vacuum MALDI source: (I) total ion current (TIC) and (II) mass spectra. 
Blue numbers in upper right corner of each spectrum provide an indication of ion 
abundance and red numbers the charge states.  
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Figure S10. (a) Photograph of the target plate holder with the glass capillary tube 
containing 3-NBN matrix:analyte crystals with acidified bovine insulin (MW 5731 Da), 
(b) total ion current (TIC) showing the 30 minute continuous ion production using the 
glass capillary tube, (c) picture capture of the open end of the glass tube containing the 
matrix:analyte crystals after placing the sample holder inside the intermediate pressure 
vacuum MALDI source of a commercial SYNAPT G2, and (d) mass spectra of bovine 
insulin at a time period of 1 to 30 min using LSI settings. Blue numbers in upper right 
corner of each spectrum provide an indication of ion abundance and red numbers the 
charge states. 
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Figure S11. MAIV mass spectra of ubiquitin in water (MW 8561 Da) with 3-NBN in 
100% ACN with 0.1% formic acid acquired using LSI settings of the SYNAPT G2 
intermediate pressure vacuum MALDI source: (a) TOF and (b) mobility TOF modes. 
Blue numbers in upper right corner of each spectrum provide an indication of ion 
abundance and red numbers the charge states.  
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Figure S12. MAIV (a) picture snapshots of matrix:analyte spot with coumarin matrix: 
(1) after indexing sample plate and (2) after 16 seconds, and mass spectra of 5 pmol 
bovine insulin with coumarin using (b) intermediate pressure vacuum MALDI source and 
(c) custom modified ESI source of SYNAPT G2 mass spectrometer. Blue numbers in 
upper right corner of each spectrum provide an indication of ion abundance and red 
numbers the charge states. 
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Figure S13. MAIV-MS using 2,5-DHAP for the analyses of lysozyme (MW ~14.3 kDa) 
in 25 mM ammonium acetate buffer in 10% MeOH; 2,5-DHAP is dissolved in 50:50 
ACN:water with 0.1% formic acid. (I) ESI source of SYNAPT G2 using a modified 
skimmer cone with the larger outer (~4.5 mm ID) and inner (~3 mm ID) cones acquired 
with a source temperature of (a) 80 C and (b) 150 C.  (II) Intermediate pressure 
vacuum MALDI source of SYNAPT G2 operated to perform laserspray ionization 
(LSIV): (a) total ion current (TIC) and (b) mass spectrum. As expected for a MALDI 
matrix, the materials are dislodged by the laser based on sufficient absorption of the 
matrix at the laser wavelength. A laser power of ‘230’, an arbitrary vendor value (‘200’ 
relates to a laser fluence of ~7.3 J cm
-2 and ‘250’ to ~12.5 J cm-2), was used. Red numbers 
indicate the charge state and blue numbers indicate the ion abundance.   
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Figure S14. MAIV (a) total ion current and (b) MS/MS mass spectra using collision-
induced fragmentation of 900 attomole clozapine (MW 326 Da) using the ‘normal’ 
analyte:matrix spot on target plate cooled on dry ice. Data acquired using ‘LSI’ settings 
without the use of a laser on the SYNAPT G2 intermediate pressure vacuum MALDI 
source. Fragmentation patterns are assigned in red [294]. Blue numbers indicate the ion 
abundance.   
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Figure S15. Extracted mass spectra of a mixture of three proteins ionized by MAIV and 
separated by IMS in the gas phase (Figure 4II.a): (a) ubiquitin (MW ~8.6 kDa), (b) 
lysozyme (MW ~14.3 kDa), and (c) myoglobin (MW ~17 kDa). Blue numbers in upper 
right corner of each spectrum provide an indication of ion abundance and red numbers 
the charge states. 
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Figure S16. MAIV-MS of (a) cocaine (MW 303 Da), (b) pesticide foramsulfuron (MW 
452 Da), and (c) extracted mass spectrum of 1,2,3,4-tetra-O-acetyl-6-
diphenylphosphoryl-β-D-mannopyranose (MW 580 Da) doped with 1 M NaCl with 3-
NBN matrix acquired using LSI settings of a commercial SYNAPT G2 intermediate 
pressure vacuum MALDI source without the use of a laser. Blue numbers in upper right 
corner of each spectrum provide an indication of ion abundance and red numbers the 
charge states. 
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Figure S17. MAIV mass spectra of ubiquitin in water (MW 8561 Da) with 3-NBN in 
100% ACN with 0.1% formic acid spotted on a) standard metal target plate, b) glass 
plate, c) filter paper, d) kim wipe tissue, e) plastic, f) aluminum foil, g) thin layer 
chromatography (TLC) plate, and h) glass plate holder. Data acquired using LSI settings 
of a commercial SYNAPT G2 intermediate pressure vacuum MALDI source without the 
use of a laser. Blue numbers in upper right corner of each spectrum provide an indication 
of ion abundance and red numbers the charge states.  
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Table S1. Summary of matrixes tested at intermediate pressure vacuum using the 
commercial MALDI source without the use of the laser. I. Compounds with 1,3-
substitution, respective isomers, and frequently with one NO2 functionality.  
I. Name Melting point,    
C 
Observations for angiotensin I as 
analyte 
 
2-nitrobenzonitrile 
109-111 - crystals formed 
- sublimed producing multiply 
charged MAIV ions 
 
3-nitrobenzonitrile 
114-117 - crystals formed 
- sublimed producing multiply 
charged MAIV ions 
 
4-nitrobenzonitrile 
144-147 - crystals formed 
- no analyte ion signal using LSI and 
MALDI settings without (MAIV) 
and with a laser (LSIV) 
 
2-nitrobenzaldehyde 
42-44 - no crystals formed 
- no signal using LSI and MALDI 
settings without (MAIV) and with a 
laser (LSIV) 
 
3-nitrobenzaldehyde 
55-58 - no crystals formed using solvent-
based sample preparation 
- sublimed using solvent-free 
preparation and formed multiply 
charged MAIV ions  
 
4-nitrobenzaldehyde 
103-106 - crystals formed 
- no analyte ion signal using LSI and 
MALDI settings without (MAIV) 
and with a laser (LSIV) 
N O 2 
H O 
N O 2 
H 
O 
N O 2 
H 
O 
N O 2 
CN 
N O 2 
C N 
N O 2 
C N 
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2-nitrophenol 
n/a - no crystals formed 
- no signal using LSI and MALDI 
settings without (MAIV) and with a 
laser (LSIV) 
 
3-nitrophenol 
96-98  - crystals formed 
- only +1 analyte charge state using 
MALDI settings and with laser 
 
4-nitrophenol 
110-115 - crystals formed 
- only +1 analyte charge state using 
MALDI settings and with laser 
 
3-nitrobenzoic acid 
139-141 - crystals formed 
- +1 analyte charge state for both LSI 
and MALDI settings using a laser in 
both cases 
 
3-nitroaniline 
111-114  - crystals formed 
- no analyte ion signal using LSI and 
MALDI settings without (MAIV) 
and with a laser (LSIV) 
 
3-nitrobenzamide 
140-143  - crystals formed 
- no analyte ion signal using LSI and 
MALDI settings without (MAIV) 
and with a laser (LSIV) 
 
3-nitroanisole 
36-38  - no crystals formed 
- no signal using LSI and MALDI 
settings without (MAIV) and with a 
laser (LSIV) 
N O 2 
N O 2 
NH2 
N O 2 
NH2 
N O 2 
OH 
N O 2 
OH 
N O 2 
OH 
N O 2 
OH 
O 
OCH3 
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3-nitroacetophenone 
76-78  - no crystals formed 
- no signal using LSI and MALDI 
settings without (MAIV) and with a 
laser (LSIV) 
 
3-cyanophenol 
78-81 - crystals formed 
- no analyte ion signal using LSI and 
MALDI settings without (MAIV) 
and with a laser (LSIV) 
 
4-cyanophenol 
110-113 - crystals formed 
- only +1 analyte charge state using 
MALDI settings and with laser 
 
3-aminobenzonitrile 
48-53 - no crystals formed 
- no signal using LSI and MALDI 
settings without (MAIV) and with a 
laser (LSIV) 
 
3-acetylbenzonitrile 
98-100 - crystals formed 
- no analyte ion signal using LSI and 
MALDI settings without (MAIV) 
and with a laser (LSIV) 
 
m-tolunitrile 
n/a - crystals formed 
- no analyte ion signal using LSI and 
MALDI settings without (MAIV) 
and with a laser (LSIV) 
 
3-methoxybenzonitrile 
n/a - no crystals formed 
- no signal using LSI and MALDI 
settings without (MAIV) and with a 
laser (LSIV) 
OCH3 
CN 
CH3 
CN 
CH3 
CN 
O 
NH2 
CN 
OH 
CN 
OH 
CN 
N O 2 
CH3 
O 
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1,3-dicyanobenzene 
163-165 - crystals formed 
- little sublimation but no analyte ion 
signal using LSI and MALDI settings 
without (MAIV) and with a laser 
(LSIV) 
1
With poor crystallization the matrix:analyte frequently sublimed/evaporated too rapidly 
during the 2-min introduction period before the sample holder was at vacuum and the 
mass spectrometer in operation. LSI and MALDI settings were used for data acquisition. 
  
CN 
CN 
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Table S2. Compounds known to produce triboluminescence.  
 
II. Name Melting point,    
C 
Observations for angiotensin I as 
analyte 
 
pthalic anhyride 
131-134 - good crystal formation 
- no sublimation 
 
benzil 
94-95 - good crystal formation 
- no sublimation 
 
triphenylphosphine oxide 
150-157 - atypical crystallization of 
matrix:analyte mixture 
- no sublimation 
 
3,6-dibromocarbazole 
204-206 - atypical crystallization of 
matrix:analyte mixture 
- no sublimation 
 
9,10-dihydroanthracene 
103-107 - atypical crystallization of 
matrix:analyte mixture 
- no sublimation 
 
acenaphtene 
90-94 - atypical crystallization of 
matrix:analyte mixture 
- no sublimation 
 
coumarin 
68-73 - good crystal formation 
- sublimed and produced multiply 
charged MAIV ions 
 
saccharin 
226-229 - atypical crystallization of 
matrix:analyte mixture 
- no sublimation NH 
S 
O 
O O 
O O 
N
H 
Br Br 
O 
P 
O 
O 
O 
O 
O 
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potassium hydrogen 
phthalate 
295-300  - atypical crystallization of 
matrix:analyte mixture 
- no sublimation 
 
triphenylmethane 
92-94 - atypical crystallization of 
matrix:analyte mixture 
- no sublimation 
 
phenanthrene 
98-100 - atypical crystallization of 
matrix:analyte mixture 
- no sublimation 
 
9-anthracenemethanol 
n/a  - atypical crystallization of 
matrix:analyte mixture 
- no sublimation 
 
triphenylamine 
124-128  - atypical crystallization of 
matrix:analyte mixture 
- no sublimation 
 
  
N
OH 
OK 
O 
OH 
O 
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Figure S18: MAIV using the (I) intermediate pressure MALDI source: (a) Screen shot 
during MAIV acquisition showing production of multiply charged ions without the use of 
the laser, (b) total ion current (TIC), and (c) mass spectrum of ubiquitin (MW 8560 Da), 
and (II) custom modified ESI source: (a) typical operation, (b) TIC, and (c) mass 
spectrum of nicotine standard mixture with 3-NBN matrix and spotted on the glass plate. 
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Figure S19: MAIV-MS of a clozapine standard (MW 326 Da) with 3-NBN matrix 
acquired with (a) wet matrix:analyte and (b) dry matrix:analyte spots loaded into the 
intermediate pressure vacuum MALDI source of SYNAPT G2 mass spectrometer using 
LSI settings. Evaporative cooling that occurs when the solution dries in vacuum is 
expected to slow sample loss during the time the sample loads.  Insets show structure and 
isotopic distributions of clozapine. 
  
  
241 
 
 
Figure S20: Mass spectra of (I) 50 fmol levofloxacin (MW 361 Da) using (a) MAIV 
with 3-NBN matrix and (b) MALDI using CHCA matrix acquired using the intermediate 
pressure MALDI source. MAIV-MS of (II) 50 fmol of bovine insulin (MW 5730 Da) 
with 3-NBN matrix using the custom modified ESI source and (III) 5 fmol clozapine 
(MW 326 Da) and 20 pmol bovine insulin mixture with 3-NBN matrix using the 
intermediate pressure vacuum MALDI source of the SYNAPT G2 mass spectrometer 
using LSI settings. Insets show isotopic distributions with structures of (I) levofloxacin 
and (III) clozapine.  
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Figure S21. MAIV-MS of (a) clozapine (MW 326 Da), (b) angiotensin I (MW 1295 Da), 
and (c) ubiquitin (MW 8560 Da) in 1 M NaCl solution with 3-NBN matrix. Data acquired 
using the intermediate pressure vacuum MALDI source of the SYNAPT G2 mass 
spectrometer using LSI settings.  
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Figure S22. (I) Solvent and pH study of 1 pmol clozapine (MW 326 Da) in (a) 50:50 
methanol:water and (b) water with 3-NBN in 100% ACN (1) with and (2) without acid, 
and  (II) pH study of 5 pmol myoglobin in water (MW ~17 kDa) with 3-NBN in 100% 
ACN (1) with and (2) without acid. Data acquired using the intermediate pressure 
vacuum MALDI source of the SYNAPT G2 mass spectrometer using LSI settings. 
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Figure S23. MAIV-MS of 1 pmol clozapine (MW 326 Da) with 3-NBN in 100% ACN 
with 0.1% formic acid. Data acquired using (a) LSI settings and (b) MALDI settings of 
the intermediate pressure vacuum MALDI source of the SYNAPT G2 mass spectrometer.  
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Figure S24: MAIV-IMS-MS of nondelipified mouse brain tissue spotted with 3-NBN 
matrix acquired using (I) LSI settings and (II) MALDI settings on the intermediate 
pressure vacuum MALDI source of the SYNAPT G2 mass spectrometer: (a) total mass 
spectra and (b) 2-D plot of drift time vs. m/z. 
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Figure S25: MAIV (I) MS and MS/MS mass spectra of small molecule mixture with 3-
NBN matrix in the transfer region: (II) without selection and extracted from the 2-D plot 
(Figure 1.II) and (III) with precursor ion selection of (a) levofloxacin [295] (MW 361 
Da), (b) fentanyl [296] (MW 337 Da), (c) clozapine [297] (MW 326 Da), (d) cocaine 
[298] (MW 303 Da), and (e) benzoylecgonine [299] (MW 289 Da). Data acquired using 
the custom modified ESI source of the SYNAPT G2 mass spectrometer. Insets in II show 
structures of the small molecule indicating the fragmentation patterns. 
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Figure S26: MAIV-IMS-MS of drug treated (90 minutes after receiving 50 mg kg
-1
 of 
clozapine) mouse brain tissue spotted with 3-NBN matrix: (a) total mass spectrum and 
(b) 2-D plot display of drift time vs. m/z. Insets in (b) show isotopic distributions and 
drift times of clozapine from tissue and standard. Data acquired using LSI settings of the 
intermediate pressure vacuum MALDI source of the SYNAPT G2 mass spectrometer. 
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Figure S27: MAIV-IMS-MS/MS of drug clozapine in (a) treated mouse brain tissue (90 
minutes after receiving 50 mg kg
-1
 of clozapine) spotted with 3-NBN matrix and (b) from 
standard with 3-NBN matrix.  Inset in (b) shows structure of clozapine indicating 
fragmentation patterns. Data acquired using LSI settings of the intermediate pressure 
vacuum MALDI source of the SYNAPT G2 mass spectrometer. 
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Figure S28: MAIV-IMS-MS of (I) clozapine treated mouse tissue removed from glass 
plate and dipped into the 3-NBN matrix solution and (II) plasma of clozapine treated 
mouse with 3-NBN matrix:  (a) total mass spectra and (b) 2-D plot of drift time vs. m/z. 
Data acquired using LSI settings of the intermediate pressure vacuum MALDI source of 
the SYNAPT G2 mass spectrometer. Insets in b show structure and isotopic distribution 
of clozapine. 
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Figure S29: MAIV (I.a) cetirizine mass spectra (MW 388 Da) from urine of a drug 
dosed individual and (b) MS/MS of cetirizine tablet, and (II) MS/MS of standard (a) 
nornicotine (exact MW 148.0995 Da) and (b) 3-NBN (exact MW 148.0267 Da)  using 
LSI settings. Data acquired using the (I) intermediate pressure vacuum MALDI source 
and (II) custom modified ESI source of SYNAPT G2 mass spectrometer. Insets in (I) 
show isotopic distribution and structure of cetirizine and (II) extracted drift time and 
structures of nornicotine and 3-NBN.  
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Figure S30: Extracted mass spectra of (a) beta amyloid (1-42) (MW 4511 Da), (b) 
bovine insulin (MW 5730 Da), and (c) ubiquitin (MW 8560 Da) from the 2-D plot 
display of drift time vs. m/z of the mixture (Figure 5) acquired in negative mode using 
the custom modified ESI source of the SYNAPT G2 mass spectrometer. Insets show 
isotopic distributions.  
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Figure S31: MAIV-IMS-MS of a model mixture of lipids (sphingomyelin MW 702 Da), 
peptides (leucine enkephalin, MW 555 Da; angiotensin II, MW 1045 Da; galanin, MW 
3560 Da), and small proteins (bovine insulin MW 5730 Da, ubiquitin MW 8560 Da)  
with 3-NBN matrix acquired using the intermediate pressure vacuum MALDI source of 
the SYNAPT G2 mass spectrometer using LSI settings: (a) total mass spectrum, (b) 2-D 
plot display of drift time vs. m/z, and (c) extracted mass spectra of the components in the 
mixture. Insets in (c) show isotopic distributions. 
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Figure S32: MAIV-IMS-MS (a) total mass spectrum, (b) 2-D plot display of drift time 
vs. m/z, and (c) extracted mass spectra of (1) lysozyme (MW 14.3 kDa) and (2) 
myoglobin (MW ~17 kDa) of the mixture (I) acquired in positive mode using the 
intermediate pressure vacuum MALDI source of the SYNAPT G2 mass spectrometer 
using LSI settings. 
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Figure S33: Deconvoluted MAIV mass spectra of (a) big model mixture (Figure S14), 
(b) protein mixture (Figure S15)  and (c) human plasma (Figure S17) using the 
BayeSpray software from Waters Corporation. 
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Figure S34: MAIV-IMS-MS (a) total mass spectrum with an inset of the extracted mass 
spectrum of both alpha and beta chains of hemoglobin, (b) 2-D plot display of drift time 
vs. m/z and (c) extracted mass spectra from (b) of (1) alpha globin (MW ~ 15.1 kDa) and 
(2) beta globin (MW ~15.9 kDa) of human plasma extracted from bandage with water 
acquired in positive mode using the intermediate pressure vacuum MALDI source of the 
SYNAPT G2 mass spectrometer using LSI settings. 
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Figure S35: MAIV-IMS-MS of isomeric mixture of beta amyloid (1-42) and (42-1) with 
3-NBN matrix: (a) total mass spectrum and (b) 2-D plot display of drift time vs. m/z 
using the intermediate pressure vacuum MALDI source using LSI settings. Insets in b 
show extracted drift times. 
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Figure S36: MAIV-IMS-MS/MS 2-D plot display of drift time vs. m/z of the isomeric 
mixture of beta amyloid (1-42) and (42-1) with 3-NBN matrix acquired using the custom 
modified ESI source of SYNAPT G2 with insets of the extracted MS/MS mass spectra 
from the 2-D plot of beta amyloid (1-42) (red) and (42-1) (yellow) (sequence coverage 
shown on top of the 2-D plot). 
  
 
1500
1000
500
m
/z
4 6  10                   12Drift time (ms)
%
0
100
1162.79
1125.11
203.18
920.60
285.24
1257.52
1300.89
1380.43
200 600 1000 1400 1800
%
0
100
185.17
774.50
284.25
1225.85
1034.69
β-amyloid (1-42)
β-amyloid (42-1)
m/z
D A E F R H D S G Y E V H H Q K L V F F A E D V G S N K G A I I G L M V G G V V I A 
A I V V G G V M L G I I A G K N S G V D E A F F V L K Q H H V E Y G S D H R F E A D 
y2
+
y3
+
b2
+
b3
+
y17
2+
y33
3+
y6
+
b23
2+
b35
3+
b34
3+
b33
3+
b31
3+
b30
3+
b23
3+
  
258 
 
APPENDIX D 
 
Copyright Permission 
 
 
  
259 
 
  
  
260 
 
  
  
261 
 
  
  
262 
 
  
  
263 
 
  
  
264 
 
  
  
265 
 
 
  
  
266 
BIBLIOGRAPHY 
                                                 
[1] Yamashita, M.; Fenn, J. Electrospray Ion Source. Another Variation on the Free-
Jet Theme. J. Phys. Chem. 1984, 88, 4451-4459. 
[2]  Tanaka, K.; Waki, H.; Ido, Y.; Akita, S.; Yoshida, Y.; Yoshida, T.; Matsuo, T. 
Protein and polymer analyses up to m/z 100,000 by laser ionization time-of- flight 
mass spectrometry. Rapid Commun. Mass Spectrom. 1988, 2, 151-153. 
[3]  Karas, M.; Hillenkamp, F. Laser desorption ionization of proteins with molecular 
masses exceeding 10,000 daltons. Anal. Chem. 1988, 60, 2299-2301. 
[4] Aebersold, R.; Goodbelt, D.R. Mass Spectrometry in Proteomics. Chem. Rev. 
2001, 101, 269-295. 
[5]  Hillenkamp, F.; Karas, M.; Beavis, R.C.; Chait, B.T.T. Matrix-assisted laser 
desorption/ionization mass spectrometry of biopolymers. Anal. Chem. 1991, 63, 
1193A-1202A. 
[6]  Zhang, H.; Caprioli, R.M. Direct Analysis of Aqueous Samples by Matrix-
assisted Laser Description Ionization Mass Spectrometry Using Membrane 
Targets Precoated with Matrix. J. Mass Spectrom. 1996, 31, 690-692. 
[7]  Caprioli, R.M.; Farmer, T.B.; Gile, J. Molecular imaging of biological samples: 
Localization of peptides and proteins using MALDI-TOF MS. Anal. Chem. 1997, 
69, 4751-4760. 
[8] Stoeckli, M.; Chaurand, P.; Hallahan, D.E.; Caprioli, R.M. Imaging Mass 
Spectrometry: A New Technique Applied to Mammalian Brain Tumor Protein 
Expression. Nat. Med. 2001, 7, 493-496.  
 
  
267 
                                                                                                                                                 
[9]  Wu, C.C.; Yates III, J.R. The Application of Mass Spectrometry to Membrane 
Proteins. Nat. Biotech. 2003, 21, 262-267.  
[10]  Trimpin, S.; Brizzard, B. Analysis of  Insoluble Proteins. Biotechniques 2009, 46, 
409-419. 
[11]  Stevens, T.J.; Arkin, I.T. Do more complex organisms have greater proportion of 
membrane proteins in their genomes? Proteins 2000, 39, 417-420. 
[12]  Wallin, E.; Von Heijne, G. Genome-wide analysis of integral membrane proteins 
from eubacterial, archaean, and eukaryotic organisms.  Protein Sci. 1998, 7, 1029-
1038.  
[13]  Rohner, T.C.; Staab, D.; Stoeckli, M. Spatial and spectral correlations in MALDI 
mass spectrometry images by clustering and multivariate analysis. Mech. Ageing 
Dev. 2005, 126, 177-185. 
[14]  Stefani, M.; Dobson, C.M. Protein aggregation and aggregate toxicity: new 
insights into protein folding, misfolding diseases, and biological evolution. J. 
Mol. Med. 2003, 81, 678-699. 
[15]  Pierson, J.; Norris, J.L.; Aerni, H.R.; Svenningsson, P.; Caprioli, R.M.; Andren, 
P.E. Molecular profiling of experimental Parkinson’s disease: Direct analysis of 
peptides and proteins on brain tissue sections by MALDI mass spectrometry. J. 
Proteome Res. 2004, 3, 289-295.  
[16]  Stauber, J.; Lemaire, R.; Franck, J.; Bonnel, D.; Croix, D.; Day, R.; Wisztorski, 
M.; Fournier, I.; Salzet, M. MALDI imaging of formalin-fixed paraffin-embedded 
  
268 
                                                                                                                                                 
tissues: application to model animals of Parkinson disease for biomarker hunting. 
J. Proteome Res. 2008, 7, 969-978. 
[17]  Quist, A.; Doudevski, I.; Lin, H.; Azimova, R.; Ng, D.; Frangione, B.; Ghiso, J.; 
Lal, R. Amyloid ion channels: A common structural link for protein-misfolding 
disease. Proc. Nat’l Acad. Sci. USA 2005, 102, 10427-10432. 
[18]  Stefani, M.; Dobson, C.M. Protein aggregation and aggregate toxicity: New 
insights into protein folding, misfolding diseases, and biological evolution. J. 
Mol. Med. 2003, 81, 678-699. 
[19]   Savas, J.N.; Stein, B.D.; Wu, C.C.; Yates, J.R. Mass spectrometry accelerates 
membrane protein analysis. Trends Biochem. Sci. 2011, 36, 388-396. 
[20]  Vestal, M.L. The Future of Biological Mass Spectrometry. J. Am. Soc. Mass 
Spectrom. 2011, 22, 953-959. 
[21] Laiko, V.V.; Baldwin, M.A.; Burlingame, A.L. Atmospheric Pressure MALDI-
MS. Anal. Chem. 2000, 72, 652-657. 
[22]  Doroshenko, V.M.; Laiko, V.V.; Taranenko, N.I.; Berkout, V.D.; Lee, H.S. 
Recent developments in atmospheric pressure MALDI mass spectrometry. Int. J. 
Mass Spectrom. 2002, 221, 39-58. 
[23] Vestal, M.L. Modern MALDI Time-of-flight mass spectrometry. J. Mass 
Spectrom. 2009, 44, 303-317. 
[24]  Sheehan, E.W.; Willoughby, R.C. (June 13, 2006) U. S. Patent 7,060,976. 
[25] Willis, D.A.; Grosu, V. Microdroplet Deposition by Laser-Induced Forward 
Transfer. Appl. Phys. Lett. 2005, 86, 244103. 
  
269 
                                                                                                                                                 
[26]  Galicia, M.C.; Vertes, A.; Callahan, J.H. Atmospheric pressure matrix-assisted 
laser desorption/ionization in transmission geometry. Anal. Chem. 2002, 74, 
1891-1895. 
[27] Trimpin, S.; Herath, T.N.; Inutan, E.D.; Cernat, S.A.; Wager-Miller, J.; Mackie, 
K.; Walker, J.M. Field-free Transmission Geometry Atmospheric Pressure 
Matrix-Assisted Laser Desorption/Ionization for Rapid Analysis of Unadulterated 
Tissue Samples. Rapid Commun. Mass Spectrom. 2009, 23, 3023-3027. 
[28] Trimpin, S.; Inutan, E.D.; Herath, T.N.; McEwen, C.N.: Matrix-assisted laser 
desorption/ionization mass spectrometry method for selectively producing either 
singly or multiply charged molecular ions. Anal. Chem. 2010, 82, 11-15. 
[29] Trimpin, S.; Inutan, E.D.; Herath, T.N.; McEwen, C.N. Laserspray Ionization - A 
New AP-MALDI Method for Producing Highly Charged Gas-Phase Ions of 
Peptides and Proteins Directly from Solid Solutions. Mol. Cell. Proteomics 2010, 
9, 362-367. 
[30] Trimpin, S. A Perspective on MALDI Alternatives - Total solvent-free analysis 
and electron transfer dissociation of highly charged ions by laserspray ionization.  
J. Mass Spectrom. 2010, 45, 471-485. 
[31] McEwen, C.N.; Trimpin, S. An Alternative Ionization Paradigm for Atmospheric 
Pressure Mass Spectrometry: Flying Elephants from Trojan Horses. Int J. Mass 
Spectrom. 2011, 300, 167-172. 
[32] Handschuh, M.; Nettesheim, S.; Zenobi, R. Laser-induced molecular desorption 
and particle ejection from organic films. Appl. Surf. Sci. 1999, 137, 125-135. 
  
270 
                                                                                                                                                 
[33] Cai, Y.; Peng, W.P.; Kuo, S.J.; Sabu, S.; Han, C.C.; Chang, H.C. Optical 
Detection and Charge State Analysis of MALDI-Generated Particles with 
Molecular Masses Greater than 5 MDa. Anal. Chem. 2002, 74, 4434-4440. 
[34] Musapelo, T.; Murray, K.K. Particle Formation in Ambient MALDI Plumes. 
Anal. Chem. 2011, 83, 6601-6608. 
[35] Knochenmuss, R.; Zhigilei, L.V. Molecular Dynamics Model of Ultraviolet 
Matrix-assisted Laser Desorption/Ionization Including Ionization Processes. J. 
Phys. Chem. B 2005, 109, 22947-22957. 
[36] Zhigilei, L.V.; Garrison, B.J. Microscopic Mechanism of Laser Ablation of 
Organic Solids in the Thermal and Stress Confinement Irradiation Regimes. J. 
Appl. Phys. 2000, 88, 1281-1298. 
[37] Zhigilei, L.V. Dynamics of the Plume Formation and Parameters of the Ejected 
Clusters in Short-pulse Laser Ablation. Appl. Phys. A 2003, 76, 339-350. 
[38]  Zhigilei, L.V.; Kodali, P.B.; Garrison, B. On the threshold behavior in laser 
ablation of organic solids. J. Chem. Phys. Lett. 1997, 276, 269-273. 
[39] McEwen, C.N.; Pagnotti, V.S.; Inutan, E.D.; Trimpin, S. New Paradigm in 
Ionization: Multiply Charged Ion Formation from a Solid Matrix without a Laser 
or Voltage. Anal. Chem. 2010, 82, 9164-9168. 
[40]  Li, J.; Inutan, E.D.; Wang, B.; Lietz, C.B.; Green, D.R.; Manly, C.D.; Richards, 
A.L.; Marshall, D.D.; Lingenfelter, S.; Ren, Y.; Trimpin, S. Matrix assisted 
ionization: New aromatic and non-aromatic matrix compounds producing 
multiply charged lipid, peptide, and protein ions in the positive and negative mode 
  
271 
                                                                                                                                                 
observed directly from surfaces. J. Am. Soc. Mass Spectrom. 2012, 23, 1625-
1643. 
[41] McEwen, C.N.; Larsen, B.S.; Trimpin, S. Laserspray Ionization on a Commercial 
AP-MALDI Mass Spectrometer Ion Source: Selecting Singly or Multiply 
Charged Ions. Anal. Chem. 2010, 82, 4998-5001. 
[42] Inutan, E.D.; Wang, B.; Trimpin, S. Commercial intermediate pressure MALDI 
ion mobility spectrometry mass spectrometer capable of producing highly charged 
laserspray ionization ions. Anal. Chem. 2011, 83,678-684. 
[43] Inutan, E.D.; Wager-Miller, J.; Mackie, K.; Trimpin, S. Laserspray Ionization 
Imaging of Multiply Charged Ions using a Commercial Vacuum MALDI Ion 
Source. Anal. Chem.2012, 84, 9079-9084. 
[44] Trimpin, S.; Ren, Y.; Wang, B.; Lietz, C.B.; Richards, A.L.; Marshall, D.D.; 
Inutan, E.D. Extending the Laserspray Ionization Concept to Produce Highly 
Charged Ions at High Vacuum on a Time-of-Flight Mass Analyzer. Anal. Chem. 
2011, 83, 5469-5475. 
[45] Trimpin, S.; Wang, B.; Inutan, E.D.; Li, J.; Lietz, C.B.; Harron, A.; Pagnotti, 
V.S.; Sardelis, D.; McEwen, C.N. A Mechanism for Ionization of Nonvolatile 
Compounds in Mass Spectrometry: Considerations from MALDI and 
InletIonization. J. Am. Soc. Mass Spectrom. 2012, 23, 1644-1660. 
[46] Inutan, E.D.; Trimpin, S. Matrix Assisted Ionization Vacuum, a New Ionization 
Method for Biological MaterialsAnalysis using Mass Spectrometry. Mol. Cell 
Proteomics 2013, 12, 792-796. 
  
272 
                                                                                                                                                 
[47] Trimpin, S.; Inutan, E.D. Matrix Assisted Ionization in Vacuum, a Sensitive and 
Widely Applicable Ionization Method for Mass Spectrometry. J. Am. Soc. Mass 
Spectrom. 2013, DOI: 10.1007/s13361-012-0571-z.  
[48] Inutan, E.D.; Richards, A.L.; Wager-Miller, J.; Mackie, K.; McEwen, C.N.; 
Trimpin, S. Laserspray Ionization - A New Method for Protein Analysis Directly 
from Tissue at Atmospheric Pressure and with Ultra-High Mass Resolution and 
Electron Transfer Dissociation Sequencing. Mol. Cell. Proteomics 2011, 10, 1-8. 
[49] Inutan, E. D.; Trimpin, S. Laserspray ionization (LSI) ion mobility spectrometry 
(IMS) mass spectrometry (MS). J. Am. Soc. Mass Spectrom. 2010, 21, 1260-1264. 
[50] Inutan, E.D.; Trimpin, S. Laserspray ionization-ion mobility spectrometry-mass 
spectrometry: Baseline separation of isomeric amyloids without the use of 
solvents desorbed and ionized directly from a surface. J. Proteome Res. 2010, 9, 
6077-6081. 
[51]  Dole, M.; Mack, L.L.; Hines, R.L.; Mobley, R.C.; Ferguson, L.D.; Alice, M. B. 
Molecular beams of macroions. J. Chem. Phys. 1968, 49, 2240-2249. 
[52]  Iribarne, J.V.; Thomson, B.A. On the evaporation of small ions from charged 
droplets. J. Chem. Phys. 1976, 64, 2287-2294. 
[53]  Vestal, M.L. Studies of ionization mechanisms involved in thermo- spray LC-MS. 
Int. J. Mass Spectrom. Ion Phys. 1983, 46, 193-196. 
[54]  Karas, M.; Gluckmann, M.; Schafer, J. Ionization in matrix-assisted laser 
desorption/ionization: singly charged molecular ions are the lucky survivors. J. 
Mass Spectrom. 2000, 35, 1-12. 
  
273 
                                                                                                                                                 
[55]  Karas, M.; Kruger, R. Ion formation in MALDI: the cluster ionization 
mechanism. Chem. Rev. 2003, 103, 427-440. 
[56]  Kennedy, E.T.; Costello, J.T.; Mosnier, J.P. New experiments in photoabsorption 
studies of singly and multiply charged ions. J. Electron Spectrosc. 1996, 79, 283-
288. 
[57]  Kononikhin, A.S.; Nikolaev, E.N.; Frankevich, V.; Zenobi, R. Multiply charged 
ions in matrix-assisted laser desorption/ionization generated from electrosprayed 
sample layers. Eur. J. Mass Spectrom. 2005, 11,257-259. 
[58]  Syka, J.E.; Coon, J.J.; Schroeder, M.J.; Shabanowitz, J.; Hunt, D.F. Peptide and 
protein sequence analysis by electron transfer dissociation mass spectrometry. 
Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 9528-9533. 
[59] Clemmer, D. E.; Jarrold, M. F. Ion mobility measurements andtheir applications 
to clusters and biomolecules. J. Mass Spectrom. 1997, 32, 577-592. 
[60] Wu, C.; Klasmeier, J.; Hill, H. H. Atmospheric pressure ion mobilityspectrometry 
of protonated and sodiated peptides. Rapid Commun. Mass Spectrom.1999, 13, 
1138-1142. 
[61] Wyttenbach, T.; Bowers, M. T. Gas-phase conformations: The ion mobility/ion 
chromatography method. Top.Curr. Chem. 2003, 225,207-232. 
[62] McLean, J. A.; Ruotolo, B. T.; Gillig, K. J.; Russell, D. H. Ion 
mobilitymassspectrometry: A new paradigm for proteomics. Int. J. Mass 
Spectrom. 2005, 240, 301-315. 
  
274 
                                                                                                                                                 
[63] Pringle, S. D.; Giles, K.; Wildgoose, J. L.; Williams, J. P.; Slade, S. E.; 
Thalassinos, K.; Bateman, R. H.; Bowers, M. T.; Scrivens, J. H. An investigation 
of the mobility separation of some peptide and protein ions using a new hybrid 
quadrupole/travelling wave IMS/oa-ToF instrument. Int. J. Mass Spectrom. 2007, 
261, 1-12. 
[64] Liu, X.; Valentine, S. J.; Plasencia, M. D.; Trimpin, S.; Naylor, S.;Clemmer, D. E. 
Mapping the Human Plasma Proteome by SCXLC-IMS-MS. J. Am. Soc. Mass 
Spectrom. 2007, 18, 1249-1264. 
[65] Trimpin, S.; Plasencia, M. D.; Isailovic, D.; Clemmer, D. E. ResolvingOligomers 
from Fully Grown Polymers with IMS-MS. Anal. Chem. 2007,79, 7965-7974. 
[66] Trimpin, S.; Clemmer, D. E. Ion mobility spectrometry/massspectrometry 
snapshots for assessing the molecular compositionsof complex polymeric 
systems. Anal. Chem. 2008, 80, 9073-9083. 
[67] Trimpin, S.; Tan, B.; Bohrer, B. C.; O’Dell, D. K.; Merenbloom, S. I.; Pazos, M. 
X.; Clemmer, D. E.; Walker, J. M. Profiling of phospholipids and related lipid 
structures using multidimensional ion mobility spectrometry-mass spectrometry. 
Int. J. Mass Spectrom. 2009, 287, 58-69. 
[68]  Mitchell, J., Jr.; Deveraux, H. D. Determination of traces of organic compounds 
in the atmosphere: role of detectors in gas chromatography. Anal. Chim. Acta 
1978, 52, 45-52. 
  
275 
                                                                                                                                                 
[69]  Sweeting, L. M.; Cashel, M. L.; Rosenblatt, M. M. Triboluminescence spectra of 
organic crystals are sensitive to conditions of acquisition. J. Lumin. 1992, 52, 
281-291. 
[70]  Sweeting, L. M. Triboluminescence with and without air. Chem. Mater. 2001, 13, 
854-870. 
[71] Inutan, E.D.; Wager-Miller, J.; Narayan, S.; Mackie, K.; Trimpin, S. The Potential 
for Clinical Applications using a New Ionization Method Combined with Ion 
Mobility Spectrometry-Mass Spectrometry. Int. J. Ion Mobility Spectrom. 2013, 
16, 145-159. 
[72] Trimpin, S.; Rouhanipour, A.; Az, R.; Rader, H.J.; Mullen, K. New aspects in 
matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry: A 
universal solvent‐free sample preparation. Rapid Commun. Mass Spectrom. 2001, 
15, 1364-1373. 
[73] Trimpin, S.; McEwen, C.N. Multisample preparation methods for the solvent-free 
MALDI-MS analysis of synthetic polymers. J. Am. Soc. Mass Spectrom. 2007, 
18, 377-381. 
[74] Seeley, E.H.; Oppenheimer, S.R.; Mi, D.; Chaurand, P.; Caprioli, R.M. 
Enhancement of protein sensitivity for MALDI imaging mass spectrometry after 
chemical treatment of tissue sections.  J. Am. Soc. Mass Spectrom. 2008, 19, 
1069-1077.  
  
276 
                                                                                                                                                 
[75]  Garrett, T.J.; Yost, R.A. Analysis of intact tissue by intermediate-pressure 
MALDI on a linear ion trap mass spectrometer. Anal. Chem. 2006, 78, 2465-
2469. 
[76]  Clarke, S.L.; Vasanthakumar, A.; Anderson, S.A.; Pondarre, C.; Koh, C.M.; 
Deck, K. M.; Pitula, J.S.; Epstein, C.J.; Fleming, M.D.; Eisenstein, R.S. Iron-
responsive degradation of iron-regulatory protein 1 does not require the Fe–S 
cluster. EMBO J. 2006, 25, 544-553. 
[77]  Navratil, M.; Mabbott, G.A.; Arriaga, E.A. Chemical microscopy applied to 
biological systems. Anal. Chem. 2006, 78, 4005- 4019. 
[78]  Trimpin, S.; Mixon, A.E.; Stapels, M.D.; Kim, M.Y.; Spencer, P.S.; Deinzer, 
M.L. Identification of endogenous phosphorylation sites of bovine medium and 
low molecular weight neurofilament proteins by tandem mass spectrometry.  
Biochemistry 2004, 43, 2091-2105. 
[79]  Gunawardena, H.P.; Emory, J.F.; McLuckey, S.A. Phosphopeptide anion 
characterization via sequential charge inversion and electron-transfer dissociation. 
Anal. Chem. 2006, 78, 3788-3793. 
[80]  Zubarev, R.A.; Kelleher, N.L.; McLafferty, F.W. Electron capture dissociation of 
multiply charged protein cations. A nonergodic process. J. Am. Chem. Soc. 1998, 
120, 3265-3266. 
[81]  Zubarev, R.A.; Horn, D.M.; Fridriksson, E.K.; Kelleher, N.L.; Kruger, N.A.; 
Lewis, M.A.; Carpenter, B.K.; McLafferty, F.W. Electron capture dissociation for 
  
277 
                                                                                                                                                 
structural characterization of multiply charged protein cations. Anal. Chem. 2000, 
72, 563-573. 
[82]  Knochenmuss, R.; Zenobi, R. MALDI ionization: the role of in-plume processes. 
Chem. Rev. 2003, 103, 441–452. 
[83]  Knochenmuss, R.A. Ion formation mechanisms in UV-MALDI. Analyst 2006, 
131, 966-986. 
[84] Gluckmann, M.; Pfenninger, A.; Kruger, R.; Thierolf, M.; Karas, M.; 
Horneffer,V.; Hillenkamp, F.; Strupat, K. Mechanisms in MALDI analysis: 
surface interaction or incorporation of analytes? Int. J. Mass Spectrom. 2001, 
210/211, 121-132. 
[85] Fournier, I.; Brunot, A.; Tabet, J.C.; Bolbach, G. Delayed extraction experiments 
using a repulsive potential before ion extraction: Evidence of clusters as ion 
precursors in UV-MALDI. Part I: Dynamical effects with the matrix 2,5-
dihydroxybenzoic acid. Int. J. Mass Spectrom. 2002, 213, 203-215. 
[86] Knochenmuss, R.A Quantitative model of ultraviolet matrix-assisted laser 
desorption/ionization including analyte ion generation. Anal. Chem. 2003, 75, 
2199-2207. 
[87] Chang, W.C.; Huang, L.C.; Wang, Y.S.; Peng, W.P.; Chang, H.C.; Hsu, N.Y.; 
Yang, W.B.; Chen, C.H. Matrix-assisted laser desorption/ionization (MALDI) 
mechanism revisited. Anal.Chim.Acta 2007, 582, 1-9. 
  
278 
                                                                                                                                                 
[88] Zhou, J.; Lee, T. D. Charge state distribution shifting of protein ions observed in 
matrix-assisted laser desorption ionization mass spectrometry. J. Am. Soc. Mass 
Spectrom. 1995, 6, 1183-1189. 
[89] Ovaberg, A.; Karas, M.; Hillenkamp, F. Matrix-assisted laser desorption of large 
biomolecules with a TEA-CO2-laser. Rapid Commun. Mass Spectrom. 1991, 5, 
128-131. 
[90] Sampson, J.S.; Hawkridge, A.M.; Muddiman, D.C. Development and 
characterization of an ionization technique for analysis of biological 
macromolecules: Liquid matrix-assisted laser desorption electrospray ionization. 
Anal. Chem. 2008, 80, 6773-6778. 
[91]  Grimm, R.L.; Beauchamp, J.L. Field-induced droplet ionization mass 
spectrometry. J. Phys. Chem. B 2003, 107, 14161-14163. 
[92]  Hiraoka, K. Laser spray: Electric field-assisted matrix-assisted laser 
desorption/ionization. J. Mass Spectrom. 2004, 39, 341-350. 
[93]  Coon, J.J.; Ueberheide, B.; Syka, J.E.; Dryhurst, D.D.; Ausio, J.; Shabanowitz, J.; 
Hunt, D.F. Protein identification using sequential ion/ion reactions and tandem 
mass spectrometry. Proc. Nat’l. Acad. Sci. U.S.A. 2005, 102, 9463-9468. 
[94]  Krutchinsky, A.N.; Chait, B.T. On the nature of the chemical noise in MALDI 
mass spectra. J. Am. Soc. Mass Spectrom. 2002, 13, 129-134. 
[95]  Katta, V.; Rockwood, A.L.; Vestal, M.L. Field limit for ion evaporation from 
charged thermospray droplets. Int. J. Mass Spectrom. Ion Proc. 1991, 103, 129-
148. 
  
279 
                                                                                                                                                 
[96]  Trimpin, S.; Deinzer, M.L. Solvent-free MALDI-MS for the analysis of β-
amyloid peptides via the mini-ball mill approach: qualitative and   quantitative 
improvements. J. Am.  Soc.  Mass  Spectrom. 2007, 18, 1533-1543. 
[97]  Trimpin, S.; Wijerathnea, K.; McEwen, C.N. Rapid methods of polymer and 
polymer additives identification: multi-sample solvent-free MALDI, pyrolysis at 
atmospheric pressure, and atmospheric solids analysis probe mass spectrometry. 
Anal. Chim. Acta 2009, 654, 20-25. 
[98]  Horneffer, V.; Dreisewerd, K.; Ludemann, H.C.; Hillenkamp, F.; Lage, M.; 
Strupat, K. Is the incorporation of analytes into matrix crystals a prerequisite for 
matrix-assisted laser desorption/ionization mass spectrometry? A study of five 
positional isomers of dihydroxybenzoic acid. Int. J. Mass Spectrom. 1999, 185-
187, 859-870. 
[99]  Trimpin, S.; Rader, H.J.; Mullen, K. Investigation of theoretical principles for 
MALDI-MS derived from solvent-free sample preparation. Part I: 
preorganization. Int. J. Mass Spectrom. 2006, 253, 13-21. 
[100]  Mikesh, L.M.; Ueberheide, B.; Chi, A.; Coon, J.J.; Syka, J.E.; Shabanowitz,  J.; 
Hunt D.F. The utility of ETD mass spectrometry in proteomic analysis. Biochim. 
Biophys. Acta 2006, 1764, 1811-1822. 
[101]  Bohrer, B.C.; Merenbloom, S.I.; Koeniger, S.L.; Hilderbrand, A.E.; Clemmer, 
D.E. Biomolecule Analysis by Ion Mobility Spectrometry. Ann. Rev. Anal. Chem. 
2008, 1, 293-327. 
  
280 
                                                                                                                                                 
[102]  Kanu, A.B.; Hill, H.H. Ion Mobility Spectrometry Detection for Gas 
Chromatography. J. Chromatogr. A 2008, 1177, 12-27. 
[103]  McLean, J.A.; Ruotolo, B.T.; Gillig, K.J.; Russell, D.H. Ion Mobility-Mass 
Spectrometry: A New Paradigm for Proteomics. Int. J. Mass Spectrom. 2005, 240, 
301-315. 
[104]  Kaur-Atwal, G.; O’Connor, G.; Aksenov, A.A.; Bocos-Bintintan, V.; Paul 
Thomas, C.L.; Creaser, C.S. Chemical Standards for Ion Mobility Spectrometry: 
A Review. Int. J. Ion Mobility Spectrom. 2009, 12, 1-14. 
[105] Pringle, S.D.; Giles, K.; Wildgoose, J.L.; Williams, J.P.; Slade, S.E.; Thalassinos, 
K.; Bateman, R.H.; Bowers, M.T.; Scrivens, J.H. An investigation of the mobility 
separation of some peptide and protein ions using a new hybrid 
quadrupole/travelling wave IMS/oa-ToF instrument. Int. J. Mass Spectrom. 2007, 
261, 1-12. 
[106]  Koeniger, S.L.; Merenbloom, S.I.; Sevugarajan, S.; Clemmer, D.E. Transfer of 
Structural Elements from Compact to Extended States in Unsolvated Ubiquitin. J. 
Am. Chem. Soc. 2006, 128, 11713-11719. 
[107] Koeniger, S.L.; Merenbloom, S.I.; Clemmer, D.E. Evidence for Many Resolvable 
Structures within Conformation Types of Electrosprayed Ubiquitin Ions. J. Phys. 
Chem. B 2006, 110, 7017-7021. 
[108] Koeniger, S.L.; Clemmer, D.E. Resolution and Structural Transitions of 
Elongated States of Ubiquitin. J. Am. Soc. Mass Spectrom. 2007, 18,322-331. 
  
281 
                                                                                                                                                 
[109]  Valentine, S.J.; Counterman, A.E.; Clemmer, D.E. Conformer-Dependent Proton-
Transfer Reactions of Ubiquitin Ions. J. Am. Soc. Mass Spectrom. 1997, 8, 954-
961. 
[110] Chaurand, P.; Schriver, K.E.; Caprioli, R.M. Instrument design and 
characterization for high resolution MALDI-MS imaging of tissue sections. J. 
Mass Spectrom. 2007, 42, 476-89. 
[111] McDonnell, L.A.; Heeren, R.M.A. Imaging mass spectrometry. Mass Spectrom. 
Rev. 2007, 26, 606-643. 
[112] Fournier, I.; Wisztorski, M.; Salzet, M. Tissue imaging using MALDI-MS: A new 
frontier of histopathology proteomics. Expert Rev. Proteomics 2008, 5, 413-424. 
[113] Trimpin, S.; Herath, T.N.; Inutan, E.D.; Wager-Miller, J.; Kowalski,P.; Claude, 
E.; Walker, J.M.; Mackie, K. Automated solvent-free matrix deposition for tissue 
imaging by mass spectrometry. Anal.Chem. 2010, 82, 359-367. 
[114]  Li, J.; Taraszka, J.A.; Counterman, A.E.; Clemmer, D.E. Influenceof solvent 
composition and capillary temperature on the conformations of electrosprayed 
ions: Unfolding of compact ubiquitin conformers from pseudonative and 
denatured solutions. Int. J. Mass. Spectrom. 1999, 185/186/187, 37-47. 
[115] Badman, E.R.; Hoaglund-Hyzer, C.S.; Clemmer, D.E. Dissociation of different 
conformations of ubiquitin ions. J. Am. Soc. Mass Spectrom. 2002, 13, 719-723. 
[116]  Grasso, G.; Mineo, P.; Rizzarelli, E.; Spoto, G. MALDI, AP/MALDI and ESI 
techniques for the MS detection of amyloid β-peptides. Int. J.Mass Spectrom. 
2009, 282, 50-55. 
  
282 
                                                                                                                                                 
[117]  Shen, C.L.; Murphy, R.M. Solvent effects on self-assembly of_-amyloid peptide. 
Biophys. J. 1995, 69, 640-651. 
[118]  Bernstein, S.L.; Wyttenbach, T.; Baumketner, A.; Shea, J.; Bitan,G.; Teplow, 
D.B.; Bowers, M.T. Amyloid β-protein: Monomer structure and early aggregation 
states of Aβ 42 and its Pro19 alloform. J. Am. Chem. Soc. 2005, 127, 2075-2084. 
[119]  Butterfield, D.A.; Boyd-Kimball, D. The critical role of methionine 35 in 
Alzheimer’s amyloid beta-peptide (1-42) - induced  oxidative  stress  and  
neurotoxicity. Biochem. Biophys. Acta 2005, 1703, 149-156. 
[120] Fournier, I.; Wisztorski, M.; Salzet, M. Tissue imaging using MALDI-MS: a new 
frontier of histopathology proteomics. Expert Rev. Proteomics 2008, 5, 413-424. 
[121] Bedair, M.; Sumner, L.W. Current and emerging mass spectrometry technologies 
for metabolomics. Trends Anal. Chem. 2008, 27, 238-250. 
[122] Jackson, S.N.; Ugarov, M.; Egan, T.; Post, J.D.; Langlais, D.; Schultz, J.A.; 
Woods, A.S. MALDI-ion mobility-TOFMS imaging of lipids in rat brain tissue. J. 
Mass Spectrom. 2007, 42, 1093-1098. 
[123] Stoeckli, M.; Chaurand, P.; Hallahan, D.E.; Caprioli, R.M. Imaging mass 
spectrometry: A new technology for the analysis of protein expression in 
mammalian tissues. Nat. Med. 2001, 7, 493-496. 
[124] Chaurand, P.; Schwartz, S.A.; Caprioli, R.M. Imaging mass spectrometry: A new 
tool to investigate the spatial organization of peptides and proteins in mammalian 
tissue sections. Curr. Opin. Chem. Biol. 2002, 6, 676-681. 
  
283 
                                                                                                                                                 
[125]  Khatib-Shahidi, S.; Andersson, M.; Herman, J.L.; Gillespie, T.A.; Caprioli, R.M. 
Direct molecular analysis of whole-body animal tissue sections by imaging 
MALDI mass spectrometry. Anal. Chem. 2006, 78, 6448-6456. 
[126]  Chaurand, P.; Cornett, D.S.; Caprioli, R.M. Molecular imaging of thin 
mammalian tissue sections by mass spectrometry. Curr. Opin. Biotechnol. 2006, 
17, 431- 436. 
[127]  Ostrowski, S.G.; Van Bell, C.T.; Winograd, N.; Ewing, A.G. Mass spectrometric 
imaging of highly curved membranes during Tetrahymena mating. Science 2004, 
305, 71-73. 
[128]  Winograd, N. The magic of cluster SIMS. Anal.Chem. 2005, 77,142A-149A. 
[129]  Jones, E.A.; Lockyer, N.P.; Vickerman, J.C. Depth profiling brain tissue sections 
with a 40 keV C-60(+) primary ion beam. Anal. Chem. 2008, 80, 2125-2132. 
[130]  Chaurand, P.; Schwartz, S.A.; Caprioli, R.M.  Assessing protein patterns in 
disease using imaging mass spectrometry. J. Proteome Res. 2004, 3, 245-252. 
[131]  Zimmerman, T.A.; Monroe, E.B.; Sweedler, J.V. Adapting the stretched sample 
method from tissue profiling to imaging. Proteomics 2008, 8, 3809-3815. 
[132]  Deininger, S.O.; Suckau, D.; Becker, M.; Schuerenberg, M. MALDI-tissue 
imaging at high resolution and speed: Essential steps towards its applications in 
histology. Proc. of the 57
th
 ASMS Conference on Mass Spectrometry and Allied 
Topics, Philadelphia, May 31–June 4, 2009. 
[133]  Touboul, D.; Piednoe, H.; Voisin, V.; De La Porte, S.; Brunelle, A.; Halgand, F.; 
Laprevote, O. Changes in phospholipid composition within the dystrophic muscle 
  
284 
                                                                                                                                                 
by matrix-assisted laser desorption/ionization mass spectrometry and mass 
spectrometry imaging. Eur. J. Mass Spectrom. 2004, 10, 657-664. 
[134]  Chaurand, P.; Schwartz, S.A.; Caprioli, R.M. Profiling and imaging proteins in 
tissue sections by MS. Anal. Chem. 2004, 76, 86A-93A. 
[135]  Han, H.; Xia, Y.; Yang, M.; McLuckey, S.A. Rapidly alternating transmission 
mode electron-transfer dissociation and collisional activation for the 
characterization of polypeptide ions. Anal. Chem. 2008, 80, 3492-3497. 
[136]  Landgraf, R.R.; Prieto Conaway, M.C.; Garrett, T.J.; Stacpoole, P.W.; Yost, R.A. 
Imaging of lipids in spinal cord using intermediate pressure matrix-assisted laser 
desorption-linear ion trap/Orbitrap MS. Anal. Chem. 2009, 81, 8488-8495. 
[137]  Zydel, F.; Trimpin, S.; McEwen, C.N. Laserspray ionization using an atmospheric 
solids analysis probe for sample introduction. J. Am. Soc. Mass Spectrom. 2010, 
21, 1889-1892. 
[138]  Richards, A.L.; Marshall, D.D.; Inutan, E.D.; McEwen, C.N.; Trimpin, S. Rapid 
Commun. Mass Spectrom. 2011, 25, 1-4. 
[139]  Takats, Z.; Wiseman, J.M.; Gologan, B.; Cooks, R.G. Mass spectrometry 
sampling under ambient conditions with desorption electrospray ionization. 
Science 2004, 306, 471-473. 
[140]  Laiko, V.V.; Moyer, S.C.; Cotter, R.J. Atmospheric pressure MALDI/ion trap 
mass spectrometry. Anal. Chem. 2000, 72, 5239-5243. 
  
285 
                                                                                                                                                 
[141]  Perkins, D.N.; Pappin, D.J.; Creasy, D.M.; Cottrell, J.S. Probability-based protein  
identification  by  searching  sequence  data- bases using mass spectrometry data. 
Electrophoresis 1999, 20, 3551-3567. 
[142]  Chaurand, P.; Norris, J.L.; Cornett, D.S.; Mobley, J.A.; Caprioli, R.M.  New 
developments in profiling and imaging of proteins from tissue sections by 
MALDI mass spectrometry. J. Proteome Res. 2006, 5, 2889-2900. 
[143]  Kaleta, B.K.; van der Wiel, I.M.; Stauber, J.; Guzel, C.; Kros, J.M.; Luider,T.M.; 
Heeren, R.M. Sample preparation issues for tissue imaging by imaging MS. 
Proteomics 2009, 9, 2622-2633. 
[144]  Schwartz, S.A.; Reyzer, M.L.; Caprioli, R.M. Direct tissue analysis using matrix-
assisted laser desorption/ionization mass spectrometry: Practical aspects of 
sample preparation. J. Mass Spectrom. 2003, 38, 699-708. 
[145]  Chaurand, P.; Schriver, K.E.; Caprioli, R.M. Instrument design and 
characterization for high resolution MALDI-MS imaging of tissue sections. J. 
Mass Spectrom. 2007, 42, 476-489.  
[146]  Caldwell, R.L.; Caprioli, R.M. Tissue profiling by mass spectrometry: A review 
of methodology and applications. Mol. Cell. Proteomics 2005, 4, 394-401. 
[147] Hortin, G.L. The MALDI-TOF mass spectrometric view of the plasma proteome 
and peptidome.  Clin. Chem. 2006, 52, 1223-1237. 
[148]  Batoy, S.M. A.B.; Akhmetova, E.; Miladinovic, S.; Smeal, J.; Wilkins, C.L. 
Developments in MALDI mass spectrometry: the quest for the perfect matrix  
Appl. Spectrosc. Rev. 2008, 43, 485-550. 
  
286 
                                                                                                                                                 
[149]  Weidner, S.M.; Trimpin, S. Mass Spectrometry of Synthetis Polymers. Anal. 
Chem. 2010, 82, 4811-4829. 
[150]  Trimpin,S. A perspective on MALDI alternatives total solvent-free analysis and 
electron transfer dissociation of highly charged ions by laserspray ionization. J. 
Mass Spectrom. 2010, 45, 471-485. 
[151]  Handschuh, M.; Nettesheim, S.; Zenobi, R. Laser-induced molecular desorption 
and particle ejection from organic films. Appl. Surf. Sci. 1999, 137, 125-135. 
[152] Alves, S.; Fournier, F.; Afonso, C.; Wind, F.; Tabet, J.C. Gas-phase 
ionization/desolvation processes and their effect on protein charge state 
distribution under matrix-assisted laser desorption/ionization conditions. Eur. J. 
Mass Spectrom. 2006, 12, 369-383. 
[153]  Wenzel, T.; Sparbier, K.; Mieruch, T.; Kostrzewa, M. Rapid Commun. Mass 
Spectrom. 2006, 20, 785-789. 
[154]  Krause, J.; Stoeckli, M.; Schlunegger, U. P. Studies on the selection of new 
matrices for ultraviolet matrix-assisted laser desorption/ionization time-of-flight 
mass spectrometry. Rapid Commun. Mass Spectrom. 1996, 10, 1927-1933. 
[155]  Cohen, L. R. H.; Strupat, K.; Hillenkamp, F. Analysis of quaternary protein 
ensembles by matrix assisted laser desorption/ionization mass spectrometry. J. 
Am. Soc. Mass Spectrom. 1997, 8, 1046-1052. 
[156]  Wortmann, A.; Pimenova, T.; Alves, S.; Zenobi, R. Investigation of the first shot 
phenomenon in MALDI mass spectrometry of protein complexes. Analyst 2007, 
132, 199-207. 
  
287 
                                                                                                                                                 
[157]  Woods, A. S.; Ugarov, M.; Egan, T.; Koomen, J.; Gillig, K. J.; Fuhrer, K.; Gonin, 
M.; Schultz, J. Lipid/peptide/nucleotide separation with MALDI-ion mobility-
TOF MS. Anal. Chem. 2004, 76, 2187-2195. 
[158]  Jackson, S. N.; Wang, H. J.; Woods, A. S.; Ugarov, M.; Egan, T.; Schultz, J. A. 
Direct Tissue Analysis of Phospholipids in Rat Brain Using MALDI-TOFMS and 
MALDI-Ion Mobility-TOFMS. J. Am. Soc. Mass. Spectrom. 2005, 16, 133-138. 
[159]  Jackson, S. N.; Ugarov, M.; Egan, T.; Post, J. D.; Langlais, D.; Schultz, J. A.; 
Woods, A. S. MALDI‐ion mobility‐TOFMS imaging of lipids in rat brain tissue. 
J. Mass Spectrom. 2007, 42, 1093-1098. 
[160]  McLean, J. A.; Ridenour, W. B.; Caprioli, R. M. Profiling and imaging of tissues 
by imaging ion mobility‐mass spectrometry. J. Mass Spectrom. 2007, 42, 1099-
1105. 
[161]  Djidja, M.; Francese, S.; Loadman, P. M.; Sutton, C. W.; Scriven, P.; Claude, E.; 
Snel, M. F.; Franck, J.; Salzet, M.; Clench, M. R. Detergent addition to tryptic 
digests and ion mobility separation prior to MS/MS improves peptide yield and 
protein identification for in situ proteomic investigation of frozen and 
formalin‐fixed paraffin‐embedded adenocarcinoma tissue sections. Proteomics 
2009, 9, 2750-2763. 
[162]  Ridenour, W.B.; Kliman, M.; McLean, J.A.; Caprioli, R.M. Structural 
characterization of phospholipids and peptides directly from tissue sections by 
MALDI traveling-wave ion mobility-mass spectrometry. Anal. Chem. 2010, 82, 
1881-1889. 
  
288 
                                                                                                                                                 
[163]  Bush, M. F.; Hall, Z.; Giles, K.; Hoyes, J.; Robinson, C. V.; Ruotolo, B. T. 
Collision cross sections of proteins and their complexes: a calibration framework 
and database for gas-phase structural biology. Anal. Chem. 2010, 82, 9557-9565. 
[164]  Lee, S.; Ewing, M. A.; Nachtigall, F. M.; Kurulugama, R. T.; Valentine, S. J.; 
Clemmer, D. E. Determination of cross sections by overtone mobility 
spectrometry: evidence for loss of unstable structures at higher overtones. J. Phys. 
Chem. B 2010, 114, 12406-12415.  
[165]  Leary, J. A.; Schenauer, M. R.; Stefanescu, R.; Andaya, A.; Ruotolo, B. T.; 
Robinson, C. V.; Thalassinos, K.; Scrivens, J. H.; Sokabe, M.; Hershey, J. W. B. 
Methodology for measuring conformation of solvent-disrupted protein subunits 
using T-WAVE ion mobility MS: an investigation into eukaryotic initiation 
factors. J. Am. Soc. Mass. Spectrom. 2009, 20, 1699-1706. 
[166]  Fenn, L. S.; Kliman, M.; Mahsut, A.; Zhao, S. R.; McLean, J. A. Characterizing 
ion mobility-mass spectrometry conformation space for the analysis of complex 
biological samples. Anal. Bioanal. Chem. 2009, 394, 235-244. 
[167]  Williams, J. P.; Lough, J. A.; Campuzano, I.; Richardson, K.; Sadler, P. J. Use of 
ion mobility mass spectrometry and a collision cross‐section algorithm to study an 
organometallic ruthenium anticancer complex and its adducts with a DNA 
oligonucleotide. Rapid Commun. Mass Spectrom. 2009, 23, 3563-3569. 
[168]  Shvartsburg, A. A.; Noskov, S. Y.; Purves, R. W.; Smith, R. D. Pendular proteins 
in gases and new avenues for characterization of macromolecules by ion mobility 
spectrometry. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 6495-6500. 
  
289 
                                                                                                                                                 
[169] Scarff, C. A.; Thalassinos, K.; Hilton, G. R.; Scrivens, J. H. Travelling wave ion 
mobility mass spectrometry studies of protein structure: biological significance 
and comparison with X‐ray crystallography and nuclear magnetic resonance 
spectroscopy measurements. Rapid Commun. Mass Spectrom. 2008, 22, 3297-
3304. 
[170]  Kim, H.; Kim, H. I.; Johnson, P. V.; Beegle, L. W.; Beauchamp, J. L.; Goddard, 
W. A.; Kanik, I. Experimental and Theoretical Investigation into the Correlation 
between Mass and Ion Mobility for Choline and Other Ammonium Cations in N2. 
Anal. Chem. 2008, 80, 1928-1936. 
[171]  Trimpin, S.; Plasencia, M.; Isailovic, D.; Clemmer, D. E. Resolving oligomers 
from fully grown polymers with IMS-MS. Anal. Chem. 2007, 79, 7965-7974. 
[172] Tao, L.; McLean, J. R.; McLean, J. A.; Russell, D. H. A collision cross-section 
database of singly-charged peptide ions. J. Am. Soc. Mass Spectrom. 2007, 18, 
1232-1238. 
[173]  Smith, D. P.; Giles, K.; Bateman, R. H.; Radford, S. E.; Ashcroft, A. E. 
Monitoring copopulated conformational states during protein folding events using 
electrospray ionization-ion mobility spectrometry-mass spectrometry. J. Am. Soc. 
Mass Spectrom. 2007, 18, 2180-2190. 
[174]  Colgrave, M. L.; Bramwell, C. J.; Creaser, C. S. Nanoelectrospray ion mobility 
spectrometry and ion trap mass spectrometry studies of the non-covalent 
complexes of amino acids and peptides with polyethers. Int. J. Mass Spectrom. 
2003, 229, 209-216. 
  
290 
                                                                                                                                                 
[175]  Hoaglund, C. S.; Valentine, S. J.; Sporleder, C. R.; Reilly, J. P.; Clemmer, D. E. 
Three-dimensional ion mobility/TOFMS analysis of electrosprayed biomolecules. 
Anal. Chem. 1998, 70, 2236-2242. 
[176]  von Helden, G.; Wyttenbach, T.; Bowers, M. T. Inclusion of a MALDI ion source 
in the ion chromatography technique: conformational information on polymer and 
biomolecular ions. Int. J. Mass Spectrom. Ion Processes 1995, 146/147, 349-364. 
[177]  Senko, S. W.; McLafferty, F. W. Mass spectrometry of macromolecules: has its 
time now come? Annu. Rev. Biophys. Biomol. Struct. 1994, 23, 763-785. 
[178]  Vidova, V.; P l, J.; Volny, M.; Novak, P.; Havlícek, V.; Wiedmer, S.K.; 
Holopainen, J.M. Visualizing spatial lipid distribution in porcine lens by MALDI 
imaging high-resolution mass spectrometry. J. Lipid Res. 2010, 51, 2295-2302. 
[179]  Tennessen, J.A.; Woodhams, D.C.; Chaurand, P.; Reinert, L.K.; Billheimer, D.; 
Shyr, Y.; Caprioli, R.M.; Blouin, M.S.; Rollins-Smith, L.A. Variations in the 
expressed antimicrobial peptide repertoire of northern leopard frog (< i> Rana 
pipiens</i>) populations suggest intraspecies differences in resistance to 
pathogens. Dev. Com. Immunol. 2009, 33, 1247-1257. 
[180]  Van Remoortere, A.; van Zeijl, R.J.M.; van den Oever, N.; Franck, J.; 
Longuespee, R.; Wisztorski, M.; Salzet, M. MALDI imaging and profiling MS of 
higher mass proteins from tissue. J. Am. Soc. Mass Spectrom. 2010, 21, 1922-
1929. 
[181]  Schwamborn, K.; Caprioli, R.M. Molecular imaging by mass spectrometry-
looking beyond classical histology. Nat. Rev. Cancer 2010, 10, 639-646. 
  
291 
                                                                                                                                                 
[182]  Rauser, S.; Marquardt, C.; Balluff, B.; Deininger, S.; Albers, C.; Belau, E.; 
Hartmer, R.; Suckau, D.; Specht, K.; Ebert, M.P.; Schmitt, M.; Aubele, M.; 
Hofler, H.; Walch, A. Classification of HER2 receptor status in breast cancer 
tissues by MALDI imaging mass spectrometry. J. Proteome Res. 2010, 9, 1854-
1863. 
[183]  Chandra, S.; Lorey, D.R. SIMS ion microscopy in cancer research: single cell 
isotopic imaging for chemical composition, cytotoxicity, and cell cycle regulation. 
Cell Mol. Biol. 2001, 47, 503-518. 
[184]  Chandra, S.; Lorey, D.R.; II; Smith, D.R. Quantitative subcellular secondary ion 
mass spectrometry (SIMS) imaging of boron-10 and boron-11 isotopes in the 
same cell delivered by two combined BNCT drugs: in vitro studies on human 
glioblastoma T98G cells. Radiat. Res. 2002, 157, 700-710. 
[185]  Sjovall, P.; Lausmaa, J.; Johansson, B. Mass spectrometric imaging of lipids in 
brain tissue. Anal.Chem. 2004, 76, 4271-4278. 
[186]  Touboul, D.; Kollmer, F.; Niehuis, E.; Brunelle, A.; Laprevote,O. Improvement of 
Biological Time-of-Flight-Secondary Ion Mass Spectrometry Imaging with a 
Bismuth  Cluster Ion Source J. Am. Soc. Mass Spectrom. 2005, 16, 1608-1618. 
[187]  Jones, E.A.; Lockyer, N.P.; Vickerman, J.C. Mass spectral analysis and imaging 
of tissue by ToF-SIMS—The role of buckminsterfullerene, C< sub> 60</sub>< 
sup>+</sup>, primary ions. Int. J. Mass Spectrom. 2007, 260, 146-157. 
  
292 
                                                                                                                                                 
[188]  Maarten Altelaar, A.F.; van Minnen, J.; Jim nez, C.R.; Heeren,R.M.A.; Piersma, 
S.R. Direct molecular imaging of Lymnaea stagnalis nervous tissue at subcellular 
spatial resolution by mass spectrometry.  Anal. Chem. 2005, 77, 735-741. 
[189]  McDonnel, L.; Piersma, S.R.; Maarten Altelaar, A.F.; Mize, T.H.; Luxembourg, 
S.L.; Verhaert, P.D.E.M.; van Minnen, J.; Heeren, R.M.A. Subcellular imaging 
mass spectrometry of brain tissue. J. Mass Spectrom. 2005, 40, 160-168. 
[190]  Altelaar, A.F.M.; Klinkert, I.; Jalink, K.; de Lange, R.P.J.; Adan, R.A.H.; Heeren, 
R.M.A.; Piersma, S.R. Gold-enhanced biomolecular surface imaging of cells and 
tissue by SIMS and MALDI mass spectrometry. Anal. Chem. 2006, 78, 734-742. 
[191]  Wiseman, J. M.; Puolitaival, S. M.; Takats, Z.; Cooks, R. G.; Caprioli, R. M. 
Mass spectrometric profiling of intact biological tissue by using 
desorption electrospray ionization. Angew. Chem., Int. Ed. 2005, 44, 7094-7097. 
[192]  Wiseman, J. M.; Ifa, D. R.; Song, Q.; Cooks, R. G. Tissue imaging at atmospheric 
pressure using desorption electrospray ionization (DESI) mass spectrometry. 
Angew. Chem. Int. Ed. 2006, 45, 7188-7192. 
[193]  Wiseman, J. M.; Ifa, D. R.; Zhuc, Y.; Kissingerc, C. B.; Manicke, N. E.; 
Kissingera, P. T.; Cooks, R. G. Desorption electrospray ionization mass 
spectrometry: Imaging drugs and metabolites in tissues. Proc. Natl. Acad. Sci. 
U.S.A. 2008, 105, 18120-18125. 
[194]  Lietz, C. B.; Richards, A. L.; Ren, Y.; Trimpin, S. Inlet ionization: protein 
analyses from the solid state without the use of a voltage or a laser producing up 
  
293 
                                                                                                                                                 
to 67 charges on the 66 kDa BSA protein. Rapid Commun. Mass Spectrom. 2011, 
25, 3453-3456. 
[195]  Richards, A. L.; Lietz, C. B.; Wager-Miller, J.; Mackie, K.; Trimpin, S. Imaging 
mass spectrometry in transmission geometry. Rapid Commun. Mass Spectrom. 
2011, 25, 815-820. 
[196]  Richards, A. L.; Lietz, C. B.; Wager-Miller, J.; Mackie, K.; Trimpin, S. 
Localization and imaging of gangliosides in mouse brain tissue sections by 
laserspray ionization inlet. J. Lipid Res. 2012, 53, 1390-1398. 
[197]  Frankevich, V.; Nieckarz, R.; Sagulenko, P.; Barylyuk, K.; Levitsky, L.; Agapov, 
A.; Perlova, T.; Gorshkov, M.; Tarasova, I.; Zenobi, R. Probing the mechanisms 
of ambient ionization by laser‐induced fluorescence spectroscopy. Rapid 
Commun. Mass Spectrom. 2012, 26, 1567-1572. 
[198]  Sidman, R. L.; Kosaras, B.; Misra, B. M.; Senft, S. L. High Resolution Mouse 
Brain Atlas, 1999. Website: http://www.hms. 
harvard.edu/research/brain/atlas.html (accessed June 9, 2012). 
[199]  Rosinke, B.; Strupat, K.; Hillenkamp, F.; Rosenbusch, J.; Dencher, N., Kruger, 
U.; Galla, H. J. Matrix-assisted laser desorption/ionization mass-spectrometry 
(MALDI-MS) of membrane-proteins and noncovalent complexes. J. Mass 
Spectrom. 1995, 30, 1462-1468. 
[200]  Bich, C.; Zenobi, R. Mass spectrometry of large complexes. Curr. Opin. Struct. 
Biol. 2009, 19, 632–639. 
  
294 
                                                                                                                                                 
[201]  Wei, J.; Buriak, J.; Siuzdak, G. Desorption-ionization mass spectrometry on 
porous silicon. Nature 1999, 399, 243-246. 
[202]  Karas, M.; Bahr, U.; Strupat, K.; Hillenkamp, F.; Tsarbopoulos, A.; Pramanik, B. 
N. Matrix dependence of metastable fragmentation of glycoproteins in MALDI-
TOF mass spectrometry. Anal. Chem. 1995, 667, 675-679. 
[203]  Nemes, P.; Vertes, A.  Laser ablation electrospray ionization for atmospheric 
pressure, in vivo, and imaging mass spectrometry. Anal. Chem. 2007, 79, 8098-
8106. 
[204]  Hopper, J. T. S.; Oldham, N. J. Collision induced unfolding of protein ions in the 
gas phase studied by ion mobility-mass spectrometry: the effect of ligand binding 
on conformational stability. J. Am. Soc. Mass Spectrom. 2009, 20, 1851-1858. 
[205]  Luxembourg, S. L.; McDonnell, L. A.; Duursma, M. C.; Guo, X. H.; Heeren, R. 
M. A. Effect of local matrix crystal variations in matrix-assisted ionization 
techniques for mass spectrometry. Anal. Chem. 2003, 75, 2333-2341. 
[206]  Tholey, A.; Heinzle, E. Ionic (liquid) matrices for matrix-assisted laser 
desorption/ionization mass spectrometry-applications and perspectives. Anal. 
Bioanal. Chem. 2006, 386, 24-37. 
[207]  Jaskolla, T. W.; Lehmann, W. D.; Karas, M. 4-Chloro-alpha-cyanocinnamic acid 
is an advanced, rationally designed MALDI matrix. Proc. Natl. Acad. Sci. U.S.A. 
2008, 105, 12200-12205. 
[208]  Tu, T.; Gross, M. L. Miniaturizing sample spots for matrix-assisted laser 
desorption/ionization mass spectrometry. Trends Anal. Chem. 2009, 28, 833-841. 
  
295 
                                                                                                                                                 
[209]  Kuprowski, M. C.; Boys, B. L.; Konermann, L. Analysis of protein mixtures by 
electrospray mass spectrometry: effects of conformation and desolvation behavior 
on the signal intensities of hemoglobin subunits. J. Am. Soc. Mass Spectrom. 
2007, 18, 1279-1285. 
[210]  Merchant, M.; Weinberger, S.R.  Recent advancements in surfaceenhanced laser 
desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000, 21, 
1164-1177. 
[211]  Sunner, J.; Dratz, E.; Chen, Y.C. Graphite surface-assisted laser 
desorption/ionization time-of-flight mass spectrometry of peptides and proteins 
from liquid solutions. Anal. Chem. 1995, 67, 4335-4342. 
[212]  Wei, J.; Buriak, J.M.; Siuzdak, G. Desorption-ionization mass spectrometry on 
porous silicon. Nature 1999, 399, 243-246. 
[213]  Hutchens, T.W.; Yip, T.T. New desorption strategies for the mass spectrometric 
analysis of macromolecules. Rapid Commun. Mass Spectrom. 1993, 7, 576-580. 
[214]  Gebhardt, C.R.; Tomsic, A.; Schruder, H.; Durr, M.; Kompa, K.L. Matrix-free 
formation of gas-phase biomolecular ions by soft clusterinduced desorption. 
Angew. Chem. Int. Ed. 2009, 48, 4162-4165. 
[215]  Yamada, I.; Matsou, J.; Toyoda, N.; Kirkpatrick, A. Materials processing by gas 
cluster ion beams. Mater. Sci. Eng. R 2001, 34, 231-295. 
[216]  Cheng, J.; Wucher, A.; Winograd, N. Molecular depth profiling with cluster ion 
beams. J. Phys. Chem. B 2006, 110, 8329-8336. 
  
296 
                                                                                                                                                 
[217]  Weibel, D.; Wong, S.; Lockyer, N.; Blenkinsopp, P.; Hill, R.; Vickerman, J.C. A 
C60 primary ion beam system for time of flight secondary ion mass spectrometry: 
Its development and secondary ion yield characteristics. Anal. Chem. 2003, 75, 
1754-1764. 
[218]  Page, J.S.; Tang,; Kelly, R.T.; Smith, R.D. Subambient pressure ionization with 
nanoelectrospray source and interface for improved sensitivity in mass 
spectrometry. Anal. Chem. 2008, 80, 1800-1805. 
[219]  Hakansson, K.; Zubarev, R.A.; Coorey, R.V.; Talrose, V.L.; Hakansson, P. 
Interaction between explosive and analyte layers in explosive matrix-assisted 
plasma desorption mass spectrometry. Rapid Commun. Mass Spectrom. 1999, 13, 
1169-1174. 
[220]  Zubarev, R.A.; Hakansson, P.; Sundqvist, N.; Talrose, V.L. Enhancement of the 
molecular ion yield in plasma desorption mass spectrometry using explosive 
matrices. Rapid Commun. Mass Spectrom. 1997, 11, 63-70. 
[221]  Pagnotti, V.S; Chubatyi, N.D.; McEwen, C.N. Solvent assisted inlet ionization: 
An ultrasensitive new liquid introduction ionization method for mass 
spectrometry. Anal. Chem. 2011, 83, 3981-3985. 
[222]  Wang, B.; Inutan, E.D.; Trimpin, S. A new approach to high sensitivity liquid 
chromatography-mass spectrometry of peptides using nanoflow solvent assisted 
inlet ionization. J. Am. Soc. Mass Spectrom. 2012, 23, 442-445. 
  
297 
                                                                                                                                                 
[223]  Wang, B.; Lietz, C.B.; Inutan, E.D.; Leach, S.; Trimpin, S. Producing highly 
charged ions without solvent using laserspray ionization: A total solvent-free 
analysis approach at atmospheric pressure. Anal. Chem. 2011, 83, 4076-4084. 
[224]  Saunders, C. Charge separation mechanisms in clouds. Space Sci. Rev. 2008, 137, 
335-353. 
[225]  Cheng, R.J. Water drop freezing: Ejection of microdroplets. Science 1970, 170, 
1395-1396. 
[226]  Zink, J.I. Triboluminescence. Accts. Chem. Res. 1978, 11, 289-295. 
[227]  Lin, S.H.; Wutz, D.; Ho, Z.Z. Eyring, H. Mechanism of triboluminescence. Proc. 
Natl. Acad. Sci. U.S.A. 1980, 77, 1245-1247. 
[228]  Zink, J.I.; Klimt, W. Triboluminescence of coumarin-fluorescence and dynamic 
spectral features excited by mechanical-stress. J. Am. Chem. Soc. 1974, 96, 4690-
4692. 
[229]  Sabbah, R.; Elwatik, K. Thermodynamic study of anthrone, coumarin, and 
phenazine. J. Thermal Anal. 1992, 38, 803-809. 
[230]  Smith, R.M. The mass spectrum of cocaine. J. Forensic Sci. 1997, 42, 475-480. 
[231]  Jagerdeo, E.; Abdel-Rehim, M. Screening of cocaine and its metabolites in human 
urine samples by direct analysis in real-time source coupled to time-of-flight mass 
spectrometry after online preconcentration utilizing microextraction by packed 
sorbent. J. Am. Soc. Mass Spectrom. 2009, 20, 891-899. 
  
298 
                                                                                                                                                 
[232]  McEwen, C.N.; McKay, R.G.; Larsen, B.S. Analysis of solids, liquids, and 
biological tissues using solids probe introduction at atmospheric pressure on 
commercial LC/MS instruments. Anal. Chem. 2005, 77, 7826-7831. 
[233]  Pieper, R.; Su.Q.; Gatlin C.L.; Huang, S.T.; Anderson, N.L.; Steiner, S. Multi-
component immunoaffinity subtraction chromatography: an innovative step 
towards a comprehensive survey of the human plasma proteome. Proteomics 
2003, 3, 422-432. 
[234]  Pieper, R.; Gatlin, C.L.; McGrath, A.M.; Makusky, A.J.; Mondal, M.; Seonarain, 
M.; Field, E.; Schatz, C.R.; Estock, M.A.; Ahmed, N.; Anderson, N.G.; Steiner, S. 
Characterization of the human urinary proteome: a method for high-resolution 
display of urinary proteins on two-dimensional electrophoresis gels with a yield 
of nearly 1400 distinct protein spots. Proteomics 2004, 4, 1159-1174. 
[235]  Wang, H.; Hanash, S. Multi-dimensional liquid phase based separations in 
proteomics. J. Chromatog. B 2003, 787, 11-18.  
[236]  Shushan, B. A review of clinical diagnostic applications of liquid 
chromatography–tandem mass spectrometry. Mass Spectrom. Rev. 2010, 29, 930-
944. 
[237]  Kasper, D.C.; Herman, J.; De Jesus, V.R.; Mechtler, T.P.; Metz, T.F.; Shushan, B. 
The application of multiplexed, multidimensional ultra-high-performance liquid 
chromatography/tandem mass spectrometry to the high-throughput screening of 
lysosomal storage disorders in newborn dried bloodspots. Rapid Commun. Mass 
Spectrom. 2010, 24, 986-994. 
  
299 
                                                                                                                                                 
[238]  Ang, C.S.; Rothacker, J.; Patsiouras, H.; Gibbs, P.; Burgess, A.W.; Nice, E.C. Use 
of multiple reaction monitoring for multiplex analysis of colorectal cancer-
associated proteins in human feces. Electrophoresis 2011, 32, 1926-1938. 
[239]  Zhang, X.; Fang, A.; Riley, C.P.; Wang, M.; Regnier, F.E.; Buck, C. Multi-
dimensional liquid chromatography in proteomics. Ana.l Chim. Acta 2010, 664, 
101-113. 
[240] Issaq, H.J. The role of separation science in proteomics research. Electrophoresis 
2001, 22, 3629-3638. 
[241]  Zhang, J.; Xu, X.; Gao, M.; Yang, P.; Zhang, X. Comparison of 2-D LC and 3-D 
LC with post-and pre-tryptic-digestion SEC fractionation for proteome analysis of 
normal human liver tissue. Proteomics 2007, 7, 500-512. 
[242]  Dixon, S.P.; Pitfield, I.D.; Perrett, D. Comprehensive multidimensional liquid 
chromatographic separation in biomedical and pharmaceutical analysis: a review. 
Biomedical Chromatog. 2006, 20, 508-529. 
[243]  Han, H.; Miyoshi, Y.; Ueno, K.; Okamura,  C.; Tojo, Y.; Mita, M.; Lindner, W.; 
Zaitsu, K.; Hamase, K. Simultaneous determination of daspartic acid and d-
glutamic acid in rat tissues and physiological fluids using a multi-loop two-
dimensional HPLC procedure. J. Chromatog. B 2011, 879, 3196-3202. 
[244]  Liu, W.; Liu, B.; Cai, Q.; Li, J.; Chen, X.; Zhu, Z. Proteomic identification of 
serum biomarkers for gastric cancer using multidimensional liquid 
chromatography and 2D differential gel electrophoresis. Clinica Chim. Acta 2012, 
413, 1098-1106.  
  
300 
                                                                                                                                                 
[245]  Zerefos, P.G.; Aivaliotis, M.; Baumann, M.; Vlahou, A. Analysis of the urine 
proteome via a combination of multidimensional approaches. Proteomics 2012, 
12, 391-400.  
[246]  Gray, T.R.; Shakleya, D.M.; Huestis, M.A. A liquid chromatography tandem 
mass spectrometry method for the simultaneous quantification of 20 drugs of 
abuse and metabolites in human meconium. Anal. Bioanal. Chem. 2009, 393, 
1977-1990. 
[247]  Isailovic, D.; Plasencia, M.D.; Gaye, M.M.; Stokes, S.T.; Kurulugama, R.T.; 
Pungpapong, V.; Zhang, M.; Kyselova ,Z.; Goldman, R.; Mechref, Y.; Novotny, 
M.V.; Clemmer, D.E. Delineating diseases by IMSMS profiling of serum N-
linked glycans. J. Proteome Res. 2012, 11, 576-585. 
[248]  Kanu, A.B.; Dwivedi, P.; Tam, M.; Matz, L.; Hill, H.H. Jr. Ion mobility-mass 
spectrometry. J Mass. Spectrom. 2008, 43, 1-22.  
[249]  Baumketner, A.; Bernstein, S.L.; Wyttenbach, T.; Bitan, G.; Teplow, D.B.; 
Bowers, M.T.; Shea, J.E. Amyloid beta-protein monomer structure: a 
computational and experimental study. Protein Sci. 2006, 15, 420-428. 
[250]  Wu, C.; Siems, W.F.; Klasmeier, J.; Hill, H.H. Separation of isomeric peptides 
using electrospray ionization/high-resolution ion mobility spectrometry. Anal. 
Chem. 2000, 72, 391–395. 
[251]  Ruotolo, B.T.; Verbeck, G.F.; Thomson, L.M.; Woods, A.S.; Gillig, K.J.; Russell, 
D.H. Distinguishing between phosphorylated and nonphosphorylated peptides 
with ion mobility−mass spectrometry. J. Proteome Res. 2002, 1, 303-306. 
  
301 
                                                                                                                                                 
[252]  Hoaglund, C.S.; Valentine, S.J.; Sporleder, C.R.; Reilly, J.P.; Clemmer, D.E. 
Three-dimensional ion mobility/TOFMS analysis of electrosprayed biomolecules. 
Anal. Chem. 1998, 70, 2236-2242. 
[253]  Thalassinos, K.; Slade, S.E.; Jennings, K.R.; Scrivens, J.H.; Giles, K.; Wildgoose, 
J.; Hoyes, J.; Bateman, R.H.; Bowers, M.T. Ion mobility mass spectrometry of 
proteins in a modified commercial mass spectrometer. Int. J. Mass Spectrom. 
2004, 236, 55-63. 
[254]  Ruotolo, B.T.; Giles, K.; Campuzano, I.; Sandercock, A.M.; Bateman, R.H.; 
Robinson, C.V. Evidence for macromolecular protein rings in the absence of bulk 
water. Science 2005, 310, 1658-1661. 
[255]  Bernstein, S.L.; Dupuis, N.F.; Lazo, N.D.; Wyttenbach, T.; Condron, M.M.; 
Bitan, G.; Teplow, D.B.; Shea, J.E.; Ruotolo, B.T.; Robinson, C.V.; Bowers, M.T. 
Amyloid-β protein oligomerization and the importance of tetramers and 
dodecamers in the aetiology of Alzheimer’s disease. Nat. Chem. 2009, 1, 326-
331. 
[256]  Benesch, J.L.; Ruotolo, B.T.; Simmons, D.A.; Robinson, C.V. Protein complexes 
in the gas phase: technology for structural genomics and proteomics. Chemical 
Rev.-Columbus 2007, 107, 3544-3567. 
[257]  Seo Y, Andaya A, Leary JA (2012) Preparation, separation, and conformational 
analysis of differentially sulfated heparin octasaccharide isomers using ion 
mobility mass spectrometry. Anal. Chem. 2012, 84, 2416-2423. 
  
302 
                                                                                                                                                 
[258]  Niñonuevo, M.R.; Leary, J.A. Ion mobility mass spectrometry coupled with rapid 
protein threading predictor structure prediction and collision-induced dissociation 
for probing chemokine conformation and stability. Anal. Chem. 2012, 84, 3208–
3214. 
[259]  Giles, K.; Williams, J.P.; Campuzano, I. Enhancements in travelling wave ion 
mobility resolution. Rapid Commun. Mass Spectrom. 2011, 25, 1559–1566. 
[260]  Li, H.; Giles, K.; Bendiak, B.; Kaplan, K.; Siems, W.F.; Hill, H.H. Jr. Resolving 
structural isomers of monosaccharide methyl glycosides using drift tube and 
traveling wave ion mobility mass spectrometry. Anal. Chem. 2012, 84, 3231-
3239. 
[261]  Chawner, R.; McCullough, B.; Giles, K.; Barran, P.E.; Gaskell, S.J.; Eyers, C.E. 
A QconCAT standard for calibration of ion mobility mass spectrometry systems. 
J. Proteome Res. 2012, 11, 5564-5572. 
[262]  Jungmann, J.H.; Heeren, R.M.A. Emerging technologies in mass spectrometry 
imaging. J. Proteomics 2012, 75, 5077-5092. 
[263]  Reid, G.E.; McLuckey, S.A. Top down protein characterization via tandem mass 
spectrometry. J Mass Spectrom. 2002, 37, 663-675. 
[264]  Moss, C.L.; Chamot-Rooke, J.; Nicol, E.; Brown, J.; Campuzano, I.; Richardson, 
K.; Williams, J.P.; Bush, M.F.; Bythell, B.; Paizs, B.; Turecek, F. Assigning 
structures to gas-phase peptide cations and cation-radicals. An infrared 
multiphoton dissociation, ion mobility, electron transfer, and computational study 
of a histidine peptide ion. The J. Phys. Chem. B 2012, 116, 3445-3456. 
  
303 
                                                                                                                                                 
[265]  Cody, R.B.; Laramee, J.A.; Durst, H.D. Versatile new ion source for the analysis 
of materials in open air under ambient conditions. Anal. Chem. 2005, 77, 2297-
2302. 
[266]  Shiea, J.; Huang, M.Z.; Hsu, H.J.; Lee, C.Y.; Yuan, C.H.; Beech, I.; Sunner, J. 
Electrospray-assisted laser desorption/ionization mass spectrometry for direct 
ambient analysis of solids. Rapid Commun. Mass Spectrom. 2005, 19, 3701–3704. 
[267]  Sampson, J.S.; Hawkridge, A.M.; Muddiman, D.C. Generation and detection of 
multiply-charged peptides and proteins by Matrix-Assisted Laser Desorption 
Electrospray Ionization (MALDESI) fourier transform ion cyclotron resonance 
mass spectrometry. J. Am. Soc. Mass Spectrom. 2006, 17, 712–1716. 
[268]  Pagnotti, V.S.; Inutan, E.D.; Marshall, D.D.; McEwen, C.N.; Trimpin, S. Inlet 
ionization: a new highly sensitive approach for liquid chromatography-mass 
spectrometry of small and large molecules. Anal. Chem. 2011, 83, 7591–7594. 
[269]  Chubatyi, N.D.; Pagnotti, V.S.; Bentzley, C.M.; McEwen, C.N. High sensitivity 
steroid analysis using liquid chromatography/solvent-assisted inlet ionization 
mass spectrometry. Rapid Commun. Mass Spectrom. 2012, 26, 887–892. 
[270]  Hoaglund-Hyzer, C.S.; Lee, Y.J.; Counterman, A.E.; Clemmer, D.E. Coupling ion 
mobility separations, collisional activation techniques, and multiple stages of MS 
for analysis of complex peptide mixtures. Anal. Chem. 2002, 74, 992-1006. 
[271]  Ferrige, A.G.; Seddon, M.J.; Green, B.N.; Jarvis, S.A.; Skilling, J.; Staunton, J. 
Disentangling electrospray spectra with maximum entropy. Rapid Commun. Mass 
Spectrom. 1992, 6, 707-711. 
  
304 
                                                                                                                                                 
[272]  Eibisch, M.; Zellmer, S.; Gebhardt, R.; Suss, R.; Fuchs, B.; Schiller, J.  
Phosphatidylcholine dimers can be easily misinterpreted as cardiolipins in 
complex lipid mixtures: a matrix-assisted laser desorption/ionization time-of-
flight mass spectrometric study of lipids from hepatocytes. Rapid Commun. Mass 
Spectrom. 2011, 25, 2619-2626. 
[273]  James, P.F.; Perugini, M.A.; O’Hair, R.A.J. Sources of artefacts in the 
electrospray ionization mass spectra of saturated diacylglycerophosphocholines: 
From condensed phase hydrolysis reactions through to gas phase intercluster 
reactions. J. Am. Soc. Mass Spectrom. 2006, 17, 384-394. 
[274]  Vestal, M.L.; Juhasz, P.; Martin, S.A. Delayed extraction MALDI TOF MS. 
Rapid Commun. Mass Spectrom. 1995, 9, 1044–1050. 
[275]  Shariatgorji, M.; Nilsson, A.; Goodwin Richard, J.A.; Svenningsson, P.; Schintu, 
N,, Banka, Z.; Kladni, L.; Hasko, T.; Szabo, A.; Andren, P.E. Deuterated matrix-
assisted laser desorption ionization matrix uncovers masked mass spectrometry 
imaging signals of small molecules. Anal. Chem. 2012, 84, 7152-7157. 
[276]  Sun, J.; Baker, A.; Chen, P. Profiling the indole alkaloids in yohimbe bark with 
ultra-performance liquid chromatography coupled with ion mobility quadrupole 
time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2011, 25, 
2591-2602. 
[277]  Plumb, R.S.; Johnson, K.A.; Rainville, P.; Smith, B.W.; Wilson, I.D.; Castro-
Perez, J.M.; Nicholson, J.K. UPLC/MSE; a new approach for generating 
  
305 
                                                                                                                                                 
molecular fragment information for biomarker structure elucidation. Rapid 
Commun. Mass Spectrom. 2006, 20, 1989–1994. 
[278]  Bateman, K.P.; Castro-Perez, J.; Wrona, M.; Shockcor, J.P.; Yu, K.; Oballa, R.; 
Nicoll-Griffith, D.A. MSE with mass defect filtering for in vitro and in vivo 
metabolite identification. Rapid Commun. Mass Spectrom. 2007, 21, 1485-1496. 
[279]  Ronci, M.; Bonanno, E.; Colantoni, A.; Pieroni, L.; Di Ilio, C.; Spagnoli, L.G.; 
Federici, G.; Urbani, A. Protein unlocking procedures of formalin-fixed paraffin-
embedded tissues: Application to MALDITOF Imaging MS investigations. 
Proteomics 2008, 8, 3702-3714. 
[280]  Cheng, F.Y.; Blackburn, K.; Lin, Y.M.; Goshe, M.B.; Williamson, J.D. Absolute 
protein quantification by LC/MSE for global analysis of salicylic acid-induced 
plant protein secretion responses. J. Proteome Res. 2009, 8, 82-93. 
[281]  Castro-Perez, J.M.; Kamphorst, J.; DeGroot, J.; Lafeber, F.; Goshawk, J.; Yu, K.; 
Shockcor, J.P.; Vreeken, R.J.; Hankemeier, T. Comprehensive LC− MSE 
lipidomic analysis using a shotgun approach and its application to biomarker 
detection and identification in osteoarthritis patients. J. Proteome Res. 2010, 9, 
2377-2389. 
[282]  Finamore, F.; Pieroni, L.; Ronci, M.; Marzano, V.; Mortera, S.L.; Romano, M.; 
Cortese, C.; Federici, G.; Urbani, A. Proteomics investigation of human platelets 
by shotgun nUPLC-MSE and 2DE experimental strategies: a comparative study. 
Blood Transfusion 2010, 8, S140-S148. 
  
306 
                                                                                                                                                 
[283]  Prasad, B.; Garg, A.; Takwani, H.; Singh, S. Metabolite identification by liquid 
chromatography-mass spectrometry. Trends Anal. Chem. 2011, 30, 360-387. 
[284]  Bijlsma, L.; Sancho, J.V.; Hernández, F.; Niessen, W. Fragmentation pathways of 
drugs of abuse and their metabolites based on QTOF MS/MS and MSE accurate-
mass spectra. J. Mass Spectrom. 2011, 46, 865-875. 
[285]  Martins-de-Souza, D.; Guest, P.C.; Guest, F.L.; Bauder, C.; Rahmoune, H.; 
Pietsch, S.; Roeber, S.; Kretzschmar, H.; Mann, D.; Baborie, A.; Bahn, S. 
Characterization of the human primary visual cortex and cerebellum proteomes 
using shotgun mass spectrometry-data-independent analyses. Proteomics 2012, 
12, 500-504. 
[286]  Cha, I.S.; Kwon, J.; Park, S.H.; Nho, S.W.; Jang, H.B.; Park, S.B.; del Castillo, 
C.S.; Hikima, J.; Aoki, T.; Jung, T.S. Kidney proteome responses in the teleost 
fish Paralichthys olivaceus indicate a putative immune response against 
Streptococcus parauberis. J. Proteomics 2012, 75, 5166-5175. 
[287]  Dong, W.; Wang, P.; Meng, X.; Sun, H.; Zhang, A.; Wang, W.; Dong, H.; Wang, 
X.J. Ultra-performance liquid chromatography–high definition mass spectrometry 
analysis of constituents in the root of radix stemonae and those absorbed in blood 
after oral administration of the extract of the crude drug. Phytochemical Anal. 
2012, 23, 657-667. 
[288]  Barbara, J.E.; Kazmi, F.; Muranjan, S.; Toren, P.C.; Parkinson, A. High-
resolution mass spectrometry elucidates metabonate (False Metabolite) formation 
  
307 
                                                                                                                                                 
from alkylamine drugs during in vitro metabolite profiling. Drug Metabolism 
Disposition 2012, 40, 1966-1975. 
[289]  Aluise, C.D.; Robinson, R.A.; Becket, T.L.; Murphy, M.P.; Cai, J.; Pierce, W.M.; 
Markesbery, W.R.; Butterfield, D.A. Preclinical Alzheimer disease: brain 
oxidative stress, Aβ peptide and proteomics. Neuro Disease 2010, 39, 221–228. 
[290]  Roher, A.E.; Lowenson, J.D.; Clarke, S.; Woods, A.S.; Cotter, R.J.; Gowing, E.; 
Ball, M.J. β-Amyloid-(142) is a major component of cerebrovascular amyloid 
deposits: implications for the pathology of Alzheimer disease. Proc. Nat’l. Acad. 
Sci. U. S. A. 1993, 90, 10836-10840. 
[291]  Pan, J.; Han, J.; Borchers, C.H.; Konermann, L. Conformerspecific hydrogen 
exchange analysis of a beta(1–42) oligomers by top-down electron capture 
dissociation mass spectrometry. Anal. Chem. 2011, 83, 5386-5393. 
[292]  Kraus, M.; Bienert, M.; Krause, E. Hydrogen exchange studies on Alzheimer’s 
amyloid-beta peptides by mass spectrometry using matrix-assisted laser 
desorption/ionization and electrospray ionization. Rapid Commun. Mass 
Spectrom. 2003, 17, 222-228. 
[293]  Ceuppens, R.; Dumont, D.; Van Brussel, L.; Van de Plas, B.; Daniels, R.; Noben, 
J.P.; Verhaert, P.; Van der Gucht, E.; Robben, J.; Clerens, S.; Arckens, L. Direct 
profiling of myelinated and demyelinated regions in mouse brain by imaging 
mass spectrometry. Int. J. Mass Spectrom. 2007, 260, 185-194. 
[294] Weinmann, W.; Müller, C.; Vogt, S.; Frei, A. LC-MS-MS analysis of the 
neuroleptics clozapine, flupentixol, haloperidol, penfluridol, thioridazine, and 
  
308 
                                                                                                                                                 
zuclopenthixol in hair obtained from psychiatric patients. J. Anal. Toxic 2002, 26, 
303-307. 
[295] Bao, D.; Truong, T.T.; Renick, P.J.; Pulse, M.E.; Weiss, W.J. Simultaneous 
determination of rifampicin and levofloxacin concentrations in catheter segments 
from a mouse model of a device-related infection by liquid 
chromatography/electrospray ionization tandem mass spectrometry. J. Pharma. 
Biomed. Anal. 2008, 46, 723-727. 
[296] Wichitnithad, W.; McManus, T.J.; Callery, P.S. Identification of isobaric product 
ions in electrospray ionization mass spectra of fentanyl using multistage mass 
spectrometry and deuterium labeling. Rapid. Commun. Mass Spectrom. 2010, 24, 
2547-2553. 
[297] Weinmann, W.; Müller, C.; Vogt, S.; Frei, A. LC-MS-MS analysis of the 
neuroleptics clozapine, flupentixol, haloperidol, penfluridol, thioridazine, and 
zuclopenthixol in hair obtained from psychiatric patients. J. Anal. Toxic 2002, 26, 
303-307.  
[298] Smith, R.M.  The Mass Spectrum of Cocaine.  J. Forensic Sci. 1997, 42, 475-480. 
[299] Wood, M.; Laloup, M.; Ramirez;F.M.M.; Jenkins, K.M.; Young, M.S.; 
Ramaekers, J.G.; De Boeck, G.; Samyn, N. Quantitative analysis of multiple illicit 
drugs in preserved oral fluid by solid-phase extraction and liquid 
chromatography-tandem mass spectrometry. Forensic Sci. Int. 2005, 150, 227-
228. 
 
309 
 
ABSTRACT 
DEVELOPMENT OF MATRIX ASSISTED IONIZATION METHODS 
FOR CHARACTERIZATION OF SOLUBLE AND INSOLUBLE 
PROTEINS FROM NATIVE ENVIRONMENTS BY MASS 
SPECTROMETRY 
by 
ELLEN DELA VICTORIA INUTAN 
August 2013 
Advisor: Prof. Sarah Trimpin 
Major:  Chemistry (Analytical) 
Degree: Doctor of Philosophy 
Matrix-assisted laser/desorption ionization (MALDI) and electrospray ionization 
(ESI) have made a huge impact in the analysis of biological materials. ESI has gained its 
popularity involving liquid based analysis, efficient fragmentation, chromatographic and 
electrophoretic separations but has a limitation for solubility restricted materials and 
surface analysis. MALDI is applicable to large biomolecule analysis and for surface 
methods useful for tissue imaging but is limited for structural characterization due to poor 
fragmentation and is ill suited for liquid based separation methods. The research 
presented here relates to new ionization methods that encompass the benefits of ESI and 
MALDI. These novel ionization methods produce multiply charged ions similar to ESI 
but directly from surfaces similar to MALDI. The formation of multiply charged ion 
extends the mass range of high performance mass spectrometers with advanced features 
310 
 
for structural characterization such as ultra-high mass resolution and mass accuracy, and 
electron transfer dissociation. The surface method approach enables the detection, 
characterization, and identification of compounds directly from native environments such 
as tissue. The use of gas phase ion mobility separation reduces spectral complexity and 
improves the dynamic range of the experiment. Among the three novel ionization 
methods presented, MAIV has the potential to analyze fragile molecules and protein 
complexes, and is applicable for both atmospheric pressure and vacuum conditions. The 
laser-based method, LSII has the potential to improve the spatial resolution for tissue 
imaging and LSIV to enhance sensitivity.  
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